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atm   atmosphere 
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1  Introduction 
1.1  Phosphines in Organometallic Chemistry and Catalysis 
Phosphines are the most widely used ligands in organometallic chemistry; hundreds of mono-, 
di-, or tridentate phosphines with various backbones and coordinating abilities have been 
devised and prepared for specific applications in homogeneous catalysis.
[1-2]
 Perhaps the most 
popular phosphine ligand used is triphenylphosphine, a shelf-stable solid that undergoes 
oxidation in air relatively slowly. Moreover, phosphines are able to coordinate metals in 
multiple oxidation states
[3]
 and, unlike most metal amine complexes, metal phosphine 
complexes tend to be lipophilic, displaying good solubility in organic solvents. These two 
features make metal phosphine complexes really useful in homogeneous catalysis. Prominent 
examples of metal phosphine complexes include Wilkinson's catalyst (Rh(PPh3)3Cl), Grubbs' 
catalyst, and tetrakis(triphenylphosphine)palladium(0) (Scheme 1). 
 
Scheme 1. Examples of phosphine metal complexes with application in catalysis. 
1.2  Introduction of Charge (Cationic Phosphines) 
Homogeneous catalysts offer a number of important advantages over their heterogeneous 
counterparts. For example, all catalytic sites are accessible because the catalyst is usually a 
dissolved metal complex. Furthermore, it is often easier to tune the chemoselectivity, 
regioselectivity, and/or enantioselectivity by modification of the ancillary ligands.
[4]
 Despite 
of these advantages, heterogeneous catalytic systems are preferred in industry due to one 
major disadvantage of homogeneous ones: the difficulty to separate the reaction products 
from the catalysts and solvents. Distillation, which would be the most efficient process to 
conduct this separation, often requires elevated temperatures, at which most homogeneous 
catalysts decompose. Other conventional separation processes, for example, chromatography 
or extraction lead to catalyst loss and are typically time-consuming and expensive, since the 
use and recycling of big amounts of solvents are required.
[5-6]
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In order to deal with this kind of problems, chemists have devoted efforts to modify the 
substituent on the ligands, thus providing catalysts with appropriate physical properties that 
allow their easy separation from the reaction mixture. One of these strategies consists of the 
attachment of polar groups or charges to the ligands, aiming to increase the solubility of the 
resulting catalyst in polar solvents.
[7-8]
 Several industrial processes already benefit from this 
strategy; an illustrative example is the Ruhrchemie/Rhône-Poulenc process for the Rh-
catalyzed hydroformylation of propene by the use of the highly water-soluble trisulfonated 
phosphine 4. After the reaction is completed, the effective separation and recovery of noble 
metal containing catalysts can be achieved by a simple phase separation. Subsequently, the 
recovered catalyst can be directly used for the next cycle.
[9]
 
 
Scheme 2. Examples of ionic phosphines with application in catalysis. 
Another interesting application regarding charged phosphines is the in situ analysis of 
reaction intermediates and catalytic species by electrospray ionization mass spectrometry.
[10]
 
ESI-MS was developed in the late 1980s by Fenn and co-workers
[11]
  and exploded in 
popularity in the 1990s due to its ability to analyze thermally fragile or highly polar 
(bio)molecules.
[12]
 The fundamental ability of this technique to transfer ions from solution to 
the gas phase with little or no fragmentation enables the direct study of complex mixtures. In 
combination with the standard advantages of mass spectrometry, the use of cationic ancillary 
ligands has led to the rise of the employment of ESI-MS in the investigation of catalytic 
mechanisms.
[13-19]
 For example, a cationic version of Grubbs’ first-generation catalyst 6 has 
been imaginatively exploited by Chen and co-workers, who used it to explore the reactivity of 
a olefin metathesis catalyst in the gas phase using ESI-MS (Scheme 2).
[20-22]
 Finally, Ooi and 
his coworkers recently developed an achiral cationic ammonium–phosphine hybrid ligand 
which was paired with a chiral binaphtholate anion. This ion-paired chiral ligand 7 is able to 
impart a remarkable stereocontrolling ability and catalyzes a highly enantioselective allylic 
alkylation of 𝛼-nitrocarboxylates (Scheme 3).[23]  
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Scheme 3. Ion-paired chiral ligands applied in asymmetric catalysis. 
The above examples demonstrate that remote cationic (or ionic) functional groups have 
dramatic influences on the physical properties of phosphine ligands, which results in 
interesting applications. It is worth to remind that this kind of modification normally does not 
significantly alter the coordination properties of the phosphorus center provided that a long 
distance between the positive charge and the phosphorus atoms exist.  
1.3  𝛼-Cationic Phosphines 
The well-established ligand toolbox, containing different types of phosphines ranging from 
electron-rich to electron-poor ones, provides a very powerful manifold to tune the primary 
reactivity of a metal catalyst. When a catalytic cycle demands very strong donation to the 
metal, trialkylphosphines are one of the most appropriate ancillary ligands; on the other hand, 
if moderate 𝜋-acceptor properties are necessary, phosphites are the ligands of choice.[24] 
However, in some cases the catalytic process demands auxiliary ligands with even stronger 𝜋-
acceptor properties than phosphites. Then, only few polyhalogenated phosphines, such PF3, 
PCl3 or P(CF3)3, are available. However, due to their difficult handling (flammable and toxic 
gases) and their moisture and oxygen sensitivity, their coordination chemistry is basically 
unexplored.
[25-26]
 It is in these situations that more stable and easy to use 𝜋-acceptor 
phosphines are required. The synthesis of ligands of this type by attachment of a positively 
charged group directly to the P-atom is one of the objectives of this thesis.
[27]
 
1.3.1 Definition and Scope 
By definition, all 𝛼-cationic phosphines contain positive charged groups that are directly 
attached to the phosphorus atom. Due to their cationic nature and close position of the 
positive charge to phosphorus, ligands containing such moieties display not only different 
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solubility in organic solvents but also very different coordination properties. It can be 
anticipated that the presence of positive charges will simultaneously decrease the σ-donor and 
increase the 𝜋-acceptor abilities of the phosphines; therefore, dramatically influencing the 
electronic properties of the metal fragment to which they are attached.
[24, 27]
  
Most 𝛼-cationic phosphines known to date have been prepared by reaction of 
chlorophosphines with an appropriate amount of a Lewis base. This process is normally 
promoted by halide sequestering reagents and can be seen as a formal abstraction of the halide 
to generate a transient phosphenium cation, which is then immediately trapped by the base. A 
complementary synthetic pathway involves the nucleophilic attack of secondary phosphines 
or TMS-substituted ones to chloro-onium salts. Both strategies satisfactorily afford α-cationic 
phosphines by either use of carbon based nucleophiles (carbenes) or nitrogen based ones 
(amines) as shown in Scheme 4.
[24]
 
 
Scheme 4. Synthetic pathways to α-cationic phosphines with different substituents. 
1.3.2 Synthetic Approaches to Monocationic Phosphines 
1.3.2.1 Imidazolium-Substituted Cationic Phosphines 
The majority of α-cationic phosphines known are imidazophosphines, which were first briefly 
mentioned by Zoller in 1988,
[28]
 and completely characterized by Kuhn et al. ten years 
later.
[29]
 He described the preparation of imidazophosphine 8a in good yield by reaction of the 
corresponding carbene, imidazol-2-ylidene, with Ph2PCl. Following this procedure, Chauvin 
et al. synthesized the imidazophosphines 8b and 8c bearing additional electron-withdrawing 
substituents, such as alkoxy groups (Scheme 5a).
[30]
 To avoid the use of free carbenes, which 
are sensitive to oxygen and moisture, Andrieu et al. described a new synthetic method 
consisting on the reaction of imidazolium-2-carboxylates with chlorophosphines. Under the 
reaction conditions applied, the free carbene, obtained by release of CO2, reacted with R2PCl 
to afford the desired compounds. Using this method, they could prepare a library of 
imidazolium phosphines 8d-8f (Scheme 5b).
[31]
 In the case of 8e, the molecular structure was 
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analyzed by X-ray diffraction analysis. This showed that the lone pair of electrons on the 
phosphorus atom is not delocalized along the imidazolium fragment and thus, remains 
available for metal coordination.
[31]
 
 
Scheme 5. Alternative routes to imidazolium-substituted cationic phosphines. 
Weigand et al. recently reported an alternative synthesis of cationic phosphines using silyl 
protected carbenes [NHC-SiMe3][TfO] instead of free ones (Scheme 6). Subsequent 
substitution of the Cl moieties on phosphorus provides access to cationic cyano- and azido-
substituted derivatives 10a and 10b.
[32]
 Interestingly, if free NHCs instead of [NHC-
SiMe3][TfO] are used for the same reaction, either adducts of the type NHC-PCl3 11
[33]
 or 
products coming from the reduction of the central phosphorus such as cation 12
[34]
 were 
obtained. 
 
Scheme 6. Alternative routes to imidazolium-substituted cationic phosphines. 
Finally, a completely different method to prepare cationic imidazolium phosphines consists 
on the selective N-alkylation of neutral imidazophosphine precursors.
[35]
 This strategy was 
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recently applied for the preparation of phosphine-imidazophosphines 14 (Scheme 7a)
[36-37]
 
and bis(imidazophosphine) 16, through a double methylation strategy (Scheme 7b).
[38]
 With 
the correct selection of the methylating reagent, in this case MeOTf, this synthetic route could 
be used to alkylate the N-atom even if the phosphine moiety is already present on the ligand 
structure.
[39]
  
  
Scheme 7. Alternative routes to imidazolium-substituted cationic phosphines. 
1.3.2.2 Cyclopropenium-Substituted Cationic Phosphines. 
The preparation of cyclopropenylidene stabilized cationic phosphines 18a-g was achieved in 
good to excellent yields by condensation of the readily available chlorocyclopropenium salt 
17a with a range of secondary phosphines and subsequent anion exchange, if necessary.
[40]
 
This synthetic strategy allowed the preparation of the desired salts on a multigram scale as 
white, air-stable solids. It has been observed that these compounds exhibit attributes similar to 
classical phosphites (Scheme 8).
[41]
 
 
Scheme 8. Synthesis of cyclopropenium-substituted cationic phosphines 18a-f. 
The π-acceptor properties of this type of cationic phosphines can be further increased by 
introduction of additional electron withdrawing groups in their structure. For example, ligand 
20, containing two very electron-withdrawing 3,5-bis-(trifluoromethyl)phenyl substituents 
was much stronger π-acceptor character (Scheme 9). However, none of the synthetic 
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procedures described above worked in this particular case due to the low nucleophilicity of 
bis(trifluoromethyl)phenyl phosphine. Hence, the secondary phosphine had to be first treated 
with 
n
BuLi to form a phosphide, which was reacted with 17a to afford the desired ligand 20 
albeit in moderate yield.
[42]
 
 
Scheme 9. Alternative routes to cyclopropenylylidene-stabilized cation 20. 
1.3.2.3 Pyridinium-Substituted Cationic Phosphines. 
In addition, our group has also reported the preparation of N-alkyl/aryl pyridiniophosphines 
21a-h by condensation of 2-chloropyridinium salts with a range of secondary phosphines. 
Pyridinium substituted phosphines 21a-h are envisioned as potentially very useful family of 
strong π-acceptor ligands owing to their much lower lying LUMO than those of 
cyclopropenium and imidazolium containing phosphines.
[24]
 Moreover, an increased solubility 
in organic solvents as well as very strong π-acceptor  properties could be accessible by 
carefully selection of the two R groups at phosphorus or by introduction of substituents on the 
pyridinium ring (Scheme 10).
[43]
 Compared with polycationic phosphines, which show low 
tendency to form metal complexes, these monocationic ligands are able to coordinate a range 
of metals, due to the decreased Coulombic repulsive interaction. 
 
Scheme 10. Synthesis of pyridinium-substituted phosphines. 
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1.3.2.4 Nitrogen-Substituted Cationic Phosphines. 
Pyridines, guanidines and amines have also been used to effect halide displacement from 
halophosphines. An example is the synthesis of 23 from Ph2PCl and  DMAP complex 23 
(Scheme 11a).
[44]
 Another representative one for this reactivity is the intramolecular halide 
displacement by a tertiary amine 24 with the aid of AlCl3 to produce a series of cationic 
phosphines 25a-d (Scheme 11b).
[45]
  
 
Scheme 11. Halide displacement from halophosphines by amines to form cationic phosphines. 
1.3.3 Synthetic Approaches to Polycationic Phosphines. 
Monocationic phosphines are relatively common and can be prepared via the reaction of 
strong N-, P-, or C-based Lewis bases with dialkyl- or diaryl-chlorophosphines.
[31, 46-49]
  
Dicationic, and specifically tricationic phosphines of the general formula [L3P]
3+
 are much 
more scarce.
[48]
 In 1991, Weiss et al. reported the syntheses of di- and tri-cations 26, 27 and 
28 by reaction of PCl3 with DMAP or DBN.
[50]
 Similar reactions for the synthesis of 29 were 
subsequently reported by Bertrand and coworkers in 1994 (Scheme 12a).
[51]
 It should be 
pointed out that only spectroscopic evidence has been reported for these compounds. Later in 
2010, Lammertsma and coworkers reported a trication 30 by reaction of PCl3 and 3,5-
dimethyl-1-trimethylsilylpyrazole in the presence of TMSOTf (Scheme 12b). In this 
compound the positive charges are evenly distributed over two phosphorus centers. Although 
30 was extremely moisture-sensitive, it appeared to be indefinitely stable at ambient 
temperature in a dry inert atmosphere and have also been characterized in the solid state.
[52]
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Scheme 12. Halide displacement from chlorophosphines by amines to form cationic phosphines. 
In 2011, our group described for the first time the isolation and structural characterization of 
the elusive [(carbene)3P]
3+
 species 31 (carbene = cyclopropenylydene) by use of an alternative 
synthetic approach, based on the use of an unprecedented “reverse electron demand” onio-
substituent transfer strategy. Instead of using silylated bases and PCl3 as starting materials, the 
alternative conceivable reaction partners, silyl-substituted phosphines and 
chlorocyclopropenium salts were used in this transformation. 1-Chlorocyclopropenium 
cations were the key precursors for this synthesis instead of the more common 
chloroimidazolium salts mainly due to the following beneficial factors: (a) an enhanced 
tendency to undergo nucleophilic attack at the chlorinated carbon;
[53]
 (b) the smaller steric 
hindrance derived from a carbene embedded in a three membered ring that facilitates the 
coordination of several of these ligands to the same central atom;
[54-57]
 (c) the stronger σ-
donor and weaker π-acceptor properties of cyclopropenylidenes as compared with NHCs. 
Note that the net donation from the carbene ligand must compensate for the continuous 
increase of formal positive charge on the phosphorus atom in order to allow the consecutive 
nucleophilic substitution process to take place.
[40, 58-59]
 Thus, by gentle heating of a mixture of 
1-chloro-2,3-bis(dialkylamino)cyclopropenium salts with P(SiMe3)3, the desired P(III)-
centered trications 31 were isolated as white or light orange solids in moderate to good yields 
(Scheme 13a). Dication 32 could also be prepared by a two-step sequence. First, condensation 
of the readily available chlorocyclopropenium tetrafluoroborate 17a with PhPH2 in refluxing 
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THF afforded monocationic salt in 76% yield. Deprotonation of this salt with KHDMS at       
-30 °C and in situ trapping of the phosphalkene intermediate with a second equivalent of 17a, 
finally yielded 32 as an air and water stable white solid. Consistent with the X-ray data, 
density functional calculations indicate that these compounds, despite their high positive 
charge, still feature a nonbonding electron pair on the P-atom (HOMO) and a very low-lying 
LUMO, depicting them as poor σ-donors and excellent π-acceptors.[60] In 2015, Weigand et 
al. reported the synthesis of dication 33 and trication 34 by a similar strategy. In contrast to 
31, trication 34 is not able to coordinate metal fragments (Scheme 13b).
[61]
  
 
Scheme 13. Synthesis of [L3P]
3+
 cations. 
Finally, it worth to mention that the preparation of bisimidazolium salts 37 has been reported 
by Chauvin group using a double methylation of 35 with MeOTf.
[62-63]
 Alternatively, the 
addition of two equivalents of MeOTf to 1,2-di(N-imidazolyl)benzene afforded the dicationic 
salt 38 in 88% yield. Subsequent addition of one equivalent of dichloro(ethyl)phosphite in the 
presence of Et3N (2 equiv.) afforded diamidiniophosphinite 39 in 32% yield, which is 
expected to be a really electron poor ligand (Scheme 14).
[30]
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Scheme 14. Alternative routes to imidazolium-substituted polycationic phosphines. 
1.3.4   Electronic Properties of α-Cationic Phosphines 
In phosphines the non-shared electron pair at phosphorus accounts for their σ-donor ability, 
while the σ*(P-C) orbitals are responsible for the π-acceptor properties. A formal increment 
of the electronegativity of one of the R groups on phosphorus is expected to lower the energy 
of all the molecular orbitals of the resulting phosphine. As a consequence, the resulting 
phosphine must behave as a poorer σ-donor, but also as a better π-acceptor ligand (Figure 1a). 
Regarding α-cationic ligands, the positive charges directly connected to the phosphorus atom 
can be considered as very strong electron withdrawing substituent and for this reason, 
decreased σ-donation and increased π-accepting properties on the resulting phosphines are 
expected (Figure 1b). Moreover, most positively charged substituents are aromatic rings 
containing empty low lying π* orbitals, which are able to overlap with those of the phosphine 
that have adequate symmetry as is the case of the P electron pair. This also withdraws electron 
density from the phosphorus.
[24]
 
 
Figure 1. Molecular structure diagram for the explanation of electronic properties of α-cationic ligands. 
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The electronic properties of phosphine ligands were evaluated by Tolman by measuring the 
carbonyl stretching frequency ῦ(CO) of the nickel complexes [Ni(CO)3L] (L= monodentate 
phosphine ligand).
[64-65]
 This frequency depends on the combination of σ-donating and π-
accepting character of L with respect to the metal center. Electron density donated by L to the 
metal enhances back donation from the metal center into the LUMO orbital of the CO ligand, 
which is the antibonding π*(CO) orbital, leading to a decrease of ῦ(CO). Strong donation from 
the phosphine thus corresponds to a lower carbonyl stretching frequency. Compared with 
Ph3P and (PhO)3P, the complexes containing cationic ligands 8d-f result in ῦ(CO) similar to 
those of phosphites (Table 1).
[31]
 
Table 1: Carbonyl stretching frequencies in RhCl(CO)(L)2 complexes in the solid state. 
 
[a] Values in cm
-1 
To avoid the use of highly toxic Ni(CO)4, a range of other metal complexes, for example 
trans-[RhCl(CO)L2], have also been investigated as model to evaluate donor properties of 
ancillary ligands (Table 2). In general, analogous trends are observed;
[66]
  however, we have 
detected some contradictions. 
Firstly, the donor ability of the cyclopropenium substituted phosphines slightly surpasses that 
of Ph3P (entries 2-6 and 16) when compared on this scale. Moreover, introduction of two -CF3 
group on the ligand structure should weaken its donor properties; however, 20 seems to be 
better donor than (MeO)3P according to the recorded ῦ(CO) data (entries 7 and 17). 
Additional not matching results have also been found in the pyridinium family of ligands, 
when the donor properties were evaluated by analysis of the CO stretching frequencies in 
trans-[RhCl(CO)L2] complexes (Table 2, entries 9-14). For example, ligand 21h that bears 
five CF3 groups should be weaker electron donor than 21e that shares the same skeleton but 
carries only one -CF3 substituent (Table 2, entries 11 and 14). According to the CO stretching 
frequencies (21e: 2004 cm
-1
 vs 21h: 2001 cm
-1
), the trends seem to be the opposite.
[43]
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An explanation for this incongruence may come from the structure of the Rh complexes. For 
ῦ(CO) analysis, the cis-located CO ligand may not be only sensitive to electronic effects, but 
also reflect geometrical distortions around the metal center owing to steric hindrance or 
through-space interactions between the CO and the other ligands. These distortions influence 
the overlap of the related CO orbitals and therefore, they decrease the wave number measured 
by IR spectroscopy. In fact, some structural distortions from the ideal square planar structure 
could be observed in the solid state of related rhodium carbonyl complexes.
[67-69]
  
An alternative experimental technique to rank the donor properties of phosphines is the 
determination of their oxidation potentials Ep (ox) by cyclic voltammetry.
[70-72]
 Electron-rich 
phosphines are easier to oxidize than electron-deficient ones and, as a consequence, the 
former should exhibit lower oxidation potentials than the latter if the orbital containing the 
electron pair is of similar shape, which is normally the case. This classification, although used 
to a lesser extent than the Tolman scale, has several intrinsic advantages; namely, it does not 
require the preparation of any metal-carbonyl complex to carry out the measurements and 
therefore it is also formally independent of steric factors.
[24]
 
Hence, the oxidation potential Ep (ox) of all these compounds were determined by cyclic 
voltammetry.
[73-74]
  These data follow the expected tendency and suggest that ligands 18a, 18f 
and 18g were donor abilities similar to that of (MeO)3P, while 20, 31 and 32 are even weaker 
donors than phosphites. This new ranking is in complete agreement with experiments on the 
catalytic activity of Au or Pt complexes bearing these ligands. 
In addition, a quite complete Tolman stereoelectronic map has recently been reported by our 
group,
[24]
 combining experimental TEPs together with calculated ones employing Gusev’s 
method for both cationic and neutral phosphines (Figure 2).
[75]
 It demonstrates that the overall 
donor ability of cationic phosphines 8a, 18 and 32 are similar or slightly weaker than those 
depicted by typical phosphites. Therefore, they might be used as interesting phosphite 
surrogates in catalytic transformations. Even more interesting is the TEP estimated for 31 
(2111 cm
-1
). This value reveals that 31 can be ranked as weaker donors than any phosphite 
ligand; only the highly reactive PF3 and P(CF3)3 were similar electronic properties. However, 
in sharp contrast to these polyfluorinated phosphines, 31 is easy to handle, air-stable solid. It 
is of note that the predicted donor endowment of bisimidazolium-substituted phosphines 39 is 
characterized by a calculated TEP of 2115 cm
-1
 and, hence, it is expected to be the weakest 
donor along the complete series. Unfortunately, no metal complex bearing this ancillary 
ligand has been prepared to date.
[24, 30]
 The lack of electron density at the phosphorus atom 
probably inhibits its coordination chemistry.  
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Table 2: Carbonyl stretching frequencies in RhCl(CO)L2 complexes in the solid state and electrochemical redox 
potential of the ligands. The values of commonly used phosphorus ligands are also included for comparison. 
 
[a] Values in cm
-1
. [b] Oxidation peak potentials reported in V. Calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
 (E1/2 =0.24 V), 
Bu4NPF6 (0.1 M) in CH2Cl2. [c] Not determined.  
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Figure 2. Tolman stereolectronic map for neutral and cationic phosphines. 
1.3.5 Applications of Cationic Phosphine Ligands. 
Pioneering research in the area of α-cationic phosphines was focused on the synthesis of 
phosphite mimics with high solubility in ionic liquids. The derived catalysts could benefit 
from the recycling opportunities provided by these ligands. For example, Knochel et al. 
reported that in the presence of the cationic phosphine 8g, the use of an ionic liquid/toluene 
biphasic solvent system allows for fast palladium catalyzed cross coupling reaction between 
organozinc reagents and aryliodides (Scheme 15). The work-up of these reactions is 
remarkably simple, since the ionic liquid phase containing the palladium catalyst is separated 
by decantation from the toluene phase. Attempts to reuse the palladium catalytic system show 
that after the third cycle, a significant decrease in yield is observed (20% lower yield and 
triple reaction time).
[76]
 
 
Scheme 15. The application of cationic ligands in Negishi coupling. 
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Andrew and coworkers have investigated the catalytic activity of a related ligand 8h, which 
also exhibited very strong π-accepting character, in two transformation, both in an ionic liquid 
phase (Scheme 16a and 16b). In the first of these two reactions, it was observed that the 
increase of the π-acceptor character in ligand 8h was beneficial for the alkynylation reaction 
of aryl bromides with phenylacetylene. The catalytic activity decreased after catalyst 
recycling due to the sensitivity of ligands to protonation in the ionic phase. Moreover, the 
accumulation of a large excess of acidic pyrrolidinium bromide might promote the C-P bond 
cleavage through the protonation of the carbenic 1,3-dimethylimidazol-2-ylidene moiety of 
the ligand at the relatively high temperatures employed. Multiple recycling of the catalyst in 
non-acidic media could be achieved for the platinum-catalyzed hydrogenation reaction of    
m-chloronitrobenzene to the corresponding aniline. The selectivity of the reaction is also 
improved by decreasing the undesirable formation of dehalogenation products. The system 
was recycled six times without noticeable metal leaching in the organic phase, and no loss of 
activity.
[77]
 
 
Scheme 16. The application of cationic ligands in alkynylation and hydrogenation. 
Another transformation where imidazolium phosphines have found application is the 
hydroformylation of alkenes (Scheme 17). Stelzer and coworkers have reported the synthesis 
of two cationic ligands 8i and 51, both of which have been tested in the hydroformylation of 
1-octene in the ionic liquid [BMIM][PF6]. In these experiments, the active catalyst was 
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prepared in situ by mixing Rh(CO)2(acac) with two equivalents of the ligand in the ionic 
liquid [BMIM][PF6]. The reaction was carried out at 100 °C and 30 bar synthesis gas pressure 
(CO: H2 = 1:1) for 1 h. The biphasic hydroformylation of 1-octene under these conditions 
showed significantly higher turnover frequency (TOF) values with ligand 8i (TOF 552, 
linear/branched ratio = 1.1), in which the positive charge is near to the P-atom. Thus, these 
data demonstrated that the increased π-acceptor character of α-cationic phosphines make the 
catalyst superior in this transformation
[78]
 In addition, it should be noted that in both cases no 
significant leaching of the Rh catalyst into the almost colorless organic layer was observed.
[79]
 
 
Scheme 17. The application of cationic ligands in hydroformylation. 
As already shown in Table 2, most cationic ligands are more electron-poor than neutral 
phosphines and many even surpass phosphites in this regard. Even more intriguing than just 
preparing phosphite surrogates is to utilize their strong π-accepting properites as ancillary 
ligands in transition-metal catalysis. These phosphines withdraw electron density from the 
metals they coordinate to and, consequently, they are expected to improve catalytic processes 
whenever high π-acidity at the metal center is required, such as in π-acid catalysis promoted 
by Pt(II)
 
and Au(I)
 
complexes. 
 As mentioned before, N-alkyl/aryl pyridiniophosphines are also quite weak σ-donor and quite 
strong π-acceptor ligands due to the very low lying π* orbitals in the pyridinium cation. These 
attributes confer a substantially enhanced π-acidity to the derived Pt(II) and Au(I) complexes 
which, as a result, also show improved ability to activate alkynes towards nucleophilic attack, 
when compared to other monocationic ligands. This superior performance has been 
demonstrated for several mechanistically diverse Pt(II)
 
and Au(I) catalyzed transformations 
such as the hydroarylation of propargyl aryl ether to chromene and the cycloisomerization of 
enynes to cyclobutenes (Scheme 18). In particular, the study of this reaction allows a direct 
comparison between pyridiniophosphines and commercially available π-acceptor ligands. As 
can be seen in Scheme 18, CO (1 atm), which is the paradigmatic π -acceptor ligands, 
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performed better in terms of reactivity than any the other ligands tested: (PhO)3P and 
(C6F5)3P. However, catalysts 54a and 54b were much more efficient and cyclobutene 53 
could be obtained in excellent yields after only few minutes.
[43]
 
 
Scheme 18. Ligand effect on the Pt-catalyzed cycloisomerization of enyne to cyclobutene  
Apart from the reaction above, the cyclization of 55, which is known to be extremely 
dependent on the global electron density at the gold atom,
[80-81]
 provides an additional 
measurement for donor properties of the ligands. π-Acidic ligands L can enhance the 
carbocationic nature of intermediate 55A, thus promoting ring contraction by a 1,2-alkyl shift 
to afford 56. In contrast, the formation of 57 through the 1,2-hydride migration process is 
favored by strongly σ-donating ligands at the gold center that increase the carbene character 
of 55A. As illustrated in Scheme 19 the selectivity obtained using cationic ligands with 
cyclopropenium group is comparable to that of phosphines.
[41]
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Scheme 19. Comparison of the selectivity of different ligands in the gold-catalyzed cyclization of allene diene.  
Polycationic phosphines have also proven to be excellent π-acceptor ligands in catalysis. A 
catalyst intensively studied in our group is complex [31][PtCl3]. The three positive charges of 
this ligand dramatically enhance the ability of Pt to activate π-systems toward nucleophilic 
attack. As a consequence, a remarkable acceleration of hydroarylation reaction was observed 
when compared with other classical π-acceptor ligands such as P(OPh)3 or P(C6F5)3 (Scheme 
20).
[82]
 Although the Pt-catalyst derived from the trication 31 is more reactive than those 
derived from phosphites or fluorophenylphosphines, this catalyst still has some limitations: 
(a) only
 
Pt(II) has been successfully coordinated to ligand 31, which severely limits its range 
of application; (b) stereochemical properties of 31 are difficult to modulate and (c) the low 
solubility of 31 in organic solvents demands the use of non-coordinating apolar anion. 
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Scheme 20. Cyclization of 2-Ethynyl-1,1′-binaphthalene into pentahelicene  as model reaction. 
1.4 Summary I 
α-Cationic ligands originally received attention because of their intrinsic advantages regarding 
catalyst recycling. However, our group has demonstrated that the strong π-acceptor character 
induced at the P-atom by the positive charge can also be beneficial in catalytic cycles where 
the rate determining step is accelerated by increasing the Lewis acidity at the metal center. 
Further development for this type of ligands are expected in two directions. First, the 
synthesis of even more electron-poor cationic ligands is interesting because it may help to 
develop new reactions that do not proceed with traditional catalysts. In addition, the 
coordination chemistry of polycationic ligands should be further studied, since ligands with 
two or three positively charged substituents at 𝛼-position only coordinate Au(I) and Pt(II) so 
far. Once the coordination was expanded to a diverse metal scope, an entire inventory of new 
reactions might be developed. 
  
  37 
 
2 Bis- and Trispyrazoylborate/methane-
Stabilized P(III)-Centered Cations  
2.1  Introduction 
As mentioned before, our group have prepared a series of α-cationic phosphines that have C-
based substituents at P-atom. These ligands are stable towards oxygen and moisture. 
Moreover, they show superior performance in π-acid catalysis due to their excellent π-
acceptor character induced by the positive charges.
[24, 27, 36, 41, 82-83]
  
To further improve the π-acceptor character of these phosphines, α-cationic phosphines 
containing N-based substituents might be appropriate options because N is more electron 
negative than C. Specifically, regarding P-based trications stabilized by N-bases, the 
precedents reported in the literature are 26-29, which were obtained by reaction of PCl3 with 
DMAP, DBN or guanidine; however, their connectivity was only evidenced by 
spectroscopy.
[50-51]
 Only recently, a solid structure of trication 30, in which the three positive 
charges are equally distributed on two phosphorus centers, has been reported by Lammertsma 
and coworkers. Unfortunately, this compound is highly sensitive towards moisture and air, 
and therefore its coordination chemistry remains unexplored.
[52]
 
 
Scheme 21. Representative polycationic phosphines. 
In this regard, we envisioned that the replacement of monodentate ligands by chelating ones 
or even scorpionates should be beneficial to mitigate their inherent instability and obtaining 
more amenable P-centered polycations. Moreover, the introduction of a remote negative 
charge on the ligand architecture might additionally increase the stability of the resulting 
complexes through attractive Coulombic interaction between the anionic ligand and the 
positively charged phosphorus atom.
[84]
 This rationale makes bis-/trispyrazoylmethane and 
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bis-/trispyrazoylborate ligands ideal candidates to attempt the synthesis of more robust P-
centered polycations and study their coordination properties. 
2.2  Results and Discussion 
2.2.1 Synthesis of bis- and trispyrazolylborate-Stabilized P-centered Cations 
To test this hypothesis, we embarked on the preparation of the desired cationic phosphanes 
using pyrazolyl borate ligands.
[50-51]
 Our starting material, potassium bispyrazoyl borate 61 
was prepared from the condensation of pyrazol (4 equiv.) and NaBH4 (1 equiv.) in toluene.
[85]
 
Suspensions of potassium bispyrazoyl borate 61 in CH2Cl2 were then treated with three 
different chlorinated phosphines (PCl3, PhPCl2, and CyPCl2) in the presence of TMSOTf (2 
equiv.) to afford white to yellow precipitates that could be easily separated from the reaction 
mixtures in all cases. Their 
31
P-NMR spectra showed signals at δ = 86.2, 87.1, and 102.8 ppm, 
respectively, which are consistent with the desired coordination of 61 to the P center and 
formation of 62-64 (Scheme 22). Subsequently, the expected connectivity could be 
unambiguously confirmed by X-ray diffraction of a single crystal of 62 (Figure 3).  
Remarkable features of 62 are the P1-N1 and P1-N2 bond distances [1.7474(11) Å and 
1.7500(11) Å, respectively] that are only slightly longer than those found in 
trispyrazoylphosphine [1.714(4) Å], despite their dative nature.
[86]
 Likewise the degree of 
pyramidalization at phosphorus (71.7%) is notable which clearly indicates retention of a 
nonbonding electron pair on this atom.
[87]
 Also interesting is the P1-O1 distance (3.139 Å), 
which is shorter than the sum of the van der Waals radii, as well as the nearly linear 
arrangement observed for O1, P1, and N4 (171.8°). These two structural parameters indicate 
donation of electron density from the triflate anion to a σ*(P1-N4) orbital of the cation which 
is indicative of some Lewis acid character at the phosphorus atom. 
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Scheme 22. Synthesis of 62-64. 
 
Figure 3. Molecular structure of 63 in the solid state (hydrogen atoms and solvent molecules removed for 
clarity; ellipsoids set at 50% probability) 
Once the preparation of compounds 62-64 was achieved, we evaluated the synthesis of 
dicationic species by employing the neutral bispyrazoylmethane ligand 66, which was 
prepared from pyrazole and CH2Cl2 in the presence of 
n
Bu4NHSO4 and K2CO3.
[88]
 Treatment 
of a CH2Cl2 solution of PhPCl2, CyPCl2, or (Et2N)PCl2 with an equimolar amount of 66 and 
two equivalents of TMSOTf induced the slow precipitation of white solids 67-68, which were 
found to be analytically pure. Their 
31
P NMR spectra displayed resonances at δ = 85.8, 110.1, 
and 107.8 ppm, respectively, which support the coordination of 66 to the P-center (Scheme 23 
and Figure 4). 
Quite intriguing are the structural features observed in the molecular structure of 69 (Figure 
5). In this compound both P1-N1 and P1-N2 bond lengths [1.8376(12) and 1.8328(13) Å] 
are clearly elongated compared with those in 67 [1.7581(13) and 1.7692(13) Å]. On the 
other hand, the P1-N5 distance [1.6264(13) Å] is shorter than expected for a typical covalent 
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P-N bond. Moreover, the nitrogen atom shows a planar trigonal environment (sum of angles = 
360°) and the C1-N5-C1 plane bisects the N1-P1-N3 angle. 
 
Scheme 23. Synthesis of 67-69. 
 
Figure 4. Molecular structure of 67 in the solid state (hydrogen atoms, solvent molecules and one triflate anion 
removed for clarity; ellipsoids set at 50% probability). 
 
Figure 5. Molecular structure of 69 in the solid state (hydrogen atoms, solvent molecules and one triflate anion 
removed for clarity; ellipsoids set at 50% probability). 
The isolation of 67-69 suggests that similar compounds may be prepared in a related manner 
employing other neutral bidentate ligands instead of pyrazoylmethanes. Particularly 
interesting is the possible use of bisoxazolidines
[89]
 (BOX ligands) since they might offer a 
fast and highly modular route for the preparation of chiral enantiopure P-centered dications. 
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We were pleased to see that bisoxazolidine 72 indeed reacted with PhPCl2, under the 
conditions already developed for bispyrazoyl methane ligands, affording the desired complex 
73 as a crystalline material in moderate yield. Although the limited data quality impeded 
satisfactory structure refinement, X-ray diffraction of a crystal 73 was good enough to 
confirm the structure of 73 (Scheme 24).  
 
Scheme 24. Synthesis of 73.  
Finally, we also attempted the isolation of formal P
3+ 
cations stabilized by scorpionate 
ligands. To this end, we chose tris(3,5-dimethylpyrazoyl)borate 75
[90]
, tetra(pyrazoyl)borate 
78
[91]
, and tris(3,5-dimethylpyrazoyl)methane 81
[92]
 as ancillary ligands, and treated them with 
PCl3 and three equivalents of TMSOTf. The white solids that precipitated from the reaction 
mixture were crystallized from CH3CN/Et2O, affording compounds 76, 79 and 82 in an 
analytically pure form. The 
1
H NMR spectra of 76 and 82 showed only two singlets in the 
aliphatic region, indicative of C3 symmetry of the newly formed complexes. Moreover, 
31
P 
NMR resonances at 7.3 (76), -2.4 (79), and -9.9 (82) ppm also support a tridentate 
coordination of the pyrazoyl ligands to the central phosphorus atom in these compounds 
(Scheme 25). Single crystals suitable for X-ray diffraction analysis could be obtained for 76 
and 79 confirming the proposed connectivities (Figure 6 and 7). It was observed that the P-N 
distances in 76 and 79 are practically identical to those observed for 63 and 67. However, the 
geometry of the trispyrazoyl ligand produces a higher degree of pyramidalization at the 
phosphorus center that reaches 85.7% in 76 and 92.4% in 79.
[87]
 In addition, each P atom is 
closely surrounded by three triflate anions in the unit cell. The P1-O1 distance in 79 is, as 
expected, the shortest among the complete series of compounds under study (2.734 Å), while 
the much longer P1-O1 contact in 76 (3.192 Å) must be attributed to the steric hindrance 
derived from the additional methyl groups on the pyrazol rings. The positive charges at P-
atom efficiently stabilize the three σ*(P-N) orbitals and thus, confer Lewis acid character to 
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the phosphorus atom. This explains the observed short distances between the central P-atom 
and the triflate anion in these compounds. 
 
Scheme 25. Synthesis of 76, 79 and 82. 
 
Figure 6. Molecular structure of 76 in the solid state (hydrogen atoms, solvent molecules and one triflate anion 
removed for clarity; ellipsoids set at 50% probability). 
 
Figure 7. Molecular structure of 79 in the solid state (hydrogen atoms, solvent molecules and one triflate anion 
removed for clarity; ellipsoids set at 50% probability). 
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2.3 Electronic Properties 
To better understand the electronic structure and bonding of these compounds, DFT 
calculations were performed at the BP86/6-311++G** level. The Wiberg bond index (Wi) on 
cation 63 was found to be 0.94 for the P1-C1 bond, but only 0.73 for both P1-N1 and P1-N3 
bonds, which is in line with their dative nature. The computed charge at phosphorus was 
+1.23e (natural population analysis), which explained the low energy of the lone pair at 
phosphorus (HOMO-6; E = -11.46 eV) and of the antibonding σ*(P-N) orbital (LUMO+1; E 
= -5.99 eV) that confers Lewis acidity at the phosphorus center (Figure 8). 
 
Figure 8. Lone pair (HOMO-6, left) and low lying σ*(P-N) orbital (LUMO+1, right) of 63. 
DFT calculations were again very useful to explain the structural features found in 69. Figure 
9 shows the shape of the HOMO in this cation. The P1-N5 bond exhibits significant π-
bonding character due to the overlap between the σ* (P-N) orbital (LUMO+1) and the 
electron lone pair on N5 (Figure 9). As a result, electron density is transferred from nitrogen 
to phosphorus and a partial double bond is established between these two atoms. 
Consequently, the P1-N5 Wi value increases to 1.13. On the other hand, the partial population 
of the antibonding orbital of 2e symmetry weakens the P-N bonds between phosphorus and 
pyrazol (Wi value of only 0.57) and lengthens them considerably (Figure 9). 
 
 
Figure 9. Fragment analysis of the HOMO of 69. 
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2.4 Attempts of Coordination 
The polycationic species were shown to display Lewis acid properties. Presumably for this 
reason, all attempts to use them as ligands resulted in either no reaction or decomposition. 
Moreover, despite their stability in argon for days at room temperature, once exposed to air, 
they decomposed immediately, demonstrating strongly hydroscopic properties. 
2.5 Summary II 
In summary, making use of an –onium substituent transfer strategy, we have been able to 
isolate and structurally characterize several P-centered polycations stabilized by bis- and tris-
(pyrazoyl)borate or methane ligands. In all of these compounds, the phosphorus center adopts 
a pyramidal environment, which is indicative of the presence of a lone pair mainly located on 
this atom. However, the high positive charge at phosphorus lowers the energy of this orbital to 
a level that makes it unavailable for donation. The same positive charge also stabilizes quite 
efficiently the σ*(P-N) orbitals, thus conferring Lewis acid character to the phosphorus atom. 
This Lewis acidity is evident from the short contacts observed between the triflate anions and 
the phosphorus centers. 
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3 Dicationic Chelating Phosphines: Synthesis, 
Structure and Reactivity 
3.1 Introduction 
α-Cationic phosphines have attracted increased attention during the past years due to the 
superior performance of the catalysts containing these ligands.
[24, 27, 93-94]
 However, the 
strongest cationic π-acceptor phosphines that can be prepared following this strategy, namely 
di- and tricationic ones, show little affinity to form coordination complexes and, until now, 
they have only been able to bind metal fragments that efficiently engage in back donation 
such as Au(I) and Pt(II). Our attempts, and that of others, to expand the coordination to other 
metal sources unfortunately failed.
[30, 60, 83]
 
 
Scheme 26. Coordination chemistry of polycationic ligands. 
In an attempt to circumvent the intrinsic shortage of polycationic ligands and gain access to a 
broader repertoire of potential metal catalysts bearing these ligands, the introduction of an 
additional donating group was envisioned as an anchor to bring the cationic moiety into the 
vicinity of the metal and thus, induce its coordination. This strategy has been used previously 
to coordinate Lewis acidic centers such as boranes to metals (Scheme 27a).
[95-96]
 Another 
example of the use of this strategy is the coordination of N-heterocyclic nitrenium ions 85
[97]
 
after the introduction of chelating phosphorus atoms on their architecture (Scheme 27a), even 
though it is known that boranes or nitrenium cations by itself are not able to coordinate these 
metals. More intriguingly, some of these complexes display superior performance in catalysis 
due to the strong 𝜋-acceptor properties of the ligands they bear. In this regard, we reasoned 
that it might be possible to use a similar strategy to facilitate the coordination of the dicationic 
ligands to metals. Hence, we decide to prepare dicationic chelating phosphines bearing a 
latent -PPh2 moiety, such as the ones described in Scheme 27b. 
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Scheme 27. Representative examples for induced coordination and the simplified structure of chelating 
polycationic ligands. 
3.2 Synthesis 
3.2.1 Synthesis of Chelating Dicationic Ligands 
To put our idea into practice, we first prepared phosphine 90 from dibromobenzene in three 
steps according to a modified literature procedure (Scheme 28).
[98-99]
 First, monolithiation of 
dibromobenzene with 
n
BuLi in dry THF at -110 
o
C followed by addition of Ph2PCl afforded 
the corresponding monophosphinated product 88. A subsequent second lithiation with 
n
BuLi 
in dry THF at – 78 oC followed by reaction with ClPO(OEt)2 gave phosphonate 89 which was 
finally reduced with LiAlH4 to diphosphine 90 in 64% yield. 
 
Scheme 28. Synthesis of primary phosphine 90. 
Unfortunately, reaction of primary phosphine 90 with 17a in the presence of Et3N (2 equiv.) 
at 60 oC afforded an unexpected cyclic compound 91, whose structure was confirmed by 
single X-ray diffraction analysis (Figure 10). Once the connectivity of 91 was elucidated, we 
concluded that probably the desired salt 91A was formed as an intermediate, but an attack of 
the electron lone pair from the -PPh2 moiety to C-1 of one cyclopropenium center, led to the 
formation of spirocyclic compound 91B, which ring opens to afford intermediate 91C. 
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Subsequent 1,5-hydride migration afforded intermediate 91D, which cycloisomerized to 91 
(Scheme 29).  
 
Scheme 29. Proposed mechanism for the formation of 91. 
 
Figure 10. Molecular structure of compound 91 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, tetrafluoroborate counter anions and solvent molecules have been omitted for clarity. 
Because the formation of the undesired compound 91 requires the attack of the electron pair 
from the P(neutral) atom to the 3-membered cyclopropenium ring, other cationic groups less 
prone to suffer from this attack were also tested. Thus, dimethyldihydroimidazolium groups 
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were selected as more appropriate substituents due to the less strained nature of these cycles. 
In fact, treatment of 2-chloro-3,5-dihydroimidazolium with primary diphosphine 90 in the 
presence of base easily provided the desired dications 92a. Anion exchange gave access to 
dications 92b-c, containing SbF6
-
 and B(Ar
F
)4
-
 counter anions. The structure of dication 92b 
was unambiguous confirmed by single X-ray diffraction analysis (Scheme 30 and Figure 11). 
 
Scheme 30. The synthesis of dihydroimidazolium substituted dication 92. 
 
Figure 11. Molecular structure of compound 92b in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, hexafluoroantimonate counter anions and solvent molecules have been omitted for clarity. 
As a structure modification of the basic architecture of dication 92, our first goal was to 
replace the phenyl backbone by a biphenyl one that functions as a linker between the two 
phosphorus atoms. This was desirable for two reasons: (a) the increased distance and 
flexibility between the two phosphorus atoms may result in completely different reactivity, 
and (b) the species derived from a rotationally hindered biphenyl system could later be 
prepared in enantiopure form once the synthesis is optimized. 
The route depicted in Scheme 31 was designed for the synthesis of dication 101. Dianiline 96 
was prepared in three steps according to a known literature procedure, consisting Sandmeyer 
reaction, Ullmann coupling, and the reduction of both nitro groups.
[100]
 Then 96 was subjected 
to Sandmeyer reaction conditions to afford the biaryl diiodide 97, which was lithiated with 
n
BuLi in dry THF at -78 
o
C followed by reaction with Ph2PCl to afford the corresponding 
monophosphinated product 98. Subsequent lithiation with 
n
BuLi in dry THF at -78 
o
C, 
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followed by reaction with ClPO(OEt)2 afforded phosphonate 99, which was finally reduced 
by LiAlH4 to deliver the desired diphosphine 100 in 85% yield. Treatment of this compound 
with 2-chloro-3,5-dihydroimidazolium 17c in the presence of base easily provided the desired 
dication 101a. Anion exchange allowed the access to dication 101b, containing SbF6
-
 counter 
anion.  
The 
31
P NMR spectra of both dications, 92 and 101, consists of two doublets (δP = -8.5, -43.8 
ppm; JP-P = 212 Hz for 92, and δP = -14.7, -44.1 ppm; JP-P = 86.7 Hz for 101), which can be 
attributed to the –PPh2 and [-P(H2Im)2]
2+ 
moieties, respectively. Single crystals suitable for X-
ray structure determination were obtained (depicted in Figures 11 and 12). All C-P bond 
lengths from 92 and 101 are in accord with typical single bonds,
[101]
 but interestingly, the P1-
P2 distance in 92 (3.076 Å) is shorter than in its neutral analogue 1,2-
bis(diphenylphosphino)benzene (3.165 Å).
[102]
 This shortening might indicate a reduction of 
the repulsive interaction between the electron lone pairs on the two phosphorus atoms. 
 
Scheme 31. The synthesis of dication 101a-b. 
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Figure 12. Molecular structure of compound 101a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, tetrafluorborate counter anions and solvent molecules have been omitted for clarity. 
3.2.2 Synthesis of Monodentate Dications 
In order to compare the coordination properties of chelating and monodentate dications, 
compounds 102-104 were also prepared following a similar sequence. Initially, PhPH2 and 
CyPH2 were reacted with chlorodihydroimidazolium salts; however, after many trials, these 
reactions failed to produce the desired dications in a clean manner. Once the 
chloroimidazolium 17c was replaced by chloroamidinium 17d, the desired dications 103 and 
104 were obtained in moderate yield. Thus, it was estimated that the failed condensation 
between chlorodihydroimidazolium and either PhPH2 or CyPH2 might be caused by the 
insolubility of the monocationic intermediate that is necessarily formed after the first 
condensation. Hence, 2-biphenylylphosphine, which contains a more lipophilic substituent 
and thus, depicts increased solubility in organic solvents, was chosen as the starting material. 
To our delight, after this modification dication 102 could be isolated as a white solid, albeit in 
low yield (Scheme 32a). In addition, chelating diphosphine 105 and 106, prepared  for 
comparison reasons, were synthesized by lithiation of 88 followed by reaction of 
(C6F5)2PCl
[103]
 and  (1-pyrrole)2PCl
[104]
 respectively (Scheme 32b). 
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Scheme 32. The synthetic route of monodentate dication and bidentate phosphines. 
 
Figure 13. Molecular structure of compound 103 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity. 
3.3 Electronic Properties of the phosphines 
At this point the donor abilities of the newly prepared ligands were estimated by comparative 
analysis of their cyclic voltammograms.
[69, 73-74]
 Ligand 92 and 101 showed oxidation peaks at 
1.050 and 0.974 V respectively, which can be assigned to the oxidation of the –PPh2 groups. 
Comparison with reference compounds reveals that the –PPh2 lone pair in 92 and 101 is less 
available than that in PPh3 (Table 3, Entry 3), probably as result of the strong electron 
  52 
 
withdrawing effect that the dicationic group exerts on the neutral phosphine moiety. This 
influence is markedly stronger in 92 due to the closer proximity of the two phosphorus atoms 
imposed by the o-phenylene linker. Accordingly, the reduction potentials of 92 and 101         
(-1.528 V and -1.504 V respectively), that can be ascribed to the electrophilic character of the 
[-P(H2Im)2]
2+
 fragments, are slightly lower than that of 102 (Table 3, Entry 5) denoting, as 
expected, a marginal loss of their strong acceptor properties when compared with their 
monodentate analogue. 
Table 3: Electrochemical redox potentials of ligands 92 and 101. The values for commonly used phosphorus-
based ligands and reference compounds are included for comparison. 
 
[a] Oxidation/reduction peaks potential reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, Bu4NPF6 (0.1 M) in 
CH2Cl2; [b] No reduction signal  observed from 0 to -2.5 V; [c] no signal detected from 0 to 2V;  
To further investigate the electronic properties of these ligands, a series of Mo-derivatives 
107a-d
[105]
 were synthesized by reaction with Mo(CO)6 in THF (Scheme 33). The donor 
endowment of 92 was compared with that of other chelating phosphines of similar structure 
by analysis of the CO stretching frequencies in the corresponding [LMo(CO)4]
n+
 (n = 0 or 2) 
derivatives. These data suggest that the dihydroimidazolium substituents impart stronger 
acceptor properties to the phosphorus atom than 1-pyrrole or –C6F5 units. Thus, 92 and 101 
can be defined as bidentate ligands which possess a neutral σ-donating group together with an 
exceptionally good π-acceptor functionality. The structure of the dicationic complex 107a was 
confirmed by single X-ray diffraction analysis, as shown in Figure 14. 
  53 
 
 
Scheme 33. Evaluation of the donor ability of 92 by IR spectroscopy 
 
Figure 14. Molecular structure of compound 107a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, hexafluoroantimonate counter anions and solvent molecules have been omitted for clarity. 
Finally, an additional probe of the Lewis acidity of the [-P(H2Im)2]
+2
 moiety could be 
obtained from the X-ray structure of compound 108, which was itself prepared by selective 
oxidation of the –PPh2 group in 92 with elemental sulfur (Scheme 34 and Figure 15). This 
compound features a S1-P1 distance of only 3.200 Å, which is significantly shorter than that 
of a neutral analogue.
[106]
 This value also reveals an attractive P1-S1 interaction in 108 that is 
attributed to donation from sulfur to one of the low lying σ*(P1-C1) orbital.  
 
Scheme 34. Selective oxidation of the phosphorus atom on dication 92b. 
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Figure 15. Molecular structure of compound 108 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity.  
To better understand the electronic properties of dication 92, its electronic structure was 
evaluated theoretically at the M06-L/TZVP level. The optimized structure compares well with 
that obtained from X-ray analysis (Figure 16). The inspection of the frontier orbitals sheds 
light on the multifaceted properties of 92. The HOMO is localized largely on the neutral 
phosphorus atom, while the significant localization of the LUMO and LUMO+1 orbitals on 
the positively charged fragment suggests suitable symmetry for π-acidic character upon metal 
coordination. Also noteworthy is the observation that the HOMO-LUMO gap for ligand 92 is 
1.0 eV lower than that of the analogous neutral ligand of 1,2-bis(diphenylphosphino)benzene. 
This suggests the possibility of a P-P bonding interaction. 
 
Figure 16. Molecular orbitals of 92 and their orbital energies computed at the M06-L/TZVP level. 
An AIM and bond order analysis in fact supports the presence of a bonding interaction. The 
electron density and its corresponding Laplacian reveal a closed shell, dative interaction 
between the P-P atoms. To assess whether the interaction is attributed purely to the proximity 
induced by the bridging ligand backbone, the phenyl backbone was replaced by two hydrogen 
atoms to determine the approximate bond strength (Figure 17). A constraint free optimization 
of the fragments resulted in 92-frag where the P-P distance increased only slightly to 3.13 Å 
from 2.99 Å in 92. The M06-L/TZVP bonding energy is determined to be -31.3 kcal/mol. The 
physical nature of the interaction was evaluated through energy decomposition at the 
BP86/TZ2P//M06-L/TZVP level. While dispersion interactions (Edisp) are expected to make 
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up a large percentage of the total favorable interaction due to a π-stacking component in this 
case, the most prominent favorable interaction component is attributed to orbital interactions 
(Eorb; 40%). Moreover, this bonding interaction may effectively account for the slightly 
reduced oxidation and reduction potentials for 92 in comparison to its monodentate analogue 
(Table 3, entries 1 and 5) through mixing of the lone pair orbital on the neutral phosphorus 
with the antibonding orbitals on the dicationic phosphorus.  
 
  92 92-frag   92-frag 
b(P1-P2)  0.033 0.024 EPauli 34.2 
2b(P1-P2) 0.036 0.030 Eelstat -26.4 
BO 0.124 0.155 Eorb -29.6 
nP1*P1-C1 6.7 8.6 Edisp -18.0 
   
Eint -39.8 
   
Edist 3.5 
  
  
E -36.3 
Figure 17. Theoretical investigation of the interaction of the two phosphorus atom on 92. Geometries, AIM 
parameters b and 
2b, Wiberg bond index, NBO perturbation energies (kcal/mol), and ETS energy 
decomposition analysis for 92 and the 92-frag computed at the BP86-D3/TZ2P//M06-L/TZVP level. 
3.4 Coordination Study 
Encouraged by this analysis we decided to evaluate the ability of 92 to function as a chelating 
ligand for different metals. To our delight, when 92b was allowed to react with PtI2(PhCN)2, a 
yellow solid 109a was obtained. The 
31
P-NMR spectrum of this product showed downfield 
shifts (δP = 39.2, 5.4 ppm, JP-P = 4.6 Hz) compared to the original chemical shift of the free 
ligand 92b (δP = - 12.3, - 47.6 ppm, JP-P = 212.4 Hz), as well as the appearance of 
characteristic 
195
Pt satellites (JP(neutral)-Pt = 2856.1 Hz, JP(cationic)-Pt = 3457.9 Hz) which 
indicated the coordination of both phosphorus centers to platinum. Subsequently, this 
connectivity was unambiguously confirmed by X-ray diffraction analysis (Figure 18). In 109a 
the geometry about the Pt center is slightly distorted square planar and the P1(cationic)-Pt1 
bond distance [2.2058(10) Å] is shorter than the P2(neutral)-Pt1 bond [(2.2559(10) Å], a clear 
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consequence of the strong π-acceptor character of the [-P(Im)2]
2+
 group. Reactions with 
PtCl2(CH3CN)2 and PdCl2(CH3CN)2 were equally successful, affording isostructural 
complexes 109b and 109e respectively. The reactivity of 92b towards Rh(I) centers was also 
analyzed. Salt 92b readily displaced cyclooctadiene in [RhCl(cod)]2 to generate a binuclear 
tetracation 109c in which both [-P(H2Im)2]
2+
 groups adopted a distal orientation (Figure 19). 
Again in this structure the shorter P1(cationic)-Rh1 bond length [2.1319(13) Å], compared to 
the P2(neutral)-Rh1 one [2.1924(13) Å], indicates strong π-acceptor properties at the cationic 
phosphine. In compound 109c, the columbic repulsion between the fragments facilitates its 
dissociation and thus, after the addition of a few drops of acetonitrile to solutions of 109c, an 
equilibrium was established and the monomeric 109d was the predominant species, as 
depicted in Scheme 35. As expected from a coordinately saturated metal fragment, in complex 
109f the Au atom coordinates with 92b only through the R-PPh2 moiety. However, it is worth 
mentioning that the P1(cationic)-Au1 distance in this compound (3.365 Å), which is just 
below the sum of the Van der Waals radii of both elements, suggests a weak Au→P(cationic) 
interaction. In addition, an aurophilic interaction was also observed in the solid state of 109f 
(3.147 Å) (Figure 21). 
 
Scheme 35. The coordination study of dication 92b. 
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Figure 18. Molecular structure of compound 109a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, hexafluoroantimonate counter anions and solvent molecules have been omitted for clarity. 
 
Figure 19. Molecular structure of compound 109c in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, hexafluoroantimonate counter anions and solvent molecules have been omitted for clarity. 
 
Figure 20. Molecular structure of compound 109d in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, hexafluoroantimonate counter anions and solvent molecules have been omitted for clarity. 
 
Figure 21. Molecular structure of compound 109f in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity. 
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Dicationic bisphosphine 101a was also allowed to react with [RhCl(cod)]2 affording an 
orange solid 110 (Scheme 36). The 
31
P-NMR spectrum showed downfield shifts (δP = 38.1, 
9.9 ppm, JP-P = 50.4 Hz) compared to the original resonances of 101 (δP = - 15.0, - 44.4 ppm, 
JP-P = 87.0 Hz), along with the appearance of characteristic P-Rh coupling constants (JP(neutral)-
Rh = 154 Hz, JP(cationic)-Rh = 216 Hz) that indicate the coordination of both P centers to Rh. 
Subsequently, this connectivity was unambiguously confirmed by X-ray diffraction analysis 
(Figure 22). In product 110 the geometry about the Rh center is slightly distorted square 
planar and the cationic P1(cationic)-Rh1 bond distance [2.1608(8) Å] is shorter than the 
P2(neutral)-Rh1 one [2.2358(8) Å], again as consequence of the strong π-acceptor character 
of the [-P(Im)2]
2+
 group. The bigger coupling constant and the shorter bond length for the 
cationic P-atom demonstrate its strong interaction with the Rh center. 
 
Scheme 36. The coordination study of dication 101a. 
 
Figure 22. Molecular structure of compound 110 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity. 
Interestingly, mixing monodentate dication 102 with different metal precursor in CD2Cl2 did 
not produce any metal complex as could be demonstrated by analysis of 
31
P NMR of the 
reaction mixtures. Compared with the free ligands, no modification was observed. This result 
strongly confirms that the coordination of 102 to various metal salts is only possible due to 
the incorporation of a chelating phosphorus atom (Figure 23). 
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Figure 23. 
31
P NMR Spectra of the reaction of compound 102 with different metal salts. Ligand 102 (5.0 mg, 
0.006 mmol) in CD2Cl2 (0.6 ml) and the corresponding metal salts were added to an NMR tube and the sample 
stirred for 5 h. After that, the magnetic stirrer was removed and 
31
P NMR spectra were recorded. 
3.5 Reductive Elimination of Bis(pentafluorophenyl)palladium Complexes 
3.5.1 Synthesis of the Biarylpalladium Complexes 
Reductive elimination is an elementary reaction step present in many catalytic cycles. During 
this process, the oxidation state from the metal is reduced by two units, making the metal 
more electron-rich. For this reason, strong π-acceptor ligands usually facilitate this step, since 
the additional charge on the metal can be easily delocalized along the ligand. This makes our 
ligands potentially quite interesting in transformations where the rate-determining step is 
reductive elimination.
[107-108]
 
In order to test this working hypothesis, relevant biarylpalladium complexes 112a-h were 
prepared, all of them bearing -C6F5 substituents.
[109]
 Polyfluorinated aryls were chosen, 
because the reductive elimination of these very electron-poor moieties is known to be 
especially difficult. In fact, the reaction is known to proceed only under extremely harsh 
conditions (concentrated HNO3).
[109]
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Scheme 37. Synthesis of biarylpalladium complexes. 
 
Figure 24. Molecular structure of compound 112b in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
 
Figure 25. Molecular structure of compound 112f in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
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Figure 26. Molecular structure of compound 112g in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, tetrafluoroborate counter anions and solvent molecules have been omitted for clarity. 
 
Figure 27. Molecular structure of compound 112h in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms, tetrafluoroborate counter anions and solvent molecules have been omitted for clarity. 
3.5.2 Experimental Investigation of the Effect of Cationic Ligands in Reductive 
Elimination Processes 
Compounds 112a-e were completely ineffective for this process, and no trace of the desired 
perfluorobiphenyl was detected under our working conditions (CD3CN at 70 °C). 
Gratifyingly, the reductive elimination of C6F5-C6F5 from 112g proceeded smoothly and a 
remarkable conversion of 72% was achieved in 15 hours (Figure 28).  
This preliminary evidence on the beneficial effect of dicationic ligand 92a encouraged us to 
test the complex 112h in this same transformation (Figure 28). It is well known in palladium 
catalysis that the employment of ancillary ligands with large bite angles also facilitates 
reductive elimination steps, because they better stabilize the linear zero valent complex 
resulting from the elimination and efficiently delocalize the excess electron density on the 
metal after this step.
[110-111]
 The kinetic profile for 112h was illustrated in Figure 28. Acetone 
was used as solvent due to the instability of 112h in acetonitrile. The reactivity clearly 
surpasses that of 112g, and gave rise to the quantitative formation of perfluorobiphenyl in 
only six hours, thus confirming our predictions. It should be mentioned that complex 112f 
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also provided reasonable conversion under the same conditions and the rate of the reaction is 
even superior to the one of 112g. This reductive elimination surely takes place through a 
tricoordinated palladium species. Therefore, a new question arosed. Do 112h and 112g 
eliminate directly through four coordinated palladium species, or is a coordination site 
liberated (by decoordination of the [-P(Im)2]
2+ 
moiety) before the actual reductive elimination 
takes place? Calculations were performed to answer this question. 
 
Figure 28: The reductive elimination of the related biarylpalladium complexes. [a] Ligand effect on the 
reductive elimination of C6F5-C6F5 from Pd(II) complexes 112a-h. Reactions were carried out in acetonitrile at 
70 °C. Due to its instability in acetonitrile, acetone was used as the solvent in the case of 112h and DCE was 
used as the solvent in the case of 112f. Conversions were determined by 
19
F NMR. 
3.5.3 Theoretical Investigation of Cationic Ligands in Reductive Elimination  
The energy profiles for the reductive elimination of 112g, 112h, and 112b were explored at 
the M06-L(SMD-CH3CN)/def2-TZVP//BP86-D3/def2-TZVP level of DFT (Figure 29). The 
direct reductive elimination from 112g is predicted to occur with a relatively facile barrier of 
22.9 kcal mol
-1
 and is overall exergonic by 8.8 kcal mol
-1
. The possibility for hemilability in 
ligand 92 during or before the reductive elimination of 112g is dismissed on account of 
monodentate structure 112g-1 being 3.4 kcal mol
-1 
higher in energy than the transition state 
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for the bidentate coordination mode in 112g-TS. In contrast, the analogous neutral complex 
112b experiences a reductive elimination barrier that is 9.3 kcal mol
-1
 higher in energy than 
that for 112g. In addition, the reaction is endergonic by 11.3 kcal mol
-1
. The difference in 
reaction free energies suggests that ligand 92 binds more strongly to Pd(0) than Pd(II) while 
1,2-bis(diphenylphosphino)benzene forms a much stronger complex 112b with Pd(II) than 
Pd(0). Lastly, the reaction barrier for ligand 101 is predicted to be 1.3 kcal/mol lower than 
that for 112g. Hence, the increase in activity observed with 112h can be readily rationalized 
based on the increased bite angle which diminishes the C-Pd-C angle and consequently, less 
distortion is required to reach the product resulting in a lower overall barrier. 
-20
-10
0
10
20
30
40
 
Figure 29. Gibbs Free Energy profile for the reductive elimination of complexes 112g (black), 112h (blue) and 
112b (red) determined at the M06-L(SMDCH3CN)/def2-TZVP//BP86-D3/def2-TZVP level of DFT. 
The details of the L-Pd binding energy were deconstructed with the aid of energy 
decomposition from the Pd(II) complex to the reductive elimination product. While the 
change in the repulsion terms (EPauli and Edist) is greater in 112g-TS, it exhibits far 
greater compensation interaction terms than 112b-TS. The orbital term is the strongest of the 
interaction terms favoring 112g-TS and indicates that the decreasing orbital interactions for 
reaching the TS is significantly less than that for 112b-TS. Moreover the change in charge 
transfer (q) from the ligand to the Pd(C6F5)2 fragment on going from the reactant complex 
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to the transition state of reductive elimination is less for 112g than for 112b which may 
contribute to the reduced energy barrier for 112g.   
Table 4. Energy decomposition analysis and NBO charge transfer (Pd(C6F5)2L). Ea = Eint+Edist 
 
EPauli Eelec Eorb Edisp Eint Edist Ea q 
112g 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
112g-TS -22.95 4.30 22.88 4.94 9.17 10.84 20.01 -0.35 
112g-PRT 30.20 -63.48 17.00 25.13 8.85 -13.98 -5.13 -0.76 
112b 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
112b-TS -38.19 16.98 41.73 8.86 29.38 0.96 30.34 -0.41 
112b-PRT 24.46 -41.57 29.50 23.26 35.65 -18.27 17.38 -0.83 
Charge transfer from the ligand inhibits Pd(II)Pd(0) reduction. The principle orbital 
interaction governing this conversion is that between the ligand HOMO and the Pd complex 
LUMO and thus, the preference can be probed through this interaction. The orbital energies 
and corresponding orbital overlaps between the ligand and Pd(C6F5)2 fragments for the 
reactant complexes 112b and 112g as well as their transition states of reductive elimination 
112b-TS and 112g-TS are shown in Table 4. The large fragment orbital energy difference for 
112g (E = 4.94 eV) as compared with 112b (E = -0.89 eV) implies a much stronger 
interaction in the latter. Moreover the HOMO in ligand 112g is more localized on the neutral 
phosphorus atom whereas in 112b the HOMO is equally distributed on both phosphorus 
atoms. This distribution difference is reflected in a more enhanced orbital overlap for the 
equally distributed neutral ligand in 112b. Upon conversion to the transition state a much 
greater distortion in the Pd(C6F5)2 fragment for 112b than that for 112g is required. This 
demand is expressed in diminished Ar-Ar bond distance resulting in an increased energy for 
the corresponding LUMO. Furthermore the overlap is diminished by 26% upon conversion to 
the TS for 112b whereas the overlap is only diminished by 10% in 112g. The greater decrease 
in the overlap combined with the increased orbital energy difference in 112b112b-TS 
signifies the greater need for reduced charge transfer from the ligand as the change in 
oxidation state favors charge removal from the Pd(C6F5)2 as the Ar-Ar bond forms (Figure 
30). 
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Figure 30. Frontier fragment orbitals for 112g, 112g-TS, 112b, and 112b-TS with their orbital energies and 
orbital overlaps, s, computed at the BP86/TZ2P//BP86/def2-TZVP level. 
By virtue of the positive charge in ligand 92, a bimodal adjustment to the ligand is imparted 
as compared to the neutral analogue for the ligand in complex 112b. The energy of the 
HOMO relating to the lone pair orbitals on the phosphorus atoms is significantly lowered by 
~-5.6 eV as compared with the neutral analogue, resulting in a significantly weaker bonding 
interaction. The second effect is the localization of the HOMO on the neutral phosphorus 
atom. This asymmetry in a chelating ligand results in diminishing overlap with transition 
metal d orbitals translating to a weaker bond as compared with a chelating ligand with a 
suitably symmetric HOMO distribution as in 112b. 
3.5.4 Reactivity of Dication 92 towards Pd(0) and Ni (0)  
Encouraged by these results, we decided to study the coordination of 92 towards Pd(0) and 
Ni(0) complexes, since metal complexes are formed after reductive elimination of the biaryl 
moiety from compound 112g-h. Hence, treatment of 92b with an equivalent amount of 
Pd2(dba)3 in CH2Cl2 resulted in the precipitation of a yellow solid 113, depicting two singlets 
in its 
31
P NMR spectrum, one at  δP = 49.4 ppm, which surely corresponds to the R-PPh2 
fragment, and a quite indicative signal at δP = 15.9 ppm, which could not be directly attributed 
to the original [-P(H2Im)2]
2+
 group (Scheme 38). Moreover, in contrast to the complex formed 
before, the 
1
H NMR spectrum of 113 indicated unequivalency of its four methyl groups. 
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Fortunately, after several attempts, crystallization from acetonitrile afforded single crystals of 
this product and its connectivity could be determined (Figure 31). In product 113 an oxidative 
addition of Pd(0) into one of the C-P(H2Im) bonds has taken place, providing a phosphinidene 
complex where the Pd(II)
 
atom additionally coordinates an acetonitrile molecule. Identical 
reactivity was observed on reaction of 92b with Ni(cod)2, although in this case the exchange 
of acetonitrile by 2,6-(dimethyl)phenylisonitrile was necessary to obtain a crystalline material 
114 (Figure 32). It is worth mentioning that the cationic P(H2Im)-fragments in 113 and 114 
still bear a non-shared electron pair at phosphorus that might still be used for coordination of 
a second metal center. 
 
Scheme 38. The coordination study of dication 92b with Pd(0) and Ni(0). 
 
Figure 31. Molecular structure of compound 113 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity. 
 
Figure 32. Molecular structure of compound 114 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and hexafluoroantimonate counter anions have been omitted for clarity. 
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3.6 Application in Catalysis  
The catalytic hydroalkylation of alkenes is a valuable, atom-economical methodology for the 
formation of C–C bonds from readily available starting materials.[112] Pioneering studies have 
led to the development of intermolecular processes that employ styrenes,
[113]
 inactivated 
alkenes,
[114-115]
 allenes,
[116-117]
 and alkynes
[118-119]
 as effective substrates that can react with 
appropriate C-based nucleophiles.
[120]
 The hydroalkylation of diene substrates is synthetically 
useful; such reactions convert readily available unsaturated hydrocarbons into versatile allyl-
containing building blocks, in which the double bond can be functionalized in a later reaction. 
Normally, the process of hydroarylation requires the activation of the alkenes by π-acidic 
metal centers. This renders them electrophilic and therefore, susceptible to addition by arene 
nucleophiles.
[121]
  
In the coordination study of 92 with Rh, it was observed that an equilibrium was established 
between 109c and its monomeric 109d, which has a vacant coordinate site available for 
further coordination. Considering the strong π-acceptor properties of 92, we reasoned that 
109d might be suitable catalyst for the type of processes mentioned above. Hence, the 
intermolecular hydroarylation of 1,3-dienes with electron-rich aromatics was chosen as model 
to test the reactivity of our catalyst. We began our investigations by treatment of 
phenylbutadiene with 92b (5 mol %), [RhCl(CO)2]2 (2.5 mol %) in the presence of indole as 
nucleophiles. KB(Ar
F
)4 (Potassium tetrakis(pentafluorophenyl)borate, 10 mol %) was added 
as anion exchange reagent to increase the solubility of 109d in DCE. Under these conditions, 
94% conversion of 116 into 118 was observed. The regioselectivity was also very good (96:4 
γ:α), probably due to the hindrance originated by the -Ph group that precluded the 
nucleophilic attack at the γ position of phenylbutadiene (Table 5). Further control experiments 
proved that neither KB(Ar
F
)4 nor [RhCl(CO)2]2 could catalyze this reaction. In order to 
determine if KB(Ar
F
)4 was responsible for the increased catalyst reactivity, the cationic ligand 
92c was synthesized. Hydroarylation of 116 in the presence of [RhCl(CO)2]2 and 92c (5 mol 
%) also afforded the desired compound in 91% conversion and a 92:8 γ/α ratio. This reaction 
demonstrated that the K
+
 from KB(Ar
F
)4 did not influence the catalytic activity. When ligands 
101b, 105, 106 or 115 were used instead of 92b under identical conditions, the desired 
product was formed in less than 5% conversion. These initial observations demonstrated the 
ability of ligand 92 as a π-acceptor ligand to increase the acidity of the Rh atom, thus 
facilitating the catalytic transformation. Of note, the use of 4-methyl-2,6-di-
t
Bu-pyridine (5 
mol%) as a Brønsted acid scavenger did not inhibit the reaction as depicted in entry 13, while 
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a strong Brønsted acid like TfOH led to decomposition of the diene, resulting in a 
complicated mixture (entry 7). 
Table 5: Optimization of Rh(I)-catalyzed hydroarylation of phenyldiene with indole. 
 
[a] Conversion to the products and the ratio of 118a and 118b; values determined by analysis of 
1
H NMR spectra 
of unpurified mixtures with CH2Br2 as an internal standard; [b] Isolated yield; [c] The diene decomposed; [d] 4-
methyl-2,6-di-
t
Bu-pyridine (5 mol%) was added to the reaction. 
Next, a range of electron-rich arenes was investigated. As shown in Table 6, phenyl-
substituted 1,3-diene underwent site-selective hydroarylation with a series of indoles at 70 °C 
to afford 118-124 in moderate to excellent yields with good to excellent selectivity. More 
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intriguingly, 1,3-dimethoxybenzene also participates in the reaction, delivering 124 in 63% 
yield (91:9 γ:α).  
In addition, we could expand the scope of the Rh(I)-catalyzed protocol to more challenging 
site-selective additions using internal dienes as substrates, but at expense of the yield. Thus, 1-
aryl-4-alkyl-substituted dienes underwent catalytic hydro-heteroarylation with N-methyl-2-
phenylindole and 1,3-dimethoxybenzene to deliver functionalized products 125 and 126 in 
33% and 43% yields respectively, with a significant increase in regioselectivity (99:1 γ:α) in 
the case of the more hindered N-methyl-2-phenylindole. Electron-deficient dienes could be 
also used for this transformation,
[122]
 although the yields were low in all cases. The selectivity 
of the addition was 96:4 γ:α and 97:3 γ:α for 128 and 129 respectively. 
Table 6: Substrate scope of Rh(I)-catalyzed hydroarylation of diene with electron-rich aromatic compounds. 
 
[a] Diene (0.2 mmol), aromatics (0.2 mmol), 92b (5 mol%), [RhCl(CO)2]2 (2.5 mol%), KB(Ar
F
)4 (10 mol%) in 
DCE (1.0 ml) was heated for 18 h at 70 
o
C; [b] Isolated yield; [c] the ratio of products were determined by 
analysis of 
1
H NMR spectra of unpurified mixtures or GCMS. 
3.6.1 Theoretical Investigation of Chelating Dicationic Ligands in Catalysis 
The origin of activation for ligand 92 was theoretically evaluated by comparing the reactant 
complex INT2 to the complex with the analogous neutral ligand (Figure 33). Presumably, the 
lowest unoccupied orbital on the diene would be the relevant orbital to interact with the 
nucleophile in the addition step. In the neutral complex, this orbital is the LUMO and in 
INT2, the orbital is the LUMO+3 (the LUMO, LUMO+1, and LUMO+2 orbitals are localized 
elsewhere but are all similar in energy). The LUMO+3 on INT2 is significantly lower than 
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the LUMO on the neutral complex by ~5 eV. Furthermore, the computed NBO charge 
transfer upon complexation reveals a net transfer of 0.02 e from the metal to the diene while 
complexation in INT2 results in a net transfer of 0.21 e from the diene to the Rh complex. 
The significantly lower LUMO of the diene and resulting positive charge accumulation 
readily accounts for the enhanced reactivity using ligand 92 relative to neutral chelating 
ligands.  
 
Figure 33. The relevant unoccupied orbitals are shown for INT1 and a neutral analogue. The NBO charge 
transfer is also shown. 
3.7 Summary III 
In summary, we outlined herein the preparation of new bidentate dicationic phosphines and 
their coordination chemistry towards different metals. Moreover, we showcased for the first 
time the utility of cationic ligands to promote difficult reductive elimination processes under 
mild condition, such as the formation of polyfluorinated biaryls from Pd(II) centers. Finally, 
the unique properties of these ligands in catalysis has been proven in the hydorarylation of 
phenyl diene with indoles and electron rich arenes. 
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4 Isolation and Coordination Chemistry of     
CAACs substituted α-Radical Phosphines  
4.1  Introduction 
Carbenes are compounds that feature a divalent carbon atom with only six electrons in its 
valence shell. In the singlet state, they possess a lone pair of electrons and a vacant orbital and 
therefore exhibit Lewis acidic and Lewis basic properties, which explains their high 
reactivity.
[123]
 Following the preparation by Bertrand group in 1988 of the first representative 
[bis-(diisopropylamino)phosphino](trimethylsilyl)carbene 130,
[124]
 a variety of stable carbenes 
were prepared and are now available, the most popular being the cyclic diaminocarbenes 131 
also known as NHCs.
[125-126]
 Following the pioneering work by Herrmann, NHCs have been 
recognized as excellent ancillary ligands for transition metal-based catalysts and also as 
organic catalysts in their own right.
[127-129]
 In the last decade, Bertrand et al. have developed a 
new type of carbene 132, namely the cyclic (alkyl)(amino)carbenes (CAACs) , which have 
attracted more and more attention due to their unusual reactivity in main group chemistry 
derived from special electronic and steric properties.
[123, 130]
 
 
Scheme 39. Representative carbenes that have been developed recently. 
In CAACs one of the electronegative and π-donor amino substituents of diaminocarbenes is 
formally replaced by a σ-donating but not π-donating alkyl group. As a consequence, CAACs 
are more nucleophilic (σ-donating) but also more electrophilic (π-accepting) than 
diaminocarbenes. Additionally, the presence of a quaternary carbon in the position α to the 
carbene center provides steric environments that differentiate CAACs dramatically from all 
other carbenes (Scheme 39b). Theses peculiar stereoelectronic properties of CAACs allow for 
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the stabilization of unusual diamagnetic and paramagnetic main group based species.
[123, 130]
 
For examples, Bertrand and coworkers described the preparation of room temperature stable 
diphosphorus
[131]
 and diantimony
[132]
 derivatives in which the central heteroatom is in the zero 
oxidation state (Scheme 40a). Nucleophilic boron compounds have also been synthesized 
using CAACs (Scheme 40b).
[133-134]
  
 
Scheme 40. Structurally characterized CAACs stabilized main group compounds. 
CAACs are also excellent ligands for transition metal complexes. Their most recent 
application consists in their use for the stabilization of paramagnetic complexes, in which the 
metal is in a formal zero or even lower oxidation state. Indeed, bis(CAAC)M complexes have 
been isolated in which the central metal is gold
[135-136]
, platinum
[137]
, palladium
[138]
, 
copper
[139]
, cobalt
[140-141]
, iron
[140]
, nickel
[142]
, manganese
[141, 143]
, and zinc
[144]
. These results 
demonstrate that CAACs are excellent π-acceptor ligands, a necessary property for the 
stabilization of zero-valent mononuclear metal complexes (Scheme 41). 
 
Scheme 41. Structurally characterized CAACs stabilized metal complexes with zero oxidation state. 
Because CAACs possess a singlet spin ground state and a smaller energy gap between the 
HOMO and the lowest unoccupied molecular orbital (LUMO) than NHCs.
[145]
 The isolation 
of CAACs stabilized radicals is also possible. The better π-accepting properties of CAACs are 
able to enhance the delocalization of the single electron to their π system, resulting in the 
decreased energetic state of the SOMO. Moreover, the presence of a quaternary center 
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adjacent to the carbene makes CAACs sterically demanding. This avoids radical dimerization 
As a consequence, CAACs have proved to be excellent ligands for the stabilization of 
phosphorus-,
[146-147]
 boron-,
[133, 148]
 silicon-
[149-152]
 and even carbon-centered neutral or cationic 
radicals
[153-155]
 (Scheme 42).  
 
Scheme 42. Structurally characterized CAACs stabilized radicals. 
4.2 α-Radical Phosphines based on CAACs 
The major task of my research was to synthesize α-cationic ligands with stronger π-accepting 
character via reaction of diverse carbenes with chlorophosphine and to explore the isolation of  
the derived radicals.
[123]
. 
4.2.1 Synthesis of Cationic Phosphines 
CAAC 137 was obtained via the same method reported by the Bertrand group.
[130]
 Imine 135, 
formed by condensation of isobutylaldehyde with 2,6-diisopropylaniline, was lithiated with 
LDA followed by reaction with isobutyl epoxide and addition of Tf2O to afford imine 136 in 
one pot. This compound was deprotonated by LDA to afford carbene 137 (Scheme 43).  
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Scheme 43. Synthesis of 137. 
Then, CAAC 137 in THF was treated with Ph2PCl, Cy2PCl and [p-(F)Ph]2PCl to generate 
yellow precipitates, which were separated from the reaction mixture by simple filtration. After 
anion exchange and recrystallization, CAAC-stabilized phosphines 138a, 138b and 138c were 
obtained in moderate to good yields (58-66%), proving the generality of our strategy (Scheme 
44).
[156]
   
 
Scheme 44. Synthesis of CAAC stabilized cationic ligand 138a-c. 
The formation of cations 138a-c was first indicated by the appearance of a signal in the 
31
P 
NMR resonance (δ = 0.0, 21.6, -4.3 ppm). These values were comparable to the ones reported 
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for imidazolium or cyclopropenium substituted compounds. Moreover, the molecular 
structures of 138a-c were unambiguously characterized by X-ray crystallography (Figure 34-
36). Two structural parameters are crucial for the understanding of the electron environment 
around the phosphorus atom in 138a-c. The P1-C1(carbene) bond lengths [138a: 1.864(3) Å, 
138b: 1.8846(11) Å, 138c: 1.8529(15) Å] are similar to those observed in neutral aromatic 
phosphines, but are significantly longer than typical P=C double bonds.
[157]
 On the other hand, 
the N1-C1(carbene) bond lengths [138a: 1.305(3) Å, 138b: 1.3057(14) Å, 138c: 1.3067(19) 
Å] are comparable to the C=N bond observed from imines (1.279 Å in DBN). In addition, the 
degrees of pyramidalization at phosphorus (138a: 56.5%, 138b: 55.3%, 138c: 53.3%) are 
comparable to those observed for neutral aromatic phosphines (56.7% for PPh3).
[87]
 These two 
parameters reveal marginal back-donation from the phosphorus to the CAAC rings and 
suggest retention of a nonbonding electron pair on this atom. The pyramidalization in 138c is 
smaller than in 138a and 138b, probably because the -CF3 group on the phenyl ring lowers the 
energy of the π-system of the phenyl group, increasing delocalization of the P electron pair 
into this ring. This also suggests indirectly that the P1-C1(carbene) bond in 138c contains 
more single bond character than 138a and 138b. 
  
Figure 34. Molecular structure of compound 138a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and solvent molecules have been omitted for clarity. 
 
Figure 35. Molecular structure of compound 138b in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
  76 
 
 
Figure 36. Molecular structure of compound 138c in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
4.2.2 Electronic Properties of Cationic Phosphines 
The donor abilities of phosphines 138a-c were evaluated by cyclic voltammetry. Phosphines 
138a-c display higher oxidation potential than phosphites and even most monocationic 
phosphines, which suggests their stronger π-acceptor properties. Among them, 138c 
containing -CF3 groups on the phenyl ring shows the highest oxidation potential and 
therefore, should represent the strongest π-acceptor properties. In addition, it was observed 
that the one electron reduction is quasi-reversible at E1/2 (138a: -1.347 V, 138b: -1.436 V, 
138c: -1.187 V) against the Cp
*
2Fe/Cp
*
2Fe
+
, as shown in Table 7 and Figures 37-39, which 
indicates the formation of stable radical that might be isolated and characterized. 
Table 7: Electrochemical redox potentials of ligands 138a-c. The values for commonly used phosphorus-based 
ligands and reference compounds are included for comparison. 
 
[a] Oxidation/reduction peaks potential reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, Bu4NPF6 (0.1 M) in 
CH2Cl2; [b] No reduction signal  observed from 0 to -2.5 V; [c] no signal detected from 0 to 2V. 
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Figure 37. Cyclic voltammograms of 138a reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, Bu4NPF6 (0.1 
M) in CH2Cl2. 
 
Figure 38. Cyclic voltammograms of 138b reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, Bu4NPF6 (0.1 
M) in CH2Cl2. 
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Figure 39. Cyclic voltammograms of 138c reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, 
n
Bu4NPF6 (0.1 
M) in CH2Cl2. 
4.2.3 Coordination of the Cationic Ligands. 
Based on the analysis of the donor ability of 138a-c, it is expected that the electron lone pairs 
on the phosphorus atoms are still available for coordination to metal salts. Thus ligands 138a-
c were reacted with (Me2S)AuCl to afford 139a-c as shown in Scheme 45. Importantly, the 
coordination of phosphorus to the gold center in each complex was confirmed by the 
displacement of the original 
31
P NMR signal, and ultimately by X-ray diffraction (Figure 40-
42). 
 
Scheme 45. Synthesis of 139a-c. 
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Figure 40. Molecular structure of compound 139a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
 
Figure 41. Molecular structure of compound 139b in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
 
Figure 42. Molecular structure of compound 139c in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
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4.3 α-Radical Phosphines 
4.3.1 Synthesis of the Radical Phosphines 
Encouraged by the distinctive cyclic voltammetry observed for these compounds, we decided 
to ascertain whether stoichiometric one electron reduction of these cations to the 
corresponding radicals could be carried out. To this end, 138a was treated with Mg(0) 
powder
[155]
 or Li(0) sand in THF at room temperature; however, no significant change was 
observed by the 
31
P NMR analysis and only starting material was recovered. This suggested 
that the reductants used were not strong enough to transfer electrons to the cationic 
phosphorus ligands. 
 
Scheme 46. Synthesis of radical 140a-c. 
When one of the strongest reductants KC8 (potassium graphite) was used for the same 
purpose, the reaction mixture turned deep red, indicating the possibility of radical formation, 
since the majority of radicals are quite colorful (Scheme 46). To further prove this hypothesis, 
a small amount of the deep red solution was taken out from the Schleck and exposed to air, 
losing its color within a few seconds. To confirm the existence of radicals, the solid obtained 
after evaporation of the solvent from the reaction mixture was dissolved in toluene and 
analyzed by EPR. The X-band EPR spectrum of 140a in toluene displays a multiplet (g = 
2.0056) due to a large hyperfine coupling constant with the phosphorus nucleus [a(31P) = 
18.00 G] and a small hyperfine coupling constant with the nitrogen nucleus [a(
14
N) = 6.00 G] 
(Figure 43). This spectrum was well-simulated with that of a carbon-centered radical that 
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shows coupling with phosphorus and nitrogen atoms. Thus, this experiment unambiguously 
supported the radical nature of 140a. In a similar manner, radicals 140b and 140c were also 
synthesized from 138b and 138c in excellent yields respectively. Their EPR spectra are 
shown in Figure 44 and 45. 
 
Figure 43. X-band EPR spectrum of 140a in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0056, a(
31
P) = 18.00 G, a(
14
N) = 6.00 G]. 
 
Figure 44. X-band EPR spectrum of 140b in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0055, a(
31
P) = 1.04 G, a(
14
N) =5.17 G]. 
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Figure 45. X-band EPR spectrum of 140c in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0056, a(
31
P) = 14.69 G, a(
14
N) = 6.12 G]. 
Finally, the connectivity of 140a and 140c was unambiguously confirmed by single X-ray 
diffraction analysis after obtaining crystals by cooling solutions of 161a and 161c in pentane 
(Figure 46 and 47). The first evidence for the formation of the radicals from cationic 
phosphines was the absence of SbF6
-
 counter anions that was present in the starting material. 
Due to the single electron reduction, the N1=C1(carbene) double bonds [133a: 1.305(3) Å, 
138c: 1.3067(19) Å] on cationic phosphines reduce their bond order as reflected in the 
elongation of the bond lengths [140a: 1.3979(17) Å, 140c: 1.394(3) Å]. On the other hand, the 
P1-C1(carbene) bonds on radicals [140a: 1.7881(14) Å, 140c: 1.785(2) Å] were shorter than 
those in their cationic precursors [133a: 1.864(3) Å, 138c: 1.8529(15) Å], showing partial 
delocalization of the single electron into the σ* orbitals of P-C(Ph).[158] In addition, the degree 
of pyramidalization at phosphorus (140a: 53.6%, 140c: 53.8%) was slightly smaller than that 
observed for neutral aromatic phosphines (56.76 for PPh3). This parameter revealed that back-
donation from the phosphorus to the CAAC rings must be marginal and suggest retention of a 
nonbonding electron pair on this atom. 
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Figure 46. Molecular structure of radical 140a in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
 
Figure 47. Molecular structure of radical 140c in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
4.3.2 Coordination of α-Radical Phosphines towards Au(I) 
The electron lone pairs on the phosphorus atoms of 140a-c were still available for the 
coordination to metal salts. To the best of our knowledge, there is no successful example of α-
radical phosphines ever investigated in coordination chemistry, probably due to its highly 
reactive properties. Hence, our next goal was to study radicals 140a-c in coordination 
chemistry. 
Initially, 140a smoothly reacted with (Me2S)AuCl in THF affording the radical complex 141, 
which was insoluble in pentane, giving the first indication of the successful coordination. In a 
similar manner, 142 and 143 were synthesized from 140a and 140b respectively in excellent 
yields. However, mixing 140c and (Me2S)AuCl in THF led to a complicated mixture, in 
which black precipitates, probably Au(0) were formed in the reaction mixture. During this 
process, the radical phosphine was probably oxidized to the cationic phosphine (Scheme 47). 
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Scheme 47. Synthesis of 141-143. 
Subsequently, to additionally confirm the existence of radicals, each of the solids 141-143 
was dissolved in toluene and evaluated by EPR analysis. The X-band EPR spectrum of 
product 141 in toluene (Figure 48) displays a multiplet (g = 2.0053) due to a small hyperfine 
coupling constant with the phosphorus nucleus [a(31P) = 7.70 G] and a large hyperfine 
coupling constant with the nitrogen nucleus (a(
14
N) = 13.83 G]. The resulting spectrum could 
be well-simulated and matched that of a carbon-centered radical involving phosphorus and 
nitrogen atoms. In a similar manner, radicals 142 and 143 in toluene were also analyzed by 
EPR spectra as shown in Figures 49-50 and their spectra were well-simulated with that of a 
carbon-centered radical that shows coupling with phosphorus and nitrogen atoms.  
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Figure 48. X-band EPR spectrum of 141 in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0053, a(31P) = 7.70 G, a(14N) = 13.83 G]. 
 
Figure 49. X-band EPR spectrum of 142 in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0046, a(
31
P) = 2.05 G, a(
14
N) = 6.16 G]. 
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Figure 50. X-band EPR spectrum of 143 in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0056, a(
31
P) = 7.75 G, a(
14
N) =5.90 G]. 
Finally, radicals 141-143 derived from 140a and 140b were unambiguously confirmed by 
single X-ray diffraction analysis (Figure 51-53). The absence of counter anions proved the 
presence of neutral radical Au complexes. Like in the free ligands, the P1-C1(carbene) bond 
lengths [141: 1.7825(13) Å, 142: 1.7985(9) Å, 143: 1.7715(13) Å] were shorter in comparison 
to their cationic species [139a: 1.873(2) Å, 139b: 1.883(4) Å], showing the delocalization of 
the single electron into σ* orbitals of the P-C(Ph) bonds. Conversely, the N1-C1(carbene) 
bond lengths [141: 1.3955(16) Å, 142: 1.4018(12) Å, 143: 1.3904(16) Å] were elongated in 
comparison to their cationic species [139a: 1.300(3) Å, 139b: 1.301(5) Å], since the 
N1=C1(carbene) double bond reduce the bond order after the single electron reduction. The 
Au1-P1 bond lengths [141: 2.2377(4) Å, 142: 2.2473(4) Å, 143: 2.2840(5) Å] were similar to 
those of their cationic species [139a: 2.2221(6) Å, 139b: 2.2269(10) Å].  
 
Figure 51. Molecular structure of compound 141 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
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Figure 52. Molecular structure of compound 142 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms have been omitted for clarity. 
 
Figure 53. Molecular structure of compound 143 in the solid state. Thermal ellipsoids at 50% probability; 
hydrogen atoms and solvent molecules have been omitted for clarity. 
4.3.3 Coordination of α-Radical Phosphines towards Other Metal Salts 
In order to further explore the coordination chemistry of the radical ligands, 140a was chosen 
as model ligand. Initially, AgSbF6 and (Me2S)CuBr were reacted with 140a, affording 
cationic phosphines 138a and 144, in which the metal salts were reduced by single electron 
transfer. Similarly, mixing of 140a with CoCl2 afforded the cationic compound 145, with 
[CoCl4]
2- 
as the counter anion (Scheme 48).  
 
Scheme 48. Attempts to coordinate 140a to other metal salts. 
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Figure 54. Molecular structure of the decomposed product 144 in the solid state. Thermal ellipsoids at 50% 
probability; hydrogen atoms have been omitted for clarity. 
 
Figure 55. Molecular structure of the decomposed product 145 in the solid state. Thermal ellipsoids at 50% 
probability; hydrogen atoms and solvent molecules have been omitted for clarity. 
4.4 Synthesis of Cationic Phosphine Oxide and the Radical thereof 
Phosphine oxides feature tetrahedral phosphorus centers, in which the P-O bond is short and 
polar. Phosphine oxides are useful ligands in various reactions, such as Kumada−Corriu 
cross-couplings
[159]
 and Suzuki−Miyaura Reactions[160]. In addition, it is quite popular to use 
phosphine oxides as hemilabile pre-ligands in catalysis.
[161-162]
 Therefore, it would be 
interesting to know whether we could obtain the cationic phosphine oxides by the oxidation of 
cationic phosphine 138a. Thus, we subjected compound 138a to oxidation using m-CPBA in 
CH2Cl2 at room temperature. The oxidation proceeded in quantitative yield affording a white 
solid 146, which was unambiguously confirmed by X-ray diffraction analysis to be the 
desired oxide (Scheme 49 and Figure 56). Subsequently, compound 146 was investigated by 
cyclovoltammetry, depicting a quasi-reversible redox potential, which indicated the 
possibility of isolating the corresponding radical (Figure 57).  
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Scheme 49. Synthesis of cationic phosphine oxide 146. 
 
Figure 56. Molecular structure of 146 in the solid state. Thermal ellipsoids at 50% probability; hydrogen atoms 
have been omitted for clarity 
 
 
Figure 57. Cyclic voltammograms of 146 reported in V and calibrated versus Cp
*
2Fe/Cp
*
2Fe
+
, 
n
Bu4NPF6 (0.1 M) 
in CH2Cl2. 
The oxide 146 was subjected to the same reaction conditions as before, using KC8. This 
produced a new red solid 147 (Scheme 50). The confirmation about the radical nature of 147 
came from EPR and X-ray analysis (Figures 58 and 59). The X-band EPR spectrum of 147 in 
toluene displayed a multiplet (g = 2.0057) due to a small hyperfine coupling constant with the 
phosphorus nucleus [a(31P) = 6.14 G] and a large hyperfine coupling constant with the 
nitrogen nucleus (a(
14
N) = 16.96 G] (Figure 59). The resultant spectrum was well-simulated 
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with that of a carbon-centered radical involving phosphorus and nitrogen atoms. Thus, the 
EPR data unambiguously supported the presence of a radical 147. Finally, red crystals of 147 
suitable for X-ray crystallography studies were obtained from pentane in the freezer and its 
structure in the solid state was confirmed by X-ray diffraction. The most obvious evidence for 
the radical is the absence of counter anions that are present in the starting material. Like in the 
ligands, the P1-C1(carbene) bond length [147: 1.7878(7) Å] was shorter in comparison to 
their cationic species [146: 1.8819(16) Å], showing the delocalization of the single electron 
into σ* orbital of P-C(Ph) bond. Conversely, the N1-C1(carbene) bond length [147: 1.3940(9) 
Å] was elongated in comparison to their cationic species [146: 1.299(2) Å], since the 
N1=C1(carbene) double bonds on cationic phosphine oxide again reduces its bond order. 
 
Scheme 50. Synthesis of radical 147. 
 
Figure 58. Molecular structure of the decomposed product 147 in the solid state. Thermal ellipsoids at 50% 
probability; hydrogen atoms have been omitted for clarity. 
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Figure 59. X-band EPR spectrum of 147 in toluene [observed spectrum in blue, simulated spectrum in red; g = 
2.0057, a(
31
P) = 6.14 G, a(
14
N) = 16.96 G]. 
4.5 Theoretical Analysis of Properties of α-Radical Phosphines  
The coordination between AuCl and radical phosphine 140a was evaluated as an example 
using charge decomposition analysis (CDA) and extended charge decomposition analysis 
(ECDA). The result displayed in Figure 60 reveals that the HOMO/SOMO of complex 140a-
AuCl is mainly contributed by the HOFO of 140a. The LUFO of AuCl with dz2 of Au and the 
HOFO-1 of 140a with lone pair on P atom contribute to the HOMO-5 of 140a-AuCl, which 
invloves the Au-P bond formation. Hence, the closer energy difference for LUFO of MCl (M 
= Au, Cu, Ag) and HOFO-1 of ligands is more favorable for M-P bond formation of the 
complex. 
3360 3410 3460 3510
Field [G] 
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Figure 60. Orbital correlation diagram for 140a-AuCl of the interaction between framents AuCl and 140a. A 
plot of important molecular orbitals of 140a-AuCl and its related fragments are also presented. LUMO: lowest 
unoccupied molecular orbital; HOMO: highest occupied molecular orbital; LUFO: lowest unoccupied fragment 
orbital; HOFO: highest occupied fragment orbital; SOMO: single occupied molecular orbital. 
The important frontier orbital energies (in eV) for all radical phosphines 140a-c and metal 
salts MCl (M = Au, Cu, Ag) were computed at the UB3LYP-D3/def2-TZVP level as shown 
in Table 8. The LUMO energies of CuCl (ELUMO = -3.30 eV) and AgCl (ELUMO = -3.63 eV) 
are much higher than that of AuCl (ELUMO = -4.21 eV). Thus, the reaction of metal salt CuCl 
and AgCl with radical phosphine ligands may be less stable than the ones of AuCl. This is 
also consistent with the complex forming energies (EL-MCl) shown in Table 8 that the EL-MCl 
values for CuCl and AgCl related complexes are more than 10 kcal/mol less than the ones for 
140a-AuCl. The energy of HOMO-1 for 140b (EHOMO-1 = -5.06 eV) and 140c (EHOMO-1 = -
5.59 eV) is, respectively, slightly higher and lower than that of 140a (EHOMO-1 = -5.48 eV). 
Comparatively, complex 140b-AuCl might be more stable than 140a-AuCl, while the 
complex 140c-AuCl might be less stable. 
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Table 8. The SOMO/HOMO and LUMO energies (in eV) for all the species at the UB3LYP-D3/def2-TZVP 
level. SOMO-1 and SOMO represent occupied and unoccupied SOMO respectively.  
 
 
1
The HOMO-1 and HOMO orbitals for MCl (M = Au, Cu, and Ag) are degenerated. 
2
The HOMO orbital for the 
ligands and coordinated species is a SOMO orbital due to the stable radical. 
 
In the case of the free ligands, the Mulliken spin density is mostly concentrated at the C1 (ca. 
65%) and N (ca. 25%) atoms, and also some small distribution on the P atom. Similar results 
could be perceived by visualizing the SOMO. There is also some small distribution of spin 
density on C13 (Scheme 47) for 140a and 140c. This is consistent with the DFT calculated 
larger hyperfine coupling constant of C13 for both ligands in comparison with 140b. 
Consequently, the spin densities on P for both ligands are slightly higher. The 
31
P atom still 
exhibit detectable hyperfine coupling in the EPR spectrum despite rather small spin densities 
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on it (<5%). The computed hyperfine coupling constants for 
14
N and 
31
P agree well with the 
ones from the simulated EPR, while the overestimation of 
31
P on 140b might be caused by the 
negative spin density (Table 10). Computationally, the α-spin density is positive, and the β-
spin density if negative. When the computed absolute β-spin density value is bigger than the 
α-spin density, the total spin density is negative. In this case the discrepancy may be related to 
the use of an unrestricted approach, which is known to generally overestimate the difference 
between α-spin and β-spin populations.[163-164] After the ligand binds to AuCl, the spin density 
distributed on Au is very small. This is also consistant with the experimental EPR simulation 
results that indicate no coupling for Au. Hence, both spin density and hyperfine coupling 
constant results are similar with the ones observed for ligands. 
Table 9. The Mulliken spin densities and SOMO-1 plot of all the ligands and AuCl coordinated species at the 
UB3LYP-D3/def2-TZVP level. 
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Table 10. Calculated hyperfine coupling constants (A in 10
-4 
cm
-1
) of all species at the UB3LYP-D3/def2-TZVP 
level of theory. Aiso values greater than 2.0 are only reported. Experimental data was reported in red color. 
 
4.6 Summary IV 
We have successfully isolated and characterized a series of CAAC derived cationic 
phophines. Their cyclovoltammetry showed a quasi-reversible redox potential, which 
indicated that stable radicals were formed after one electron reduction. As a result, a series of 
α-radical phosphines have been synthesized and fully characterized. More intriguingly, these 
radical phosphines could coordinate to Au(I) and form a range of stable gold complexes that 
are unprecedented. In addition, we were also able to synthesize the radical phosphorus oxide. 
All of the synthesized radicals have been characterized by EPR and most have been 
crystallized. These novel compounds could be named as α-radical phosphine ligands, which 
might be useful in catalysis. 
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5 Experimental Part 
5.1 General Experimental Conditions 
5.1.1 Working Techniques 
All moisture- and oxidation-sensitive reactions were performed in carefully dried glassware 
under argon atmosphere. The saturated aqueous solutions of sodium chloride, sodium 
bicarbonate, sodium carbonate and ammonium chloride, were saturated over sediment, unless 
indicated otherwise. 
 
Solvents and reagents 
 
All solvents were purified by distillation before use by following standard procedures. Dry 
solvents were obtained by distillation over the appropriate drying agent (vide infra) and then 
kept under argon atmosphere: diethyl ether, tetrahydrofuran, toluene, benzene, pentane and 
n
hexane (sodium, benzophenone as indicator); N,N'-dimethylformamide (Desmodur
®
, 
dibutyltin dilaurate); CH2Cl2, acetone, acetonitrile, Et3N (calcium hydride); fluorobenzene 
(phosphorus pentoxide), methanol and ethanol (magnesium). 1,2-Dichloro-ethane was 
purchased from Sigma-Aldrich and used as received. Other commercial reagents were 
obtained from various sources and used without further purification. 
 
Inert gas atmosphere 
 
Air and moisture-sensitive reactions were conducted under argon atmosphere. Argon was 
obtained from Air Liquide with higher than 99.5% purity. 
 
Chromatographic methods 
 
Reactions were mostly monitored by thin layer chromatography (TLC) using silica gel  
pre-coated polyester sheets (40 × 80 mm, Polygram
®
 SIL G/UV254 from Macherey-Nagel). 
The spots were visualized with UV-light (λ = 254 nm) and/or by staining with 
phosphomolybdic acid or potassium permanganate stains.  
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Flash column chromatography was performed using silica gel 60 (Merck, 60 Å, 230-400 
mesh 0.040-0.063 mm) and separations were conducted at slightly elevated pressure in a glass 
column. 
5.1.2 Analytical Methods 
Nuclear magnetic resonance spectroscopy (NMR) 
Spectra were recorded on Bruker DPX 300 (
1
H: 300 MHz, 
13
C: 75 MHz, 
31
P: 121 MHz), 
Bruker AV 400 (
1
H : 400 MHz, 
13
C: 100 MHz, 
31
P: 161 MHz), and Bruker AV 500 (
1
H: 500 
MHz, 
13
C: 125 MHz, 
31
P: 202 MHz) spectrometers at room temperature (298 K). Chemical 
shifts (δ) are given in parts per million (ppm) relative to tetramethylsilane (1H and 13C, 
internal standard) and H3PO4 (
31
P, external standard) and coupling constants (J) in Hertz (Hz). 
The corresponding solvent signals were used as a references: CDCl3: δC 77.0 ppm, δH 7.26 
ppm; CD2Cl2: δC 54.0 ppm, δH 5.32 ppm; CD3CN: δC 1.32 ppm, δC 118.26 ppm δH 1.94 
ppm; [D8]-toluene δC 20.4 ppm, δC 125.5 ppm, δC 128.3 ppm, δC 129.2 ppm, δC 137.9 
ppm, δH 2.08 ppm, δH 6.97 ppm, δH 7.01 ppm and δH 7.09 ppm. The 1H NMR multiplicities 
are assigned as follows: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), sextet 
(sext), septet (sept), multiplet (m), broad (br.). The signals have been assigned using 1D and 
2D experiments. 
 
Infrared spectroscopy 
 
IR spectra were recorded using ATR (attenuated total reflection) on a Spectrum One (Perkin-
Elmer) spectrometer at room temperature. The characteristic absorption bands are given in 
wavenumbers [cm
-1
]. 
 
Analytical gas chromatography 
 
GC-MS couplings were performed on an Agilent Technology GC 6890 Series and MSD 5973 
(carrier gas: helium) with HP6890 Series Injector, employing an MN Optima
®
5 column (30 m 
× 0.25 mm × 0.25 mm). The mass spectra were recorded with an Agilent Technology 5973 
Network MSD spectrometer. Quantitative evaluation of the integration was based on the 
substance peaks without considering response factors, unless stated otherwise. 
 
Mass spectrometry (MS) 
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Mass spectra were measured on a Finnigan MAT 8200 (70 eV) or MAT 8400 (70 eV) 
spectrometer by electron ionization, chemical ionization, or fast atom/ion bombardment 
techniques. High resolution masses were determined on a Bruker APEX III FT-MS 
spectrometer (7 T magnet). All masses are given in atomic units per elementary charge (m/z) 
and reported in percentage relative to the basic peak. The mechanistic studies (cf. Chapter 
4.5.2) were performed by ESI-MS with a Finnigan Ultra Mass TSQ 7000. 
 
X-ray crystal structure analysis 
 
The crystal structures were measured in the X-ray department of the Max Planck Institute for 
Coal Research in Mülheim an der Ruhr, led by Dr. C. W. Lehmann. The measurements were 
made using a Bruker-AXS Kappa CCD diffractometer. 
 
Electron paramagnetic resonance (EPR) 
 
X-band EPR spectra were recorded on a Bruker ELEXSYS E500 spectrometer equipped with 
a Bruker dual-mode cavity (ER4116DM) and a Bruker high-sensitivity microwave bridge 
Super-X (ER-049X) with integrated microwave frequency counter. The magnetic field 
controller was externally calibrated with a Bruker NMR field probe (ER035M). The liquid 
samples were measured in 2mm quartz tubes and the spectra were simulated with the program 
ESIM/ISO (available from E. Bill by mail to ebill@gwdg.de). 
 
5.1.3 Starting Materials as well as in Working Group-made Chemicals 
Commercially available chemicals were used without further purification unless otherwise 
stated. Working group's internal chemicals: 2-phenylylphosphine. 
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5.2 Synthesis  
Compound 62 
 
PCl3 (0.16 ml, 1.8 mmol) and TMSOTf (0.65 ml, 3.6 mmol) were added at – 78°C to a 
solution of K[BH2(Pz)2] (0.334 g, 1.8 mmol) in CH2Cl2 (5 ml). The mixture was allowed to 
warm up to r.t. overnight. Then the solvent was filtered off and the yellow solid washed with 
CH2Cl2 (2 x 5 ml). The crude product thus obtained was extracted with CH3CN (2 x 5 ml) at 0 
°C and the combined solvents removed in vacuo to afford 62 as a white solid (157.1 mg, 24 
%). m.p.: 95 °C (dec.). 
1
H NMR (CD3CN, 300 MHz): δ = 8.60 (d, J = 2.1 Hz, 2H), 8.42 (s, 
2H), 6.86 (m, 2H), 4.08 – 3.53 ppm (br s, 2H). 13C NMR (CD3CN, 100 MHz): δ = 146.9, 
143.2 (d, JC–P = 30.8 Hz),  122.2 (q, JC–F = 320.2 Hz), 111.1 ppm (d, JC–P = 6.0 Hz). 
31
P NMR 
(CD3CN, 121 MHz): δ = 85.7 ppm. 
11
B NMR (CD3CN, 128 MHz,): δ = 8.1 ppm. 
19
F NMR 
(CD3CN, 282 MHz): δ = –  79.3 ppm. IR ῦ = 442, 516, 575, 633, 779, 913, 1024, 1060, 1084, 
1162, 1225, 1419, 2456, 3112, 3139 cm
– 1
. Elemental analysis for C7H8BClF3N4O3PS 
(362.46): calcd. for C 23.20%, H 2.22%, N 15.46%, found: C 23.14%, H 2.56%, N 16.12%.  
 
Compound 63 
 
PhPCl2 (1.5 ml, 10.7 mmol) and TMSOTf (1.9 ml, 10.7 mmol) were added at – 78°C to a 
suspension of K[H2B(Pz)2] (2.0 g, 10.7 mmol) in CH2Cl2 (10 ml) and the mixture was 
allowed to warm up to r.t. overnight. Then the solvent was filtered off and the white solid left 
washed with CH2Cl2 (2 x 5 ml). The crude product was then extracted with CH3CN (2 x 5 ml) 
at 0 °C and the combined solvent removed in vacuo to afford 63 as a white solid (2.5 g, 57%). 
Colourless crystals suitable for X−ray crystallography were obtained from a CH3CN/Et2O at –
30 °C. m.p.: 101 °C (dec.). 
1
H NMR (CD3CN, 400 MHz): δ = 8.62 (dd, J = 3.3 Hz, JH–P = 3.9 
Hz, 2H), 8.29 (s, 2H), 7.57 (m, 1H), 7.48 (m, 2H), 7.09 (m, 2H), 6.88 (dd, J = 2.4 Hz, JH–P 
=5.1 Hz, 2H), 3.25 ppm (br, JH–B = 138 Hz). 
13
C NMR (CD3CN, 100 MHz): δ = 145.8, 144.0 
(d, JC–P = 26.7 Hz), 133.3, 131.6 (d, JC–P = 17.4 Hz), 130.7 (d, JC–P = 19.4 Hz), 130.3 (d, JC–P 
= 5.6 Hz), 122.2 (q, JC–F = 319.7 Hz), 110.7 ppm (d, JC–P = 5.2 Hz). 
31
P NMR (CD3CN, 162 
MHz): δ = 87.1 ppm. 11B NMR (CD3CN, 128 MHz): δ = – 7.1 ppm (t, JB–H = 105 Hz). 
19
F 
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NMR (CD3CN, 282 MHz): δ = – 79.3 ppm. IR ῦ = 416, 443, 465, 517, 633, 690, 746, 780, 
950, 983,1027, 1061, 1092,1139, 1252, 1388, 1419, 2461, 3020, 3138 cm
– 1
. Elemental 
analysis for C13H13BF3N4O3PS (404.05) calcd. for: C 38.64%, H 3.24%, N 13.86%,found: C 
37.78%, H 2.89%, N 13.65%.  
 
Compound 64 
 
CyPCl2 (0.21 ml, 1.3 mmol) and TMSOTf (0.24 ml, 1.300 mmol) were added at –78°C to a 
suspension of K[H2B(Pz)2] (250.0 mg, 1.301 mmol) in CH2Cl2 (5 ml) and the mixture was 
allowed to warm up to r.t. overnight. Then the solvent was filtered off and the white solid 
obtained washed with CH2Cl2 (2 x 5 ml). Then the crude product was extracted with CH3CN 
(2 x 5 ml) at 0 °C and the organic solvent removed in vacuo to afford  64 as a white solid 
(302.1 mg, 55%). mp: 113 °C (dec), 
1
H NMR (CD3CN, 400 MHz): δ = 8.42 (dd, J = 3.3 Hz, 
JH–P = 3.3 Hz, 2H), 8.3702 (s, 2H), 6.32 (dd, J = 2.7 Hz, JH–P = 4.6, Hz, 2H), 4.01 (br, JH–B = 
128 Hz), 3.16 (m, 2H), 1.79 (m, 3H), 1.35 (m, 7H) ppm, 
13
C NMR (CD3CN, 100 MHz): δ = 
145.5, 143.7 (d, JC–P = 25.3 Hz), 122.1 (q, JC–F = 320.9 Hz), 110.6 (d, JC–P = 5.4 Hz), 39.5 (d, 
JC–P = 20.5 Hz), 25.9, 25.8, 25.7, 25.6, 25.5 ppm. 
31
P NMR (CD3CN, 162 MHz): δ = 102.8 
ppm. 
11
B NMR (CD3CN, 128 MHz): δ = – 8.1 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 79.3 
ppm. IR ῦ = 6 35, 697, 792, 875, 1027, 1073, 1137, 1222, 1263, 1414, 2425, 2490, 2859, 
2928, 3105, 3137 cm
– 1
. Elemental analysis for C13H19BF3N4O3PS (410.16): calcd. for C 
38.07%, H 4.67%, N 13.66%, found: C 38.03%, H 4.23%, N 13.12%.  
 
Compound 67 
 
PhPCl2 (1.8 ml, 13.5 mmol) and TMSOTf (4.9 ml, 27.0 mmol) were added at – 78°C to a 
solution of [H2C(Pz)2] (2.0 g, 13.500 mmol) in CH2Cl2 (10 ml) and the mixture allowed to 
warm up to r.t. overnight. Then the solvent was filtered off and the white solid thus obtained 
washed with CH2Cl2 (2 x 5 ml). The crude product was dissolved in CH3CN (5 ml), 
precipitated with Et2O (15 ml) and dried in vacuo to afford 67 as a white solid (2.83 g, 38%). 
Colourless crystals suitable for X−ray crystallography were obtained from a CH3CN/Et2O at – 
30°C. m.p.: 86 °C (dec.). 
1
H NMR (CD3CN, 400 MHz): δ = 8.98 (dd, J = 2.5 Hz, JH–P = 2.5 
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Hz, 2H), 8.75 (s, 2H), 7.70 (m, 1H), 7.60 (m, 2H), 7.39 (m, 2H), 7.29 (d, J = 14.9 Hz, 1H), 
7.10 (m, 2H), 5.87 (d, J = 14.9 Hz, 1H) ppm. 
13
C NMR (CD3CN, 100 MHz): δ = 147.9 (d, JC–
P = 19.4 Hz), 145.1, 134.7, 131.9 (d, JC–P = 18.7 Hz), 131.0 (d, JC–P = 5.5 Hz), 128.3 (d, JC–P = 
24.3 Hz), 121.9 (q, JC–F = 320.3 Hz), 111.7 (d, JC–P = 2.2 Hz), 63.3 ppm. 
31
P NMR (CD3CN, 
162 MHz): δ = 85.8 ppm. 19F NMR (CD3CN, 282 MHz): δ = – 79.3 ppm. IR ῦ = 675, 838, 
894, 1029, 1162, 1220, 1241, 1377, 1563, 1580, 2827, 3136 cm
–1
. Elemental analysis for 
C15H13F6N4O6PS2 (554.38): calcd. for C 32.50%, H 2.36%, N 10.11%,  found: C 32.11%, H 
2.76%, N 10.60%.  
 
Compound 68 
 
CyPCl2 (0.26 ml, 1.7 mmol) and TMSOTf (0.61 ml, 3.4 mmol) were added to a suspension of 
[H2C(Pz)2] (250.0 mg, 1.7 mmol) in CH2Cl2 (5 ml) at – 78°C and the mixture allowed to 
warm up to r.t. overnight. The solvent was then evaporated in vacuo and the resulting solid 
dissolved in CH3CN (2 ml). Then Et2O (10 ml) was added to precipitate the product 68 as a 
white solid (433.3 mg, 46%). m.p.: 93 °C (dec.). 
1
H NMR (CD3CN, 400 MHz): δ = 8.80 (s, 
2H), 8.76 (s, 2H), 7.56 (s, 1H), 7.05 (s, 2H), 6.84 (s, 1H), 2.97 (m, 1H), 1.94 (m, 2H), 1.85 
(m, 1H), 1.54 (m, 4H), 1.34 ppm (m, 3H). 
13
C NMR (CD3CN, 100 MHz): δ = 147.3 (d, JC–P = 
20.9 Hz), 144.9 (d, JC–P = 2.8 Hz), 121.9 (q, JC–F = 320.4 Hz), 112.1 (d, JC–P = 5.4 Hz), 63.4, 
40.5 (d, JC–P = 26.9 Hz), 25.6, 25.5, 25.4, 25.3, 25.2 ppm. 
31
P NMR (CD3CN, 162 MHz): δ = 
110.1 ppm.
19
F NMR (CD3CN, 282 MHz): δ = – 79.3 ppm. IR ῦ = 573, 609, 759, 1023, 1159, 
1246, 1567, 2744, 2853, 3039, 3121 cm
– 1
. Elemental analysis for C15H19F6N4O6PS2 (560.42): 
calcd. for C 32.15%, H 3.24%, N 10.00%, found: C 31.18%, H 3.34%, N 9.68%.  
 
Compound 69 
 
(Et2N)PCl2 (0.29 ml, 2.0 mmol) and TMSOTf (0.73 ml, 4.0 mmol) were added to a solution 
of [H2C(Pz)2]  (296.0 mg, 2.0 mmol) in CH2Cl2 (4 ml) at – 78°C and the mixture was allowed 
to warm up to r.t. overnight. The solvent was then filtered off and the white solid thus 
obtained washed with CH2Cl2 (2 x 5 ml). Crude 69 was then dissolved in CH3CN and 
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precipitated with Et2O (362.1 mg, 33%). Colourless crystals suitable for X−ray 
crystallography were obtained from CH3CN/Et2O at – 30°C. m.p.: 103 °C (dec.). 
1
H NMR 
(CD3CN, 400 MHz): δ = 8.69 (s, 2H), 8.61 (s, 2H), 7.27 (d, J = 11.36 Hz, 1H), 7.08 (t, J = 
2.88 Hz, 1H), 7.08 (d, 11.36 Hz, 1H), 3.38 (m, 4H), 1.23 ppm (t, J = 7.1 Hz, 6H). 
13
C NMR 
(CD3CN, 75 MHz): δ = 143.7 (d, JC–P = 9.0 Hz), 142.1, 111.7, 63.2, 43.9, 43.7, 13.8, 13.7 
ppm. 
31
P NMR (CD3CN, 162 MHz): δ = 107.8 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 
79.3 ppm. IR ῦ = 515, 574, 632, 759, 1023, 1100, 1158, 1347, 1391, 1445, 1522, 1567, 2854, 
2997, 3120 cm
– 1
. Elemental analysis for C13H18F6N5O6PS2 (549.40): calcd. for C 28.42%, H 
3.40%, N 12.75%, found: C 28.23%, H 3.28%, N 12.75%.  
 
Compound 73 
 
PhPCl2 (0.75 ml, 5.4 mmol) and TMSOTf (2.0 ml, 10.8 mmol) were added at – 78°C to a 
suspension of bisoxazoline 72 (1.28 g, 5.4 mmol) in CH2Cl2 (20 ml) and the mixture allowed 
to warm up to r.t. overnight. Filtration of the solvent afforded a white solid that was 
subsequently washed with CH2Cl2 (2 x 10 ml). Crude 73 was then dissolved in CH3CN at 0°C 
and precipitated with Et2O to afford the desired product as a white solid (1.55 g, 45%). m.p.: 
65.2– 67.8 °C. 1H NMR (CD3CN, 300 MHz): δ = 8.11 – 8.05 (m, 2H), 7.94 – 7.90 (m, 1H), 
7.80 – 7.74 (m, 2H), 5.08 – 5.04 (m, 4H), 2.19 (s, 3H), 2.04 (s, 3H), 1.85 (s, 6H), 1.08 (s, 6H) 
ppm. 
13
C NMR (CD3CN, 75 MHz): δ = 175.7 (d, JC–P = 6.9 Hz ), 138.1 , 135.9 (d, JC–P = 33.9 
Hz), 131.7 (d, JC–P = 11.1 Hz), 129.3 (d, JC–P = 29.2 Hz), 86.3 , 75.6 (d, 12.9), 41.9 (d, J = 1.1 
Hz), 29.6, 26.5 (d, J = 2.1 Hz), 25.6 (d, J = 10.0 Hz), 22.7 ppm (d, J = 1.9 Hz). 
31
P NMR 
(CD3CN, 162 MHz): δ = 88.8 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 79.17 ppm. IR ῦ = 
435, 493, 516, 573, 634, 693, 739, 934, 1026, 1149, 1245, 1329, 1382, 1495, 1599, 1656, 
2941 cm
– 1
. Elemental analysis for C21H27F6N2O8PS2 (644.54): calcd. for C 39.13%, H 4.22%, 
N 4.35%, found: C 38.33%, H 4.22%, N 4.35%.  
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Compound 76 
 
PCl3 (0.56 ml, 6.4 mmol) and TMSOTf (2.3 ml, 12.8 mmol) were added at – 78°C to a 
suspension of K[HB(3,5– Me2Pz)3] (2.05 g, 6.1 mmol) in CH2Cl2 (10 ml) and the mixture was 
allowed to warm up to r.t. overnight. Filtration of the solid afforded a white solid that was 
subsequently washed with CH2Cl2 (2 x 5 ml). The crude product was extracted with CH3CN 
(2 x 10 ml) and the solvent evaporated in vacuo to afford 76 as a white solid (1.134 g, 24%). 
Colourless crystals suitable for X−ray crystallography were obtained from CH3CN/Et2O 
solution at – 30°C. m.p.: 118 °C (dec), 1H NMR (CD3CN, 300 MHz): δ = 6.44 (d, JH–P =4.4, 
Hz, 3H), 4.79 (br, JH–B = 162 Hz), 2.70 (s, 9H), 2.57 ppm (s, 9H). 
3
C NMR (CD3CN, 101 
MHz): δ = 158.3, 156.2 (d, JC–P = 19.3 Hz), 122.0 (d, JC–F = 320.7 Hz), 111.2 (q, JC–P = 2.2 
Hz), 13.1 (d, JC–P = 8.8 Hz), 12.8 ppm. 
31
P NMR (CD3CN, 121 MHz): δ = 7.3 ppm. 
11
B NMR 
(CD3CN, 128 MHz): δ = – 9.9 (d, JB–H = 129 Hz) ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 
79.3 ppm. IR ῦ = 516, 573, 605, 633, 691, 756, 789, 906, 1023, 1099, 1160, 1223, 1435, 
1522, 2700, 3040, 3142 cm
– 1
. Elemental analysis for C17H22BF6N6O6PS2 (626.29): calcd. for 
C 32.60%, H 3.54%, N 13.42%, found: C 32.11%, H 3.52%, N 12.95%.  
 
Compound 79 
 
PCl3 (0.16 ml, 1.8 mmol) and TMSOTf (0.65 ml, 3.6 mmol) were added at – 78°C to a 
solution of K[B(Pz)4] (572 mg, 1.8 mmol) in CH2Cl2 (5 ml) and the mixture was allowed to 
warm up to r.t. overnight. After filtration of the supernatant the white solid obtained washed 
with CH2Cl2 (2 x 5 ml) and extracted with CH3CN (2 x 10 ml). Evaporation of the solvent in 
vacuo afforded the desired product 79 as a white solid (588 mg, 43%). Colourless crystals 
suitable for X−ray crystallography were obtained from a CH3CN/Et2O solution at 5 °C. m.p.: 
122 °C (dec.). 
1
H NMR (CD3CN, 300 MHz): δ = 8.86 (s, 3H), 8.61 (s, 3H), 8.28 (s, 1H), 8.08 
(s, 1H), 6.85 (d, JH– P = 2.6, 3H), 6.82 (s, 1H). 
13
C NMR (CD3CN, 75 MHz): δ = 146.5 (d, JC–
P = 19.3 Hz), 145.5, 136.3, 121.8 (q, JC–F = 320.2 Hz), 110.8, 110.7 (d, JC–P = 3.2 Hz) ppm. 
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31
P NMR (CD3CN, 121 MHz): δ = – 0.4 ppm. 
11
B NMR (CD3CN, 128 MHz): δ = – 1.3 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 79.3 ppm. IR ῦ = 567, 594, 766, 864, 1065, 1109, 1157, 
1243, 1392, 1157, 2659, 3133 cm
– 1
. Elemental analysis for C14H12BF6N8O6PS2 (608.20): 
calcd. for C 27.65%, H 1.99%, N 18.42%, found: C 27.96%, H 1.67%, N 18.14%.  
 
Compound 82 
 
PCl3 (0.23 ml, 2.6 mmol) and TMSOTf (1.4 ml, 7.9 mmol) were added to a solution of 
[HC(3,5–Me2Pz)3] (790 mg, 2.6 mmol) in CH2Cl2 (5 ml) at – 78°C and the mixture was 
allowed to warm up to r.t. overnight. Filtration of the solvents afforded a white solid that 
washed with CH2Cl2 (2 x 5 ml). Crude 82 was then dissolved in CH3CN (5 ml) and 
precipitated with Et2O (15 ml) to afford a white solid (608 mg, 29%). m.p.: 102 °C (dec.). 
1
H 
NMR (CD3CN, 400 MHz): δ = 9.60 (s, 1H), 6.75 (d, JH–P =4.8 Hz, 3H), 2.89 (s, 9H), 2.88 
ppm (s, 9H). 
13
C NMR (CD3CN, 101 MHz): δ = 161.6 (d, JC–P = 15.2 Hz), 158.5, 121.8 (q, 
JC–F = 320.2 Hz), 112.6, 70.8 (d, JC–P = 3.6 Hz), 15.1 (d, JC–P = 5.4 Hz), 13.6 ppm. 
31
P NMR 
(CD3CN, 121 MHz): δ = – 9.9 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 79.2 ppm. IR ῦ = 
447, 515, 573, 631, 707, 760, 844, 944, 1022, 1078, 1160, 1207, 1417, 1584, 2709, 2940, 
3135 cm
– 1
. Elemental analysis for C19H22F9N6O9PS3 (776.56): calcd. for C 29.39%, H 2.86%, 
N 10.82%, found: C 29.52%, H 3.02%, N 10.50%.  
 
Compound 91 
 
To a solution of [2-(diphenylphosphino)phenyl]phosphine (200.0 mg, 0.340 mmol) in THF 
(10 ml) was added with chlorocyclopropenium salt (243.7 mg, 0.680 mmol) and Et3N (0.1 ml, 
0.710 mmol). The resulting mixture was stirred at 60 
o
C overnight. After cooling to r.t., the 
solvent was removed in vacuo, the left was dissolved in CH2Cl2 and the resulting solution 
washed three times with sat. NaBF4. Once dried over Na2SO4, the organic phase was 
concentrated and the left was crystallized from CH2Cl2/Et2O to afford compound 91 as a 
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white solid (146.0 mg, 46%). Colourless crystals suitable for X−ray crystallography were 
obtained from CH2Cl2/Et2O at r.t. 
1
H NMR (CD2Cl2, 500 MHz): δ = 8.19 – 8.16 (m, 1H), 7.92 
– 7.80(m, 1H), 7.71 – 7.67 (m, 2H), 7.42 – 7.38 (m, 2H), 4.47 (d, J = 2.70 Hz, 1H), 3.86 (br, 
1H), 3.67 – 7.62 (m, 1H), 3.35 – 7.32 (m, 1H), 2.84 – 2.81 (m, 1H), 1.48 – 0.90 (m, 48H), 
0.50 ppm (d, J = 6.80 Hz, 3H). 
13
C NMR (CD3CN, 125 MHz): δ = 178.5 (dd, J = 90.6 Hz, J = 
1.7 Hz), 143.5 (d, J = 22.5 Hz), 137.2 (d, J = 5.6 Hz), 136.3 (d, J = 5.2 Hz), 136.2 (dd, J = 
20.2 Hz, J = 3.0 Hz), 135.5 (dd, J = 20.6 Hz, J = 2.9 Hz),  134.3 (d, J = 11.4 Hz),  133.3 (d, J 
= 11.3 Hz), 133.2 (d, J = 11.4 Hz), 132.9 (dd, J = 65.4 Hz, J = 8.9 Hz), 132.3 (d, J = 14.0 Hz), 
131.4 (d, J = 12.5 Hz), 131.0 (d, J = 13.0 Hz), 121.4 (d, J = 84.2 Hz), 120,1 (d, J = 80.9 Hz), 
107.6 (d, J = 91.9 Hz), 81.2, 69.5 (dd, J = 8.7 Hz, J = 4.2 Hz), 52.1, 50.0, 46.8 (dd, J = 81.2 
Hz, J = 22.0 Hz), 44.1, 27.0, 26.0, 25.1, 24.4 (d, J = 8.5 Hz), 23.5 (d, J = 6.0 Hz), 22.92, 
22.86, 21.4, 20.1 ppm. 
31
P NMR (CD3CN, 121 MHz): δ = 31.9 (d, J = 24.8 Hz), – 16.2 ppm 
(d, J = 24.8 Hz). 
11
B NMR (CD3CN, 96 MHz): δ = – 1.1 ppm. 
19
F NMR (CD3CN, 282 MHz): 
δ = – 152.5 ppm. HRMS calcd. for C48H70N4BF4P2
+
: 851.510320, found 851.509943. IR ῦ = 
491, 528, 585, 646, 690, 724, 911, 1050, 1099, 1149, 1205, 1249, 1353, 1376, 1440, 1462, 
1543, 1568, 1856, 2129, 2262, 2880, 2938, 2974 cm
– 1
. 
 
Compound 92a 
 
2–Chloro–1,3–dimethylimidazolidinium tetrafluoroborate (150.0 mg, 0.680 mmol) and Et3N 
(0.100 ml, 0.710 mmol) were added to a solution of [2-(diphenylphosphino)phenyl]phosphine 
(100.0 mg, 0.340 mmol) in THF (5 ml) and the resulting mixture stirred at 60 
o
C overnight. 
After cooling to r.t., the solvent was filtered and the left washed with CHCl3 to afford a white 
solid. This solid was stirred with NaBF4 (149.6 mg, 1.360 mmol) in CH3CN (5 ml) overnight. 
Subsequently the solvent was removed in vacuo and the resulting white solid extracted with 
CH2Cl2 (3 × 20 ml). The combined organic phase thus obtained was evaporated in vacuo to 
afford 92a as a white solid (146.3 mg, 65%). 
1
H NMR (CD3CN, 400 MHz): δ = 7.76 – 7.68 
(m, 3H), 7.53 – 7.45 (m, 6H), 7.42 – 7.38 (m, 1H), 7.34 – 7.30 (m, 4H), 3.84 – 3.80 (m, 8H), 
2.98 ppm (s, 12H). 
13
C NMR (CD3CN, 100 MHz): δ = 164.4 (dd, J = 47.5 Hz, J = 18.0 Hz), 
144.3 (dd, J = 35.6 Hz, J = 5.1 Hz), 137.1 (d, J = 7.8 Hz), 136.6 (d, J = 8.2 Hz), 135.2 (d, J = 
1.4 Hz), 134.5, 134.3, 134.0 (dd, J = 6.0 Hz, J = 1.0 Hz), 133.2, 131.3, 130.4, (d, J = 7.3 Hz), 
127.3 (dd, J = 39.5 Hz, J = 3.1 Hz), 53.4, 36.8 ppm (d, J = 8.7 Hz).
 31
P NMR (CD3CN, 121 
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MHz): δ = – 12.3 (d, JP–P = 211.6 Hz), – 47.6 ppm (d, JP–P = 212.6 Hz).
 11
B NMR (CD3CN, 
96 MHz): δ = – 1.2 ppm. 19F NMR (CD3CN, 282 MHz): δ = – 151.8 ppm. HRMS calcd. for 
C28H34N4BF4P2
+
: 575.228360, found 575.228243. IR ῦ = 425, 457, 522, 653, 699, 741, 762, 
936, 998, 1094, 1111, 1300, 1337, 1418, 1434, 1445, 1523, 1579, 3105 cm
– 1
. 
 
Compound 92b 
 
2–Chloro–1,3–dimethylimidazolidinium tetrafluoroborate (150.0 mg, 0.680 mmol) and Et3N 
(0.100 ml, 0.710 mmol) were added to a solution of [2-(diphenylphosphino)phenyl]phosphine 
(100.0 mg, 0.340 mmol) in THF (5 ml) and the resulting mixture stirred at 60 
o
C overnight. 
After cooling to r.t., the solvent was filtered and the left washed with CHCl3 to afford a white 
solid. This solid was stirred with NaSbF6 (352.0 mg, 1.360 mmol) in CH3CN (5 ml) 
overnight. Subsequently the solvent was removed in vacuo and the resulting white solid 
extracted with CH2Cl2 (3 × 10 ml). The combined organic phase thus obtained was 
evaporated in vacuo to afford 92b as a white solid (234.9 mg, 72%). Colourless crystals 
suitable for X−ray crystallography were obtained from CH2Cl2/Et2O at – 20 
o
C. 
1
H NMR 
(CD3CN, 400 MHz): δ = 7.76 – 7.68 (m, 3H), 7.53 – 7.45 (m, 6H), 7.42 – 7.38 (m, 1H), 7.34 
– 7.30 (m, 4H), 3.84 – 3.80 (m, 8H), 2.98 ppm (s, 12H). 13C NMR (CD3CN, 100 MHz): δ = 
164.4 (dd, J = 47.5 Hz, J = 18.1 Hz), 144.3 (dd, J = 30.0 Hz, J = 4.9 Hz), 137.1 (d, J = 7.2 
Hz), 136.6 (d, J = 8.4 Hz), 135.0, 134.4 (d, J = 18.6 Hz), 134.0 (dd, J = 6.0 Hz, J = 1.0 Hz), 
133.2, 131.3, 130.4, (d, J = 7.3 Hz), 127.3 (dd, J = 40.6 Hz, J = 4.2 Hz), 53.4, 36.8 ppm (d, J 
= 8.7 Hz).
 31
P NMR (CD3CN, 121 MHz): δ = – 10.7 (d, JP–P = 212.4 Hz), – 46.1 ppm (d, JP–P 
= 212.4 Hz).
 19
F NMR (CD3CN, 376 MHz): δ = – 124.0 ppm (sextet, JF– Sb(I=5/2) = 1933 Hz, 
octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for C28H34N4SbF6P2
+
: 723.119040, found 
723.119040. IR ῦ = 422, 456, 518, 653, 699, 745, 767, 934, 998, 1090, 1107, 1300, 1335, 
1412, 1434, 1445, 1521, 1576, 3103 cm
– 1
. 
 
Compound 92c 
 
  107 
 
92b (96.0 mg, 0.100 mmol) and KB(Ar
F
)4 (143.6 mg, 0.2 mmol) in CH2Cl2 (2 ml) stirred for 
10 min at r.t. After filtration, the filtrate was evaporated in vacuo to afford the desired 
compound 92c as a white solid (183.0 mg, 99%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 7.82 – 
7.77 (m, 1H), 7.64 – 7.59 (m, 1H), 7.57 – 7.51 (m, 3H), 7.50 – 7.45 (m, 4H), 7.36 – 7.31 (m, 
1H), 7.28 – 7.22 (m, 4H), 3.87 – 3.80 (m, 8H), 3.04) ppm (s, 12H). 13C NMR (CD2Cl2, 125 
Mz): δ = 164.1 (dd, J = 54.8 Hz, J = 23.9 Hz), 149.4 (br), 147.6 (br), 144.3 (dd, J = 35.7 Hz, J 
= 1.8 Hz), 139.7 (m), 137.7 (m), 135.8 (d, J = 1.8 Hz), 135.7 (m), 133.9 (d, J = 9.2 Hz), 
133.6, 133.5, 133.4, 131.6, 131.5, 130.2 (d, J = 8.0 Hz), 125.1 (dd, J = 42.6 Hz, J = 7.0 Hz), 
52.8, 36.5 ppm (d, J = 8.7 Hz). 
31
P NMR (CD2Cl2, 162 MHz): δ = – 9.8 (d, JP–P = 213.8 Hz), – 
49.1 ppm (d, JP–P = 213.8 Hz). 
19
F NMR (CD2Cl2, 282 MHz): δ = – 133 (m), – 163.2 (t, JF–F = 
20.2 Hz), – 167.3 ppm (t, JF–F = 18.1 Hz). 
11
B NMR (CD2Cl2, 96 MHz): δ = – 16.7 ppm. 
HRMS calcd. for C28H34N4P2
+
: 244.112390, found 244.112387. IR ῦ = 489, 501, 573, 610, 
661, 683, 713, 756, 774, 930, 954, 976, 1084, 1274, 1297, 1374, 1413, 1460, 1513, 1577, 
1643 cm
– 1
. 
 
Compound 99 
 
n
BuLi (1.6 M in hexanes, 2.92 ml, 4.672 mmol) was added dropwise to Rac–98 (2.3 g, 4.672 
mmol) in THF (25 ml) at – 78 °C and the mixture stirred for 1 h at – 78 °C. Then 
ClP(O)(OEt)2 (0.680 ml, 4.672 mmol) in THF (5 ml) was added dropwise and the mixture 
was allowed to warm to r.t. overnight. After that all volatiles were removed in vacuo and the 
crude phosphate was purified by column chromatography (SiO2, hexane:EtOAc = 3:1) to 
afford the rac–phosphate 99 (1.1 g, 47%). 1H NMR (CDCl3, 400 MHz): δ = 7.90 (dd, J = 15.2 
Hz, J = 7.12 Hz, 1H), 7.38 –  7.34 (m, 1H), 7.32 – 7.18 (m, 14H), 3.99 – 3.12 (m, 4H), 1.97 
(s, 3H), 1.27 (s, 3H), 1.15 ppm (q, J = 5.8 Hz, 6H). 
13
C NMR (CDCl3, 100 MHz): δ = 145.5 
(dd, J = 33.5 Hz, J = 4.1 Hz), 143.4 (d, J = 8.2 Hz), 143.3 (d, J = 9.0 Hz), 139.7 (d, J = 13.9 
Hz), 138.4 (dd, J = 15.3 Hz, J = 2.3 Hz), 138.0 (d, J = 11.4 Hz), 137.0 (d, J = 6.5 Hz), 136.9 
(d, J = 13.4 Hz), 135.4 (d, J = 22.7 Hz), 133.9 (d, J = 2.9 Hz), 133.0 (d, J = 17.1 Hz), 131.7 
(d, J = 1.8 Hz), 131.1 (d, J = 9.2 Hz), 130.5, 129.0, 128.4 (d, J = 7.7 Hz), 128.0 (d, J = 4.9 
Hz), 127.5 (d, J = 10.4 Hz), 127.3 (d, J = 15.6 Hz), 127.1 (d, J = 2.8 Hz), 61.8 (t, J = 5.4 Hz), 
20.5 (d, J = 2.7 Hz), 19.4, 16.4 ppm (dd, J = 11.7 Hz, J = 6.0 Hz). 
31
P NMR (CDCl3, 121 
MHz): δ = 17.7, – 16.2 ppm. HRMS calcd. for C30H32O3P2Na
+
: 525.171490, found 
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525.171893. IR ῦ = 426, 445, 485, 514, 539, 574, 591, 696, 751, 787, 878, 953, 998, 1051, 
1090, 1156, 1192, 1254, 1367, 1391, 1433, 1444, 1479, 1584, 2864, 2902, 2977, 3051 cm
– 1
. 
 
Compound 100 
 
To LiAlH4 (135.9 mg, 3.582 mmol) in Et2O (5 ml) at – 78 °C was added the previously 
prepared rac–phosphate 99 (600.0 mg, 1.194 mmol) in Et2O (5 ml) over the course of ca. 0.5 
h. This gray suspension stirred at – 78 °C for an additional 15 min, allowed to warm to r.t. 
overnight. After this time, the reaction mixture was cooled to 0 °C. Deoxygenated water was 
carefully added and stirred until gas evolution ceased. The organic layer was then transferred 
into a schlenk and the solid was extracted with Et2O (2 × 15 ml). Subsequently, the combined 
organic phases were dried with Na2SO4, filtered through Celite and the solvent removed in 
vacuo to afford 100 as a white solid (404.1 mg, 85%). 
1
H NMR (CDCl3, 400 MHz): δ = 7.43 
(t, J = 6.8 Hz, 1H), 7.27 – 7.15 (m, 13H), 7.12 – 7.10 (m, 1H), 7.10 – 7.03 (m, 1H), 3.72 (dd, 
J = 31.6 Hz, J = 12.0 Hz, 1H), 3.21 (dd, J = 31.6 Hz, J = 12.0 Hz, 1H), 1.93 (s, 3H), 1.48 ppm 
(s, 3H). 
13
C NMR (CDCl3, 400 MHz): δ = 146.4 (dd, J = 31.4 Hz, J = 3.7 Hz), 144.1 (dd, J = 
16.2 Hz, J = 7.0 Hz), 137.9 (d, J = 12.3 Hz), 137.5 (d, J = 9.8 Hz), 137.2 (t, J = 3.0 Hz), 136.7 
(d, J = 12.3 Hz), 136.4 (d, J = 6.3 Hz), 134.6 (d, J = 21.1 Hz), 133.6 (d, J = 19.2 Hz), 132.5 
(d, J = 9.8 Hz), 132.2 (d, J = 2.0 Hz), 131.1, 130.,0, 129.9 (d, J = 2.9 Hz), 128.8, 128.4 (d, J = 
4.1 Hz), 128.36 (d, J = 2.7 Hz), 128.30, 127.9, 127.6 (d, J = 4.7 Hz), 20.1, 19.8 ppm. 
31
P 
NMR (CDCl3, 121 MHz): δ = – 15.0 (d, JP–P = 20.1 Hz), – 125.6 ppm (d, JP–P = 20.1 Hz). 
HRMS calcd. for C26H25P2
+
: 399.142680, found 399.142604,
 IR ῦ = 438, 490, 506, 537, 553, 
573, 743, 768, 787, 827, 914, 998, 1026, 1067, 1094, 1147, 1206, 1261, 1306, 1379, 1400, 
1434, 1475, 1566, 1584, 2294, 2851, 2913, 3001, 3048 cm
– 1
. 
 
Compound 101a 
 
2–Chloro–1,3–dimethylimidazolidinium tetrafluoroborate (110.0 mg, 0.502 mmol) and Et3N 
(0.070 ml, 0.527 mmol) were added to a solution of 100 (100.0 mg, 0.251 mmol) in THF (5 
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ml). The resulting mixture was stirred at 60 
o
C overnight. After cooling to r.t., the solvent was 
filtered and the left washed with CHCl3, affording a white solid. This solid was stirred with 
NaBF4 (220.0 mg, 2.008 mmol) in CH3CN (5 ml) overnight. Subsequently the solvent was 
removed in vacuo and the resulting white solid extracted with CH2Cl2. The combined organic 
phase thus obtained was evaporated in vacuo to afford 101a as a white solid (78.9 mg, 41%). 
Colourless crystals suitable for X−ray crystallography were obtained from CH3COCH3/Et2O 
at r.t. 
1
H NMR (CD3CN, 400 MHz): δ = 7.71 – 7.70 (m, 1H), 7.56 – 7.50 (m, 2H), 7.47 – 7.26 
(m, 10H), 7.16 – 7.09 (m, 3H), 4.07 (d, J = 2.4 Hz, 4H), 3.95 – 3.90 (m, 2H), 3.83 – 3.79 (m, 
2H), 3.13 (s, 6H), 2.78 (s, J = 0.6 Hz, 6H), 1.81 (s, 3H), 1.20 ppm (m, 3H).
 13
C NMR 
(CD3CN, 100 MHz): δ = 166.1 (dd, J = 47.6 Hz, J = 0.8 Hz), 163.2 (dd, J = 53.2 Hz, J = 4.9 
Hz), 145.7 (dd, J = 34.8 Hz, J = 5.7 Hz), 142.2 (dd, J = 8.2 Hz, J = 1.9 Hz), 141.5 (d, J = 7.2 
Hz), 141.2 (d, J = 7.0 Hz), 140.0 (dd, J = 6.2 Hz, J = 1.4 Hz), 139.7 (dd, J = 34.8 Hz, J = 5.7 
Hz), 137.1 (d, J = 8.9 Hz), 136.3 (d, J = 22.4 Hz), 135.9, 134.6, 133.8 (dd, J = 8.0 Hz, J = 3.9 
Hz), 133.6 (d, J = 1.8 Hz), 133.4 (d, J = 3.4 Hz), 133.3 (d, J = 2.8 Hz), 132.8, 131.2, 131.1 (d, 
J = 0.9 Hz), 130.3 (d, J = 2.4 Hz), 129.9 (d, J = 5.9 Hz), 129.8 (d, J = 8.6 Hz), 54.5, 52.6, 38.0 
(dd, J = 11.2 Hz, J = 3.5 Hz), 37.2 (d, J = 10.8 Hz), 19.5 (d, J = 2.3 Hz), 18.9 ppm (d, J = 3.2 
Hz).
 31
P NMR (CD3CN, 121 MHz): δ = – 14.6 (d, JP–P = 87.0 Hz), – 44.3 ppm (d, JP–P = 87.0 
Hz).
 11
B NMR (CD3CN, 96 MHz): δ = – 1.2 ppm.
 19
F NMR (CD3CN, 282 MHz): δ = – 151.8 
ppm.
 
HRMS calcd. for C36H42N4BF4P2
+
: 679.290520, found 679.290843.
 IR ῦ = 438, 461, 
480, 493, 506, 531, 576, 633, 646, 698, 746, 754, 767, 787, 931, 1024, 1047, 1223, 1297, 
1332, 1363, 1411, 1435, 1447, 1526, 1579, 1709, 2923, 3504 cm
– 1
. 
 
Compound 101b 
 
2–Chloro–1,3–dimethylimidazolidinium tetrafluoroborate (110.0 mg, 0.502 mmol) and Et3N 
(0.070 ml, 0.527 mmol) were added to a solution of 100 (100.0 mg, 0.251 mmol) in THF (5 
ml). The resulting mixture was stirred at 60 
o
C overnight. After cooling to r.t., the solvent was 
filtered and the left washed with CHCl3, affording a white solid. This solid was stirred with 
NaSbF6 (517.5 mg, 2.000 mmol) in CH3CN (5 ml) overnight. Subsequently the solvent was 
removed in vacuo and the resulting white solid extracted with CH2Cl2. The combined organic 
phase thus obtained was evaporated in vacuo to afford 101b as a white solid (162.9 mg, 61%). 
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1
H NMR (CD3CN, 400 MHz): δ = 7.78 – 7.72 (m, 1H), 7.58 – 7.52 (m, 2H), 7.49 – 7.26 (m, 
10H), 7.18 – 7.12 (m, 3H), 4.10 (s, 4H), 3.98 – 3.92 (m, 2H), 3.85 – 3.80 (m, 2H), 3.15 (s, 
6H), 2.79 (s, J = 0.6 Hz, 6H), 1.81 (s, 3H), 1.21 ppm (m, 3H).
 13
C NMR (CD3CN, 100 MHz): 
δ = 165.7 (d, J = 47.9 Hz), 163.0 (dd, J = 53.2 Hz, J = 4.9 Hz), 145.5 (dd, J = 34.8 Hz, J = 5.7 
Hz), 141.8 (d, J = 8.1 Hz), 141.3 (d, J = 6.8 Hz), 141.0 (d, J = 7.0 Hz), 139.8 (d, J = 6.2 Hz), 
139.5 (dd, J = 7.8 Hz, J = 1.7 Hz), 136.9 (d, J = 8.9 Hz), 136.1 (d, J = 22.4 Hz), 135.6, 134.4, 
133.6 (dd, J = 8.4 Hz, J = 4.0 Hz), 133.3 (d, J = 17.7 Hz), 133.1, 132.5, 131.0, 130.9, 130.1 
(d, J = 2.4 Hz), 129.8 (d, J = 5.9 Hz), 129.6 (d, J = 8.6 Hz), 54.3, 52.4, 37.8 (dd, J = 11.2 Hz, 
J = 3.5 Hz), 37.0 (d, J = 10.8 Hz), 19.2 (d, J = 1.8 Hz), 18.7 ppm (d, J = 3.0 Hz).
 31
P NMR 
(CD3CN, 121 MHz): δ = – 15.0 (d, JP–P = 85.1 Hz), – 44.4 ppm (d, JP–P = 87.0 Hz).
 19
F NMR 
(CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 
Hz). HRMS calcd. for C32H41ONP
+
: 486.292280.
 
HRMS calcd. for C36H42N4SbF6P2
+
: 
827.182162, found 827.1829.
 IR ῦ = 438, 461, 480, 493, 506, 531, 576, 633, 646, 698, 746, 
754, 767, 787, 931, 1024, 1047, 1223, 1297, 1332, 1363, 1411, 1435, 1447, 1526, 1579, 1709, 
2923, 3504 cm
– 1
. 
 
Compound 102 
 
2–Chloro–1,3–dimethylimidazolidinium tetrafluoroborate (132.6 mg, 0.602 mmol) and Et3N 
(0.088 ml, 0.632 mmol) were added to a solution of Diphenyl(2– phosphinophenyl)phosphine 
(56.0 mg, 0.340 mmol) in THF (5 ml) and the resulting mixture stirred at 60 
o
C overnight. 
After cooling to r.t., the solvent filtered off to afford a white powder, which was dissolved in 
CH2Cl2 and washed with sat. NaSbF6 twice. Evaporation of the organic phase afforded the 
desired product 102 as a white solid, which could be purified by recrystallization in 
CH3CN/Et2O (60.9 mg, 24%). 
1
H NMR (CD3CN, 400 MHz): δ = 7.84 – 7.79 (m, 1H), 7.66 – 
7.57 (m, 6H), 7.43 – 7.41 (m, 2H), 3.96 – 3.82 (m, 8H), 2.88 ppm (s, 12H). 13C NMR 
(CD3CN, 100 MHz): δ = 164.1 (d, J = 47.1 Hz), 150.1 (d, J = 34.1 Hz), 139.7 (d, J = 8.0 Hz), 
135.7, 135.0, 133.0 (d, J = 6.0 Hz), 130.8 (d, J = 1.4 Hz), 130.5 (d, J = 13.8 Hz), 130.3 (d, J  = 
4.0 Hz), 128.9 (d, J = 24.1 Hz), 128.6, 53.4, 36.9 ppm (d, J = 9.0 Hz).
 31
P NMR (CD3CN, 121 
MHz): δ = – 43.1 ppm. 19F NMR (CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 
1945 Hz, octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for C22H29N4F6PSb
+
: 615.106410, found 
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615.106603.
 IR ῦ = 435, 455, 468, 554, 653, 707, 761, 779, 935, 1206, 1301, 1337, 1413, 
1447, 1526, 1583 cm
– 1
. 
 
Compound 103 
 
At – 78 oC, PhPH2 (50.0 mg, 0.454 mmol) in THF (5 ml) was cannulated to 
chlorodipiperidinocarbenium hexafluoroantimonate (410.1 mg, 0.908 mmol) and KHDMS 
(181.2 mg, 0.908 mmol) in one schlenk and the resulting mixture was warmed to r.t. 
overnight. The solvent was removed in vacuo and the left was stirred with NaSbF6 (352.0 mg, 
1.360 mmol) in CH3CN (5 ml) overnight. Subsequently the solvent was removed in vacuo and 
the resulting white solid extracted with CH2Cl2. The combined organic phase thus obtained 
was evaporated in vacuo and the resulting solid washed with Et2O and a small amout of 
CH2Cl2 to afford the desired compound 103 as a white solid (155.5 mg, 41%). Colourless 
crystals suitable for X−ray crystallography were obtained from CH2Cl2/Et2O at r.t. 
1
H NMR 
(CD3CN, 400 MHz): δ = 7.91 – 7.36 (m, 5H), 4.22 – 3.21 (m, 16H), 1.82 – 1.37 ppm (m, 
24H). 
13
C NMR (CD3CN, 100 MHz): δ = 173.9 (d, J = 25.0 Hz), 137.5 (d, J = 23.6 Hz), 
134.8, 132.1 (d, J = 10.3 Hz), 122.8, 56.0, 26.3, 23.3 ppm. 
31
P NMR (CD3CN, 121 MHz): δ = 
– 15.3 ppm. 19F NMR (CD3CN, 282 MHz): δ = – 124.0 ppm (sextet, JF–Sb(I=5/2) = 1933 Hz, 
octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for C28H45N4SbF6P1
+
: 703.231110, found 
703.231803. IR ῦ = 460, 496, 586, 654, 752, 859, 1013, 1132, 1255, 1290, 1362, 1441, 1538, 
1557, 2864, 2945 cm
– 1
. 
 
Compound 104 
 
At – 78 oC, cyclohexylphosphine (50.0 mg, 0.430 mmol) in THF (5 ml) was cannulated to 
chlorodipiperidinocarbenium hexafluoroantimonate (388.7 mg, 0.861 mmol) and KHDMS 
(171.8 mg, 0.861 mmol) in one schlenk and the resulting mixture was warmed to r.t. 
overnight. The solvent was removed in vacuo and the left was stirred with NaSbF6 (352.0 mg, 
1.360 mmol) in CH3CN (5 ml) overnight. Subsequently the solvent was removed in vacuo and 
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the resulting white solid extracted with CH2Cl2 (3 × 10 ml). The combined organic phase thus 
obtained was evaporated in vacuo and the resulting solid washed with Et2O and a small amout 
of CH2Cl2 to afford the desired compound 104 as a white solid (297 mg, 73%). 
1
H NMR 
(CD3CN, 400 MHz): δ = 3.68 (m, 16H), 3.32 – 3.13 (m, 1H), 1.92 – 1.84 (m, 4H), 1.84 – 1.26 
ppm (m, 30H). 
13
C NMR (CD3CN, 100 MHz): δ = 174.5 (d, J = 34.7 Hz), 55.9 (d, J = 5.1 
Hz), 38.88 (d, J = 23.2 Hz), 32.83 (d, J = 17.8 Hz), 27.1 (d, J = 15.9 Hz), 26.5, 25.7 (d, J = 
2.1 Hz), 23.3 ppm. 
31
P NMR (CD3CN, 121 MHz): δ = – 3.7 ppm. 
19
F NMR (CD3CN, 282 
MHz): δ = – 124.0 ppm (sextet, JF– Sb(I=5/2) = 1933 Hz, octet, JF– Sb(I=7/2) = 1049 Hz), HRMS 
calcd. for C28H51N4SbF6P1
+
: 709.278630, found 709.278753. IR ῦ = 483, 578, 653, 780, 860, 
1012, 1130, 1255, 1354, 1445, 1533, 2862, 2943 cm
– 1
. 
 
Compound 105 
 
n
BuLi (1.6 M in hexanes, 0.340 ml, 0.590 mmol) was added dropwise to (2– 
Bromophenyl)diphenylphosphine (200.0 mg, 0.586 mmol) in THF (5 ml) at – 78 °C and the 
mixture stirred for 1 h at – 78 °C. (C6F5)2PCl (238.0 mg, 0.590 mmol) in THF (2 ml) was 
added dropwise. The reaction was then allowed to warm to r.t. overnight and after that all 
volatiles were removed in vacuo. The crude was purified by column chromatography (SiO2, 
hexane: toluene = 5: 1) to afford the desired diphosphine 105 as a white solid (103.5 mg, 
28%). 
1
H NMR (C6D6, 400 MHz): δ = 7.32 – 7.30 (m, 1H), 7.18 – 7.13 (m, 1H), 7.05 – 7.02 
(m, 5H), 6.95 – 6.88 ppm (m, 7H). 13C NMR (C6D6, 100 MHz): δ = 149.5 (m), 146.9 (m), 
142.6 (dm, JC–F = 258.5 Hz), 138.3 (dd, J = 34.0 Hz, J = 11.4 Hz), 138.2 (d, J = 34.3 Hz, J = 
11.4 Hz), 137.7 (q, JC–F  = 252.8 Hz), 135.9 (q, J = 5.0 Hz), 133.7, 133.5, 132.7 (d, J = 8.9 
Hz), 130.4, 129.8, 129.0, 128.8 ppm (d, J = 7.0 Hz). 
31
P NMR (C6D6, 121 MHz): δ = – 16.6 
(dt, JP–F = 184.5 Hz, JP–P = 5.1 Hz), – 56.4 ppm (dq, JP–F = 184.5 Hz, JP–P = 30.2 Hz). 
19
F 
NMR (C6D6, 282 MHz): δ = – 129.2 (m), – 149.8 (m), – 160.5 ppm (m). HRMS calcd. for 
C30H14F10P2: 626.040937, found 626.041114. IR ῦ = 407, 439, 478, 494, 511, 521, 586, 631, 
675, 745, 800, 840, 972, 1026, 1082, 1260, 1284, 1306, 1378, 1434, 1440, 1514, 1585, 1641, 
2859, 2963, 3055 cm
– 1
. 
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Compound 106 
 
n
BuLi (1.6 M in hexanes, 0.689 ml, 1.102 mmol) was added dropwise to (2–
Bromophenyl)diphenylphosphine (376.0 mg, 1.102 mmol) in THF (5 ml) at – 78 °C. The 
mixture stirred for 1 h at – 78 °C and (pyrrolyl)2PCl (218.9 mg, 1.102 mmol) in THF (2 ml) 
was added dropwise. The reaction was then allowed to warm to r.t. overnight and after that all 
volatiles were removed in vacuo. The crude was purified by column chromatography (SiO2, 
hexane:toluene = 3:1) to afford the desired diphosphine 106 as a white solid (304.2 mg, 65%). 
1
H NMR (C6D6, 300 MHz): δ =  7.29 – 7.26 (m, 1H), 7.21 – 7.19 (m, 3H), 7.00 – 7.97 (m, 
7H), 6.92 – 6.88 (m, 2H), 6.81 – 6.78 (m, 1H), 6.76 – 6.74 (m, 4H), 6.23 ppm (t, J = 2.1Hz, 
4H). 
13
C NMR (C6D6, 100 Mz): δ = 144.6 (dd, JC–P = 32.3, JC–P = 12.6 Hz), 141.9 (dd, JC–P = 
28.3, JC–P = 14.2 Hz), 136.5 (dd, JC–P = 10.3, JC–P = 4.6 Hz), 135.5 (d, JC–P = 3.2 Hz), 133.8 (d, 
JC–P = 19.6 Hz), 130.6 (dd, JC–P = 10.3, 5.3 Hz), 130.5 (d, JC–P = 73.1 Hz), 128.8, 128.7 (d, JC–
P = 7.0 Hz), 127.3, 124.6 (d, JC–P = 13.8 Hz), 112.6 ppm (d, JC–P = 3.9 Hz). 
31
P NMR (C6D6, 
121 MHz): δ = 66.1 (d, JP–P = 167.3 Hz), – 18.6 ppm (d, JP–P = 167.3 Hz). HRMS calcd. for 
C26H22N2P2Na
+
: 447.114760, found 447.115045. IR ῦ = 419, 474, 498, 546, 616, 662, 693, 
731, 766, 803, 100, 1057, 1074, 1176, 1241, 1262, 1292, 1389, 1434, 1449, 1478, 1555, 1582, 
2924, 2961, 3063 cm
– 1
. 
 
Compound 107a 
 
92b (36.4 mg, 0.038 mmol) and Mo(CO)6 (10.0 mg, 0.038 mmol) was stirred in THF (2 ml) at 
75 
o
C overnight. After cooling to r.t., the solvent was evaporated in vacuo and washed with 
CH2Cl2 to afford the desired compound as a yellow solid (19.9 mg, 49%). Yellow crystals 
suitable for X– ray analysis were obtained from a saturated solution in CH3CN/Et2O at r.t. 
1
H 
NMR (CD3CN, 400 MHz): δ = 8.15 – 8.07 (m, 1H), 8.04 – 7.89 (m, 3H), 7.68 – 7.27 (m, 
10H), 4.01 (s, 8H), 3.14 – 2.92 (br, 12H). 13C NMR (CD3CN, 125 Mz): δ = 213.6 (dd, JC–P = 
32.5, JC–P = 10.0 Hz), δ =  213.1 (dd, JC–P = 23.8, JC–P = 7.6 Hz), 208.2 (m), 162.4 (d, JC–P =  
22.7Hz), 144.9 (dd, JC–P = 42.2, JC–P = 35.1 Hz), 138.4 (d, JC–P = 15.6 Hz), 136.5 (d, JC–P = 
  114 
 
12.1 Hz), 136.2 (dd, JC–P = 4.7 Hz, JC–P = 2.2 Hz) , 135.1 (dd, JC–P = 5.8 Hz, JC–P = 1.7 Hz), 
134.4 (d, JC–P = 13.2 Hz), 133.0 (m), 132.4, 130.3 (d, JC–P = 10.4 Hz), 129.8 (dd, JC–P = 41.6 
Hz, 35.9 Hz), 53.5 (m), 53.5 ppm (m). 
31
P NMR (CD3CN, 162 MHz): δ = 60.1 (d, JP–P = 13.7 
Hz), 40.2 ppm (d, JP–P = 13.7.7 Hz). 
19
F NMR (CD3CN, 282 MHz): δ = – 124.0 ppm (sextet, 
JF–Sb(I=5/2) = 1933 Hz, octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for C32H34N4F6MoP2Sb
+
: 
933.004530, found 933.004662. IR ῦ = 514, 524, 657, 697, 796, 1016, 1090, 1259, 1297, 
1572, 1847, 1938, 1973, 2403, 2963 cm
– 1
. 
 
Compound 107b 
 
(Dipyrrolylphosphino)–2–diphenylphsphine 106 (100.0 mg, 0.236 mmol) and Mo(CO)6 
(62.2mg, 0.236 mmol) in THF (3 ml) was stirred overnight at 70 
o
C. After cooling to r.t., the 
solvent was evaporated in vacuo to afford the desired compound 107b as a yellow solid 
(113.2 mg, 76%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 7.57 (m, 3H), 7.49 (m, 1H), 7.44 – 7.26 
(m, 10H), 6.72 (dt, J = 4.2, J = 2.1 Hz, 4H), 6.32 ppm (td, J = 2.1, J = 1.1 Hz, 4H). 
13
C NMR 
(CD2Cl2, 100 Mz): δ = 215.7 – 214.8 (m), 209.0 – 207.9 (m), 145.0 (dd, JC–P = 40.9, JC–P = 
33.8 Hz), 143.1 (dd, JC–P = 42.9, JC–P = 34.9 Hz), 135.6 (dd, JC–P = 37.8, JC–P = 2.9 Hz), 133.9 
(d, JC–P = 14.9 Hz), 132.6 (dd, JC–P = 5.0 Hz, JC–P = 2.0 Hz) , 132.6 (d, JC–P = 12.7 Hz), 131.1 
(d, JC–P = 5.5 Hz), 130.6 (d, JC–P = 1.8 Hz), 130.5 (d, JC–P = 2.1 Hz), 129.0 (d, JC–P = 9.7 Hz), 
124.3 (d, JC–P = 7.5 Hz), 113.0 ppm (d, JC–P = 5.7 Hz). 
31
P NMR (CD2Cl2, 162 MHz): δ = 
139.2 (d, JP–P = 4.7 Hz), 56.9 ppm (d, JP–P = 4.7 Hz). HRMS calcd. for C30H22N2O4MoP2Na
+
: 
656.999890, found 657.000215. IR ῦ = 416, 504, 525, 571, 585, 671, 732, 999, 1037, 1067, 
1116, 1177, 1234, 1434, 1449, 1481, 1572, 1896, 1936, 2030, 3062, 3251 cm
– 1
. 
 
Compound 107c 
 
(Dipentafluorophenylphosphino)–2–diphenylphsphine 105 (100.0 mg, 0.160 mmol) and 
Mo(CO)6 (42.2mg, 0.160 mmol) in THF (3 ml) was stirred at 70 
o
C overnight. After cooling 
to r.t., the solvent was evaporated in vacuo to afford the desired compound 107c as a white 
solid (114.6 mg, 86%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 7.76 – 7.72 (m, 1H), 7.61 – 7.56 
  115 
 
(m, 4H), 7.43 – 7.40 ppm (m, 9H). 13C NMR (CD2Cl2, 100 Mz): δ = 216.6 (dd, JC–P = 31.8, 
JC–P = 8.7 Hz), 215.1 (d, JC–P = 26.0 Hz), 208.5 (m), 146.5 (dm, JC–F = 251.0 Hz), 143.1 (dm, 
JC–F = 258.2 Hz), 142.9 (dd, JC–P = 43.4, JC–P = 35.0 Hz), 139.5 (m), 137.0 (m), 135.9 (dd, JC–
P = 37.4, JC–P = 2.5 Hz), 134.8 (d, JC–P = 15.6 Hz), 133.4 (d, JC–P = 12.8 Hz), 132.5 (d, JC–P = 
12.7 Hz), 131.7 (dd, JC–P = 16.5, JC–P = 2.0 Hz), 130.5 (d, J = 2.0 Hz), 128.9 (d, J = 9.7 Hz), 
111.2 ppm (d, JC–P = 21.2 Hz). 
31
P NMR (CD2Cl2, 162 MHz): δ = 60.5 (d, JP–P = 7.3 Hz), 31.1 
ppm (q, JP–F = 10.6, JP–F = 10.1 Hz). 
19
F NMR (CD2Cl2, 282 MHz):
 δ = – 128.6 (m), – 149.6 
(m), – 160.0 ppm (m). EI–MS calcd. for C34H14O4F10MoP2: 834.37, found 834.25. IR ῦ = 
424, 542, 585, 631, 665, 693, 729, 799, 976, 1009, 1086, 1190, 1260, 1287, 1322, 1384, 1436, 
1470, 1514, 1639, 1911, 2028, 2072, 2963, 3058 cm
– 1
. 
 
Compound 108 
 
S8 (2.0 mg, 0.063 mmol) and 92b (30.0 mg, 0.031 mmol) in DCE (2 ml) were stirred at 70 
o
C 
for 48 h. After removal of the solvent in vacuo, the remaining solid was washed with Et2O 
and pentane to afford 108 as a white solid (23.6 mg, 76%). Colourless crystals suitable for 
X−ray crystallography were obtained from a saturated solution of the compound in 
CH2Cl2/Et2O at r.t. 
1
H NMR (CD3CN, 400 MHz): δ = 7.78 – 7.70 (m, 9H), 7.63 – 7.61 (m, 
4H), 7.37 – 7.30 (m, 1H), 3.97 – 3.91 (m, 8H), 2.79 ppm (s, 12H). 13C NMR (CD3CN, 100 
MHz): δ = 166.0 (d, J = 45.2 Hz), 141.7 (dd, J = 83.4 Hz, J = 32.5 Hz), 142.4 (dd, J = 9.6 Hz, 
J = 2.0 Hz), 135.8 (dd, J = 8.4 Hz, J = 8.4 Hz), 135.1 (d, J = 10.5 Hz), 134.9 (d, J = 2.6 Hz), 
134.2 (d, J = 3.0 Hz), 133.7 (d, J = 10.9 Hz), 130.4 (d, J = 13.0 Hz), 129.7 (dd, J = 86.7 Hz, J 
= 0.9 Hz), 123.1 (dd, J = 11.0 Hz, J = 9.6 Hz), 55.3, 53.3, 36.3, 36.2 ppm.
 31
P NMR (CD3CN, 
121 MHz): δ = 44.3 (d, JP–P = 32.1 Hz), – 51.1 ppm (d, JP–P = 32.1 Hz). 
19
F NMR (CD3CN, 
282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 Hz). 
HRMS calcd. for C28H34N4SbF6P2S
+
: 755.091860, found 755.091565. IR ῦ = 422, 437, 448, 
474, 505, 521, 651, 690, 716, 738, 753, 767, 840, 929, 1000, 1105, 1187, 1293, 1329, 1409, 
1441, 1484, 1518, 1572, 1715, 2962, 3066 cm
– 1
. 
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Compound 109a 
 
Ptl2(PhCN)2 (20.0 mg, 0.031 mmol) and 92b (29.5 mg, 0.031 mmol) in CH2Cl2 (2 ml) was 
stirred overnight. After removal of the solvent in vacuo, the remaining solid was washed with 
pentane, affording the desired product as a yellow solid 109a (40.3 mg, 95%). Yellow crystals 
suitable for X−ray crystallography were obtained from a saturated solution of 
CH3COCH3/Et2O at 0 
o
C. 
1
H NMR (CD3CN, 400 MHz): δ = 8.45 – 8.40 (m, 1H), 7.96 – 7.91 
(m, 2H), 7.77 – 7.70 (m, 7H), 7.62 – 7.57 (m, 4H), 4.07 – 4.00 (m, 8H), 3.24 ppm (s, 12H). 
13
C NMR (CD3CN, 100 MHz): δ = 154.3 (d, J = 49.5 Hz), 138.7 (m), 138.5 (m), 136.3 (m), 
136.2 (m), 136.1 (m), 135.9 (m), 135.1 (m), 134.9 (d, JC–P = 2.8 Hz), 134.5 (d, JC–P = 3.6 Hz), 
127.6 (d, JC–P = 68.7 Hz), 54.5 (d, JC–P = 3.3 Hz), 39.6 ppm (d, JC–P = 3.0 Hz). 
31
P NMR 
(CD3CN, 121 MHz): δ = 39.2 (dt, JP–P = 4.6 Hz, JP–Pt = 2856.1 Hz), 5.4 ppm (d, JP–P = 4.6 Hz, 
JP–Pt = 3457.9 Hz). 
19
F NMR (CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 3890 
Hz, octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for C28H34N4SbF6P2I2Pt
+
: 1171.893620, found 
1171.893250. IR ῦ = 452, 503, 543, 598, 645, 689, 750, 922, 998, 1101, 1114, 1300, 1408, 
1437, 1520, 1586, 1979, 2220, 3007, 3061 cm
– 1
. 
 
Compound 109b 
 
CH2Cl2 (2 ml) was added to a mixture of PtCl2(CH3CN)2 (10.9 mg, 0.031 mmol) and 92b 
(30.0 mg, 0.031 mmol) and the mixture stirred overnight. After removal of the solvent in 
vacuo, the solid left washed with pentane and dried, affording the desired product 109b as a 
white solid (36.8 mg, 96%).
1
H NMR (CD3CN, 400 MHz): δ = 8.28 – 8.23 (m, 1H), 8.05– 
7.95 (m, 3H), 7.80 – 7.68 (m, 6H), 7.62 – 7.57 (m, 4H), 4.10 – 4.05 (m, 8H), 3.25 ppm (s, 
12H). 
13
C NMR (CD3CN, 100 MHz): δ = 153.1 (d, J = 53.0 Hz), 143.0 (dd, J = 63.5 Hz, J = 
40.9 Hz), 138.9 (dd, J = 7.8 Hz, J = 2.7 Hz), 138.2 (dd, J = 19.3 Hz, J = 4.1 Hz), 137.3 (dd, J = 
9.2 Hz, J = 2.2 Hz), 136.6 (dd, J = 1.7 Hz, J = 3.6 Hz), 135.2 (dd, J = 19.9 Hz, J = 8.4 Hz), 
134.7 (d, J = 3.0 Hz), 130.6 (d, J = 12.7 Hz), 128.0 (dd, J = 67.5 Hz, J = 22.5 Hz), 126.0 (d, J 
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= 71.3 Hz),54.5 (d, J = 3.6 Hz), 39.3 ppm (d, J = 2.5 Hz). 
31
P NMR (CD3CN, 121 MHz): δ = 
39.5 (t, JP–Pt  = 3006.0 Hz), 8.5 ppm (t, JP–Pt  = 3893.4 Hz). 
19
F NMR (CD3CN, 376 MHz): δ = 
– 124.0 ppm (sextet, JF–Sb(I=5/2) = 1933 Hz, octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for 
C28H34N4SbF6P2Cl2Pt
+
: 987.022430, found 988.022211. IR ῦ = 472, 505, 525, 654, 690, 735, 
748, 767, 922, 997, 1102, 1117, 1205, 1294, 1437, 1521, 1581 cm
– 1
. 
 
Compound 109c and 109d 
 
[RhCl(COD)]2 (5.0 mg, 0.013 mmol) and 92b (24.7 mg, 0.026 mmol) in CH2Cl2 (2 ml) was 
stirred overnight. After removal of the solvent in vacuo, the solid left washed with pentane, 
affording the desired product 109c as an orange solid (26.3 mg, 92%). The compound 109c in 
CD3CN is equilibrium between 109c and 109d, which can be proved by the related 
31
P NMR 
Spectra. Mixing of the solution of 92b and [RhCl(COD)]2 in CH2Cl2 at – 78 
o
C, orange 
crystals of 109c suitable for X−ray crystallography were obtained by slowly warming up the 
solution. Orange crystals of 109d suitable for X−ray crystallography were directly obtained 
from solutions of the title compound in CH3CN/CH2Cl2/Et2O at r.t. 
 
Compound 109e 
 
PdCl2(PhCN)2 (7.2 mg, 0.019 mmol) and 92b (18.0 mg, 0.019 mmol) in CH2Cl2 (2 ml) was 
stirred overnight. After removal of the solvent in vacuo, the solid left washed with pentane 
and dried, affording the desired product 109e as a white solid (19.4 mg, 91%). 
1
H NMR 
(CD3CN, 400 MHz): δ = 8.28 – 8.23 (m, 1H), 8.10 – 8.06 (m, 2H), 8.00 – 7.90 (m, 1H), 7.85 
– 7.72 (m, 6H), 7.64 – 7.59 (m, 4H), 4.11 – 4.06 (m, 8H), 3.24 ppm (s, 12H). 13C NMR 
(CD3CN, 100 MHz): δ = 155.4 (d, J = 41.8 Hz), 139.8 (dd, J = 6.9 Hz, J = 2.2 Hz), 138.6 (dd, 
J = 23.6 Hz, J = 2.9 Hz), 137.5 (d, J = 1.7 Hz), 137.4 (d, J = 2.1 Hz), 137.3 (d, J = 1.5 Hz), 
137.2, 135.3 (d, J = 11.5 Hz), 135.0 (d, J = 3.3 Hz), 130.7 (d, J = 12.8 Hz), 126.9 (d, J = 64.5 
Hz), 54.7 (d, J = 3.4 Hz), 39.4 ppm (d, J = 2.8 Hz). 
31
P NMR (CD3CN, 121 MHz): δ = 63.7 
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(d, JP–P  = 5.9 Hz), 22.8 ppm (d, JP–P  = 5.9 Hz). 
19
F NMR (CD3CN, 376 MHz): δ = – 124.0 
ppm (sextet, JF–Sb(I=5/2) = 1933 Hz, octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for 
C28H34N4SbF6P2Cl2Pd
+
: 898.961130, found 898.960595. IR ῦ = 426, 452, 495, 507, 525, 678, 
699, 746, 767, 938, 987, 1102, 1117, 1205, 1265, 1294, 1437,1489, 1521, 1581, 2935 cm
– 1
. 
 
Compound 109f 
 
(Me2S)AuCl (9.2 mg, 0.031 mmol) and 92b (30.0 mg, 0.031 mmol) in CH2Cl2 (2 ml) were 
stirred overnight. After removal of the solvent in vacuo, the solid left washed with pentane 
and dried, affording the desired product 109f as a white solid (34.6 mg, 93%). Colorless 
Crystals suitable for X−ray crystallography were obtained from CH3CN/CH2Cl2/Et2O. 
1
H 
NMR (CD3CN, 400 MHz): δ = 7.88 – 7.81 (m, 2H), 7.75 – 7.70 (m, 3H), 7.70 – 7.61 (m, 8H), 
7.36 – 7.30 (m, 1H), 4.01 (d, J = 1.3, 8H), 2.83 ppm (s, 12H). 13C NMR (CD3CN, 100 MHz): 
δ = 163.7 (dd, J = 39.6 Hz, J = 3.1 Hz), 140.8 (dd, J = 8.2 Hz, J = 1.8 Hz), 138.6 (dd, J = 59.6 
Hz, J = 37.2 Hz), 137.6 (dd, J = 9.8 Hz, J = 6.0 Hz), 136.9 (d, J = 8.3 Hz), 135.9 (d, J = 14.2 
Hz), 135.5, 134.5 (d, J = 2.8 Hz), 131.1 (d, J = 12.3 Hz), 126.0 (dd, J = 65.4 Hz, J = 3.0 Hz), 
120.6 (d, J = 2.3 Hz), 53.7, 36.3 ppm (d, J = 9.1 Hz). 
31
P NMR (CD3CN, 121 MHz): δ = 26.8 
(d, JP–P = 125.3 Hz), – 44.7 ppm (d, JP–P = 125.3 Hz). 
19
F NMR (CD3CN, 282 MHz): δ = – 
122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for 
C28H34N4P2F6ClSbAu
+
: 955.054890, found 955.054898. IR ῦ = 454, 498, 509, 549, 645, 693, 
796, 930, 1023, 1100, 1206, 1261, 1296, 1334, 1411, 1438, 1482, 1520, 1578, 2921, 2962 
cm
– 1
. 
 
Compound 110 
 
[RhCl(COD)]2 (6.4 mg, 0.013 mmol) and 101a (20.0 mg, 0.026 mmol) in CH3CN (2 m l) 
were stirred overnight. After removal of the solvent in vacuo, the solid left washed with 
CH2Cl2 and pentane, and dried, affording 110 as a yellow solid (21.6 mg, 86%). Yellow 
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crystals suitable for X−ray crystallography were obtained from CH3CN/CH2Cl2/Et2O at r.t. 
1
H 
NMR (CD3CN, 400 MHz): δ = 7.75 – 8.60 (m, 3H), 7.59 – 7.42 (m, 7H), 7.42 – 7.35 (m, 3H), 
7.33 – 7.28 (m, 1H), 7.26 – 7.16 (m, 1H), 7.14 – 7.10 (m, 1H), 4.32 – 4.20 (m, 2H), 4.16 (s, 
3H), 4.02 (s, 3H), 3.96 – 3.90 (m, 2H), 3.81 – 3.89 (m, 1H), 3.78 – 3.66 (m, 2H), 3.45 – 3.33 
(m, 1H), 3.03 (s, 3H), 2.75 (s, 3H), 1.74 (s, 3H), 1.62 ppm (s, 3H). 
13
C NMR (CD3CN, 125 
MHz): δ = 164.8 (d, J = 33.6 Hz), 154.8, 143.1 (d, J = 9.5 Hz), 142.5 (d, J = 7.6 Hz), 140.5 
(d, J = 18.2 Hz, J = 4.0 Hz), 137.0 (d, J = 52.9 Hz), 136.9 (dd, J = 11.5 Hz, J = 6.1 Hz), 
135.9, 135.7 (d, JC– P = 10.4 Hz), 135.5 (d, J = 12.9 Hz), 134.8, 132.7, 132.3 (d, J = 50.0 Hz), 
132.0, 131.2 (d, J = 7.6 Hz), 130.1 (d, J = 9.3 Hz), 130.0 (d, J = 5.3 Hz), 129.6 (d, J = 10.6 
Hz), 129.5 (d, J = 10.0 Hz), 129.4 (d, J = 9.7 Hz), 127.8 (d, J = 51.0 Hz), 121.7 (d, J = 59.1 
Hz), 55.4, 53.7, 53.6, 51.5, 42.6 (d, J = 4.4 Hz), 39.4 (d, J = 11.0 Hz), 39.0, 37.4, 20.7, 19.8 
ppm. 
31
P NMR (CD3CN, 121 MHz): δ = 38.1 (dd, JP–Rh = 153.9 Hz, JP–P = 50.2 Hz), 11.9 ppm 
(dd, JP–Rh = 215.7 Hz, JP–P = 50.2 Hz). 
11
B NMR (CD3CN, 96 MHz): δ = – 1.2 ppm, 
19
F NMR 
(CD3CN, 282 MHz): δ = – 151.9 ppm. IR ῦ = 463, 698, 754, 792, 868, 936, 1052, 1292, 1401, 
1661, 2112, 2325, 3205, 3369 cm
– 1
. 
 
Compound 112b 
 
Pd(C6F5)2(cod) (50.0 mg, 0.031 mmol) and 1,2–bis(diphenylphosphino)benzene (30.4 mg, 
0.031 mmol) were stirred overnight in CH2Cl2 (2 ml). After removal of the solvent in vacuo, 
the solid left washed with pentane and dried, affording the desired product as a white solid 
112b (76.8 mg, 95%). Colorless crystals suitable for X−ray crystallography were obtained 
from CH2Cl2. 
1
H NMR (CD2Cl2, 600 MHz): δ = 7.75 – 7.72 (m, 2H), 7.61 – 7.60 (m, 2H), 
7.51 – 7.49 (m, 4H), 7.47 – 7.44 (m, 8H), 7.39 – 7.37 ppm (m, 8H). 13C NMR (CD2Cl2, 150 
MHz): δ = 146.3 (dm, JC–F = 230.4), 142.5 (t, JC–P = 43.0 Hz), 137.5 (dm, JC–F = 241.9 Hz), 
136.5 (dm, JC–F = 237.4 Hz), 133.9 (t, JC–P = 8.6 Hz), 133.7 (t, JC–P = 8.6 Hz), 133.1, 131.8, 
130.6 (d, J = 47.9 Hz), 129.2 ppm (t, J = 4.5 Hz). 
31
P NMR (CD2Cl2, 121 MHz): δ = 52.3 
ppm.
 19
F NMR (CD2Cl2, 282 MHz): δ = – 113.7 (m), – 161.2 (t, JF– F = 20.7 Hz), – 163.1 (tm, 
JF– F = 20.7 Hz) ppm. MS–EI calcd. for C42H24F10P2Pd: 886.02, found 886.90, IR ῦ = 411, 
422, 445, 498, 544, 602, 617, 668, 687, 741, 760, 774, 950, 1000, 1027, 1055, 1098, 1159, 
1186, 1254, 1281, 1308, 1346, 1432, 1496, 1608, 1633, 3062 cm
– 1
. 
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Compound 112c 
 
Pd(C6F5)2(cod) (43.8 mg, 0.080 mmol) and the diphosphine 105 (50.0 mg, 0.080 mmol) were 
stirred overnight in CH2Cl2 (2 ml). After removal of the solvent in vacuo, the remaining solid 
was washed with pentane and dried, affording the desired product 112c as a white solid (81.7 
mg, 96%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 8.07 – 7.96 (m, 1H), 7.84 – 7.82 (m, 1H), 7.76 – 
7.65 (m, 2H), 7.63 – 7.54 (m, 2H), 7.36 – 7.52 ppm (m, 8H). 13C NMR (CD2Cl2, 100 MHz): δ 
= 147.6 (dm, JC–F = 81.4 Hz), 147.3 (dm, JC–F = 252.3 Hz), 144.9, 144.4 (dm, JC–F = 258.2 
Hz), 141.4 (dd, JC–P = 50.8 Hz, JC–P = 44.5 Hz), 138.5 (dm, JC–F = 243.4 Hz), 138.1 (dm, JC–F 
= 216.5 Hz), 136.2 (JC–F = 253.6 Hz), 134.7 (dd, JC–P = 19.9 Hz, JC–P = 1.1 Hz), 134.5 (dd, JC–
P = 5.5 Hz, JC–P = 2.0 Hz), 134.3 (dd, JC–P = 6.3 Hz, JC–P = 1.8 Hz), 133.7 (d, JC–P = 12.5 Hz), 
133.3 (d, JC–P = 15.7 Hz), 132.3 (d, JC–P = 2.6 Hz), 129.8, 129.4 ppm (d, JC–P = 11.1 Hz). 
31
P 
NMR (CD2Cl2, 121 MHz): δ = 51.0 (m), 16.9 ppm (m). 
19
F NMR (CD2Cl2, 282 MHz): δ = – 
115.0 (m), – 118.1 (m), – 127.1 (m), – 145.7 (m), – 159.0 (m), – 160.7 (t, JF–F = 19.7 Hz), – 
161.4 (t, JF–F = 19.7 Hz), – 163.5 (td, JF–F = 20.1 Hz, JF– P = 9.4 Hz), – 164.0 ppm (td, JF–F = 
20.1 Hz, JF–P = 10.4 Hz). HRMS calcd. for C42H14F20P2PdNa
+
: 1088.917860, found 
1088.917765. IR ῦ = 458, 483, 519, 536, 631, 670, 692, 745, 797, 954, 977, 1017, 1091, 
1260, 1297, 1360, 1455, 1475, 1499, 1519, 1642, 2963 cm
– 1
. 
 
Compound 112d 
 
1,2–bis(dichlorophosphino)ethane (0.500 ml, 3.300 mmol) was added dropwise to a solution 
of 2,2’–biphenol (1.2 g, 6.600 mmol) and Et3N (1.840 ml, 13.200 mmol) in Et2O (30 ml) at – 
78 
o
C, and the mixture allowed to warm to r.t. overnight. The reaction was then filtered and 
the filtrate evaporated in vacuo to give a white solid, which was washed with a small amout of 
CH2Cl2 and dried, affording bis(1,2– biphenylphosphino)ethane as a white solid (983.1 mg, 
65%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 7.47 (dd, J = 7.5 Hz, J = 1.8 Hz, 4H), 7.37 (dt, J = 
7.5 Hz, J = 1.8 Hz, 4H), 7.30 (dt, J = 7.5 Hz, J = 1.3 Hz, 4H), 7.12 (d, J = 7.9 Hz, 4H), 1.95 
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ppm (t, J = 6.7 Hz, 4H). 
13
C NMR (CD2Cl2, 100 MHz): δ = 151.4 (t, J = 3.1 Hz), 132.2, 
130.6, 129.7, 125.6, 122.2, 26.1 ppm (dd, J = 42.1 Hz, J = 19.5 Hz). 
31
P NMR (CD2Cl2, 121 
MHz): δ = 207.2 ppm. HRMS calcd. for C26H20O4P2: 458.083314, found 458.083689. IR ῦ = 
416, 429, 480, 516, 591, 669, 703, 762, 883, 939, 978, 1036, 1060, 1094, 1202, 1245, 1268, 
1400, 1435, 1474, 1496, 1595, 1713, 2404, 2943, 3023, 3070, 3185 cm
– 1
. 
 
Pd(C6F5)2(cod) (53.8 mg, 0.098 mmol) and bis(1,2–biphenylphosphino)ethane (45.0 mg, 
0.098 mmol) were dissolved in CH2Cl2 (2 ml) and stirred overnight. After removal of the 
solvent in vacuo, the solid left was washed with pentane and dried, affording 112d as a white 
solid (82.1 mg, 93%). 
1
H NMR (CD2Cl2, 400 MHz): δ = 7.48 – 7.45 (m, 4H), 7.36 – 7.34 (m, 
8H), 7.15 – 7.13 (m, 4H), 2.41 ppm (d, J = 23.0 Hz, 4H). 13C NMR (CD2Cl2, 100 MHz): δ = 
148.23 (d, JC–P = 11.3 Hz), 148.22, 146.1 (dm, J = 226.3 Hz), 137.4 (dm, JC–F = 245.2 Hz), 
136.1 (dm, JC–F = 252 Hz), 130.5, 129.6, 129.2, 126.6, 121.0, 26.8 ppm (t, J = 23.2 Hz). 
31
P 
NMR (CD2Cl2, 121 MHz): δ = 202.2 ppm (m). 
19
F NMR (CD2Cl2, 282 MHz): δ = – 114.5 
(m), – 161.9 (t, JF–F = 19.9 Hz), – 163.1 (td, JF–F = 19.9 Hz, JF–P = 9.1 Hz)  ppm. HRMS 
calcd. for C38H20O4F10P2PdNa
+
: 920.960310, found 920.960340. IR ῦ = 435, 493, 523, 536, 
595, 654, 716, 755, 772, 823, 871, 912, 954, 1012, 1045, 1094, 1191, 1248, 1274, 1361, 1403, 
1456, 1498, 1532, 1606, 1633, 2916, 3067 cm
– 1
. 
 
Compound 112e 
 
(Dipyrrolylphosphino)–2–diphenylphosphine (38.7 mg, 0.091 mmol) and Pd(C6F5)2(cod) 
(50.0 mg, 0.091 mmol) were dissolved in CH2Cl2 (1 ml) and stirred overnight. Then, the 
solvent was evaporated in vacuo and washed with Et2O to afford the desired compound 112e 
as a white solid (73.3 mg, 93%). 
1
H NMR (CD2Cl2, 500 MHz): δ = 7.50 – 7.91 (m, 1H), 7.85 
– 7.81 (m, 1H), 7.80 – 7.75 (m, 2H), 7.53 – 7.49 (m, 2H), 7.46 – 7.33 (m, 8H), 6.86 – 6.84 (m, 
5H), 6.40 – 6.38 ppm (m, 4H). 13C NMR (CD2Cl2, 125 Mz): δ = 147.2 (dm, JC–F = 68.6 Hz), 
145.3 (dm, JC–F = 72.8 Hz), 141.8 (dd, JC–P = 49.6, JC–P = 37.0 Hz), 140.8 (dd, JC–P = 52.1, JC–
P = 43.2 Hz), 138.1 (dm, JC–F = 241.6 Hz), 136.8 (d, JC– F = 250.6 Hz), 135.62 (d, JC–P = 6.0 
Hz), 134.23 (d, JC–P = 19.3 Hz), 133.59 (d, JC–P = 12.6 Hz), 133.3 (dd, JC–P = 5.9 Hz, JC–P = 
1.6 Hz), 132.2 (d, JC–P = 2.5 Hz), 132.1 (dd, JC–P =15.8, JC–P = 2.4 Hz), 129.4 (d, JC–P = 10.9 
Hz), 128.9 (d, JC–P =49.7 Hz), 124.1 (d, JC–P =8.2 Hz), 114.8 ppm (d, JC–P =Hz). 
31
P NMR 
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(CD2Cl2, 162 MHz): δ = 109.1 (br), 47.9 ppm (br). 
19
F NMR (CD2Cl2, 282 MHz): – 115.02 
(m), – 161.59 (m), – 163.57 (dm, JF–P = 139.0 Hz). HRMS calcd. for C38H22N2F10P2PdNa
+
: 
887.002710, found 887.002477. IR ῦ = 421, 450, 478, 511, 537, 566, 608, 627, 672, 702, 725, 
776, 953, 1001, 1055, 1100, 1115, 1237, 1350, 1360, 1436, 1498, 1531, 3060 cm
– 1
. 
 
Compound 112f 
 
2–Diphenylphosphino–2'–(N,N–dimethylamino)biphenyl (30.0 mg, 0.055 mmol) and 
Pd(C6F5)2(cod) (20.8 mg, 0.055 mmol) were stirred in CH2Cl2 (2 ml) for 2 d. Then the solvent 
was evaporated in vacuo and washed with Et2O to afford compound 112f as a pale yellow 
solid (41.4 mg, 92%). Yellow crystals suitable for X– ray analysis were obtained from 
saturated CH2Cl2/pentane solution. 
1
H NMR (CD2Cl2, 300 MHz): δ = 8.05 – 7.99 (m, 2H), 
7.70 – 7.65 (m, 1H), 7.55 – 7.46 (m, 4H), 7.42 – 7.32 (m, 2H), 7.23 – 7.16 (m, 3H), 6.98  – 
6.75 (m, 5H), 6.59 – 6.56 (m, 1H), 3.04 ppm (s, 6H). 13C NMR (CD2Cl2, 125 Mz): δ = 155.33 
(m), 150.5 (d, JC–P = 22.0 Hz), 147.2 (m), 145.8 (m), 144.6 (m), 138.2 (m), 135.5 (d, JC–P = 
13.3 Hz), 133.7, 132.5 (m), 131.9, 131.6, 131.4 (d, JC–P = 11.4 Hz), 130.5, 129.4 (d, JC–P = 
10.6 Hz), 128.4 (d, JC–P = 10.2 Hz), 128.2 (d, JC–P = 5.6 Hz), 122.4 (br), 116.6 (br), 47.3 ppm 
(m). 
31
P NMR (CD2Cl2, 162 MHz): δ = 23.2 ppm (m). 
19
F NMR (CD2Cl2, 282 MHz): δ = – 
112.92 (m), – 114.28 (m), – 115.26 (m), – 117.93 (m), – 162.35 (t, JF–F = 19.8 Hz), – 162.95 
(t, JF–F = 19.8 Hz), – 163.64 (m), – 163.88, – 164.43 (m), – 164.94 ppm (m). HRMS calcd. for 
C38H24NF10PPdNa
+
: 844.041910, found 884.041289. IR ῦ = 433, 450, 494, 538, 692, 760, 
788, 852, 949, 1041, 1058, 1099, 1213, 1274, 1344, 1362, 1435, 1493, 1577, 2965, 3067 cm
– 
1
. 
 
Compound 112g 
 
Pd(C6F5)2(cod) (100.0 mg, 0.182 mmol) and 92a (120.3 mg, 0.182 mmol) were dissolved in 
CH2Cl2 (4 ml) and stirred overnight. After removal of the solvent in vacuo, the remaining 
solid was washed with CH2Cl2 and pentane, and dried, affording 112g as a white solid (168.8 
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mg, 84%). Colorless crystals suitable for X−ray crystallography were obtained from saturated 
CH3CN/CH2Cl2/Et2O solutions of the title compound. 
1
H NMR (CD3CN, 400 MHz): δ = 8.25 
– 8.20 (m, 1H), 8.16 – 8.11(m, 1H), 8.10 – 8.05 (m, 2H), 7.68 – 7.65 (m, 2H), 7.53 – 7.50 (m, 
8H), 4.14 – 4.10 (m, 8H), 3.03 ppm (s, 12H). 13C NMR (CD3CN, 125 MHz): δ = 157.2 (dd, 
JC–P = 26.2 Hz, JC–P = 1.1 Hz), 147.6 (dm, JC–F = 194.2 Hz), 146.0 (dm, JC–F = 191.3 Hz), 
144.2 (dd, JC–P = 52.0 Hz, JC–P = 44.5 Hz), 140.6 (br), 138.8 (dd, JC–P = 5.6 Hz, JC–P = 2.3 
Hz), 138.3 (d, JC–P = 20.2 Hz), 137.8 (dm, JC–F = 256.1 Hz), 137.5 (d, JC–P = 13.4 Hz), 137.2 
(dd, JC–P = 7.2 Hz, JC–P = 1.7 Hz), 134.4 (d, JC–P = 12.5 Hz), 134.1 (d, JC–P = 2.8 Hz), 130.6 
(d, JC–P = 11.4 Hz), 127.9 (d, JC–P = 53.4 Hz), 126.3 (dd, JC–P = 50.3 Hz, JC–P = 33.7 Hz), 54.3 
(d, JC–P = 2.1 Hz), 38.3 ppm (d, JC–P = 3.4 Hz). 
31
P NMR (CD3CN, 121 MHz): δ = 49.0 (m), 
11.9 ppm (m). 
11
B NMR (CD3CN, 96 MHz): δ = – 1.1 ppm. 
19
F NMR (CD3CN, 282 MHz): δ 
= – 116.8 (m), – 117.6 (m), – 157.9 (t, JF–F = 19.7 Hz ), – 159.9 (t, JF–F = 19.2 Hz), – 161.8 
(dt, JF–F = 19.7, JF–P = 8.7 Hz), – 163.6 ppm (dt, JF–F = 20.3, JF–P = 8.3 Hz). HRMS calcd. for 
C40H34N4BF14P2Pd
+
: 1015.119220, found 1015.115674. IR ῦ = 465, 499, 518, 536, 643, 691, 
735, 775, 1300, 1363, 1440, 1458, 1501, 1589, 1600 cm
– 1
. 
 
Compound 112h 
 
Pd(C6F5)2(cod) (50.0 mg, 0.065 mmol) and 101a (35.8 mg, 0.065 mmol) were dissolved in 
CH3COCH3 (3 ml) and stirred for 48 h. After removal of the solvent in vacuo, the solid left 
was washed with CH2Cl2 and pentane, and dried, to afford 112h as a light yellow solid (57.5 
mg, 73%). 
1
H NMR (CD3COCD3, 400 MHz): δ = 8.08 – 8.04 (m, 1H), 7.97 (d, J = 7.8 Hz, 
1H), 7.93 – 7.78 (m, 3H), 7.71 – 7.62 (m, 2H), 7.56 – 7.44 (m, 3H), 7.43 – 4.40 (m, 1H), 7.36 
– 7.29 (m, 3H), 7.20 – 7.12 (m, 2H), 4.49 – 4.31 (m, 4H), 3.84 – 3.74 (m, 8H),  3.59 – 3.54 
(m, 2H),  3.25 (s, 3H), 3.23 (s, 3H), 1.89 (s, 3H), 1.50 ppm (s, 3H). 
13
C NMR (CD3COCD3, 
100 MHz): δ = 158.3 (dd, JC–P = 24.4 Hz, JC–P = 3.6 Hz), 156.6 (d, JC–P = 14.3 Hz), 144.3 (d, 
JC–P = 8.3 Hz), 144.0 (d, JC–P = 10.8 Hz), 142.3 (dd, JC–P = 23.3 Hz, d, JC–P = 3.0 Hz), 138.1 
(d, JC–P = 2.0 Hz), 137.7(dd, JC–P = 13.5 Hz, JC–P = 5.5 Hz), 136.8 (dd, JC–P = 12.5 Hz, JC– P = 
2.8 Hz), 136.4 (d, JC–P = 2.2 Hz), 134.7 (d, JC–P = 10.0 Hz), 134.2 (d, JC–P = 4.5 Hz), 133.9 (d, 
JC–P = 2.4 Hz), 132.1 (d, JC–P = 7.3 Hz), 131.9 (d, JC–P = 2.5 Hz), 131.6 (d, JC–P = 41.8 Hz), 
131.3 (d, JC–P = 8.7 Hz), 130.5 (d, JC–P = 8.6 Hz), 130.4 (d, JC–P = 11.3 Hz), 129.2 (d, JC–P = 
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10.7 Hz), 128.6 (t, JC–P = 24.6 Hz), 126.5 (dd, JC–P = 51.8 Hz, JC– P = 1.8 Hz), 125.3 (d, JC–P = 
48.6 Hz), 56.1 (d, JC–P = 1.5 Hz), 54.1 (d, JC–P = 2.2 Hz), 53.6 (d, JC–P = 2.2 Hz), 53.4, 42.5 
(dd, JC–P = 6.2 Hz, JC–P = 5.1 Hz), 39.7 (t, JC–P = 9.4 Hz), 37.6, 37.3 (d, JC–P = 6.3 Hz), 20.9 
(d, JC–P = 2.5 Hz), 19.9 ppm (d, JC–P = 1.6 Hz). 
31
P NMR (CD3COCD3, 121 MHz): δ = 15.3 
(m), 12.6 ppm (m). 
11
B NMR (CD3COCD3, 96 MHz): δ = – 1.0 ppm. 
19
F NMR (CD3COCD3, 
282 MHz): δ = – 110.8 (m), – 111.0 (m), –113.7 (m), – 114.2 (m ), – 156.7 (t, JF–F = 19.9 Hz), 
– 160.7 (m), – 161.6 (t, JF–F = 19.9 Hz), – 163.4 (m), – 163.9 ppm (m). HRMS calcd. for 
C48H42N4BF14P2Pd
+
: 1119.178050, found 1119.178274. IR ῦ = 420, 458, 468, 501, 521, 544, 
696, 747, 766, 783, 924, 956, 1056, 1298, 1442, 1504, 1580 cm
– 1
. 
 
Compound 113 
 
Compound 92b (20.0 mg, 0.021 mmol) and Pd(dba)2 (12.0 mg, 0.021 mmol) in CH2Cl2 (2 ml) 
were stirred at r.t. for 2 h and then the solvent was evaporated in vacuo. The resulting solid 
was extracted with CH3CN and recrystallized from CH3CN, CH2Cl2 and Et2O to afford the 
desired compound 113 as a yellow solid (4.9 mg, 21%). The colorless crystals suitable for X– 
ray analysis were obtained from CH3CN/CH2Cl2/Et2O. 
1
H NMR (CD3CN, 600 MHz): δ = 
7.69 – 7.55 (m, 13H), 7.55 – 7.50 (m, 1H), 3.90 – 3.84 (m, 2H), 3.83 – 3.76 (m, 2H), 3.75 – 
3.66 (m, 4H), 3.35 (s, 3H), 3.04 (s, 3H), 2.94 ppm (s, 6H). 
13
C NMR (CD3CN, 125 Mz): δ = 
196.5 (dd, JC–P = 126.7 Hz, , JC–P = 16.4 Hz), 176.6 (dd, JC–P = 80.7 Hz, JC–P = 1.7 Hz), 146.2 
(dd, JC–P = 40.9 Hz, JC–P = 20.9 Hz), 135.4 (dd, JC–P = 56.0Hz, , JC–P = 15.8 Hz), 135.1 (d, JC–P 
= 2.4 Hz), 134.6 (dd, JC–P = 4.4 Hz, JC–P = 1.8 Hz), 134.21, 134.20 (d, JC–P = 9.3 Hz), 134.1 
(d, JC–P = 11.3 Hz), 134.0 (d, JC–P = 21.8 Hz), 133.4 (d, JC–P = 2.6 Hz), 130.8 (dd, JC–P = 11.0 
Hz, JC–P = 2.4 Hz), 130.7 (d, JC–P = 1.7 Hz), 130.4 (d, JC–P = 47.5 Hz), 129.7 (d, JC–P = 96.8 
Hz), 128.6 (d, JC–P = 48.2 Hz), 52.8 (d, JC–P = 5.2 Hz), 52.5 (d, JC–P = 4.6 Hz), 52.4 (d, JC–P = 
1.0 Hz), 37.7, 37.6, 37.4, 37.3, 37.2 ppm (m). 
31
P NMR (CD3CN, 162 MHz): δ = 49.4, 15.9 
ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 124.0 ppm (sextet, JF–Sb(I=5/2) = 1933 Hz, octet, JF–
Sb(I=7/2) = 1049 Hz). HRMS calcd. for C28H34N4F6P2SbPd
+
: 829.022380, found 829.022889. IR 
ῦ = 426, 495, 507, 534, 591, 652, 699, 752, 774, 920, 940, 1103, 1203, 1291, 1333, 1407, 
1438, 1546, 1567, 2301, 2929 cm
– 1
. 
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Compound 114 
 
Compound 92b (50.0 mg, 0.052 mmol) and Ni(cod)2 (14.3 mg, 0.052 mmol) were stirred 
overnight in CH2Cl2 (2 ml). A yellow precipitate was separated from the solution. 2,6–
dimethylphenyl isocyanide (16.7 mg, 0.128 mmol) was added in CH2Cl2 (2 ml) and the 
mixture stirred overnight. After evaporation of the solvent, the solid was washed with Et2O 
and recrystallized from CH2Cl2/Et2O to afford the desired compound 114 as a yellow solid 
(22.1 mg, 37%). The yellow crystal suitable for X– ray analysis was obtained from a saturated 
solution of the title compound in CH2Cl2/Et2O. 
1
H NMR (CD2Cl2, 600 MHz): δ = 7.74 – 7.48 
(m, 13H), 7.37 (t, J = 8.2 Hz, 1H), 7.32 (t, J = 7.7 Hz, 1H), 7.14 (d, J = 7.7 Hz, 2H), 3.98 (s, J 
= 4H), 3.88 – 3.71 (m, 4H), 3.33 (s, 6H), 3.01 (s, 6H), 1.98 (s, 6H). 13C NMR (CD2Cl2, 125 
Mz): δ = 199.2 (dd, JC–P = 71.0 Hz, , JC–P = 22.3 Hz), 176.7 (dd, JC–P = 76.9 Hz, JC–P = 3.7 
Hz), 146.2 (m), 144.7 (dd, JC–P = 39.7 Hz, , JC–P = 15.4 Hz), 136.2, 135.4 (dd, JC–P = 59.0 Hz, 
JC–P = 20.0 Hz), 135.0, 134.1, 133.5, 133.3, 133.2, 132.8 (dd, JC–P = 35.4 Hz, , JC–P = 17.5 
Hz), 131.7, 130.7 (d, JC– P = 11.4 Hz), 130.4 (d, JC–P = 8.3 Hz), 129.0, 125.6, 52.7, 51.7, 37.43, 
37.41, 37.34, 37.28, 18.3 ppm (m). 
31
P NMR (CD2Cl2, 162 MHz): δ = 56.9 (d, JP– P = 4.3 Hz), 
23.7 ppm (d, JP– P = 4.3 Hz). 
19
F NMR (CD2Cl2, 282 MHz): δ = – 124.0 ppm (sextet, JF–
Sb(I=5/2) = 1933 Hz, octet, JF–Sb(I=7/2) = 1049 Hz). HRMS calcd. for C37H43N5F6P2Sb
+
: 
912.128170, found 912.128332. IR ῦ = 442, 487, 515, 530, 651, 693, 713, 752, 773, 791, 939, 
957, 1097, 1205, 1287, 1438, 1536, 1566, 2164 cm
– 1
. 
 
Compound 118 
 
Indole (25.8 mg, 0.220 mmol) and phenyl 1,3–butadiene (26.0 mg, 0.200 mmol) were added 
to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and KB(Ar
F
)4 
(14.3 mg, 0.020) in DCE (1 ml), and the reaction was stirred at 70 °C for 18 h. The resulting 
oil was purified by column chromatography (SiO2, Hexane:EtOAc = 20:1) to afford the 
desired compound 118 as a colorless oil (41.0 mg, 86% yield).
 1
H NMR (CDCl3, 400 MHz): δ 
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= 7.95 (br, 1H), 7.69 (dd, J = 7.9 Hz, J = 0.6 Hz, 1H), 7.40 – 7.35 (m, 3H), 7.31 – 7.27 (m, 
2H), 7.23 – 7.17 (m, 2H), 7.10 (ddd, J = 7.9 Hz, J = 7.8 Hz, J = 0.6 Hz, 1H), 7.03 (dd, J = 2.3 
Hz, J = 0.6 Hz, 1H), 6.51 – 6.48 (m, 2H), 3.95 (p, J = 6.8 Hz, 1H), 1.58 ppm (d, J = 7.0 Hz, 
3H).
 13
C NMR (CDCl3, 100 MHz): δ = 137.9, 136.7, 135.6, 128.6, 128.3, 127.0, 126.9, 126.3, 
122.1, 120.6, 120.5, 119.8, 119.4, 111.2, 34.4, 20.8 ppm. HRMS calcd. for C18H18N
+
: 
248.143420, found 248.143374. IR ῦ = 424, 497, 581, 693, 742, 765, 807, 928, 966, 1009, 
1095, 1221, 1244, 1337, 1417, 1455, 1492, 1598, 1618, 2869, 2927, 2963, 3024, 3055, 3417 
cm
– 1
.
 
Compound 119 
 
5–Bromoindole (43.1 mg, 0.220 mmol) and phenyl 1,3–butadiene[165] (26.0 mg, 0.200 mmol) 
were added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) 
and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 70 °C 
for 18 h. The resulting oil was purified by column chromatography (SiO2, Hexane:EtOAc = 
20:1) to afford the desired compound 119 as a light yellow oil (53.5 mg, 82% yield). 
1
H NMR 
(CDCl3, 400 MHz): δ = 8.00 (br, 1H), 7.78 (m, 1H), 7.40 – 7.35 (m, 2H), 7.31 – 7.28 (m, 2H), 
7.27 – 7.25 (m, 2H), 7.23 – 7.17 (m, 2H), 7.03 (d, J = 2.0 Hz, 1H), 6.51 – 6.39 (m, 1H), 3.88 
(p, J = 6.7 Hz, 1H), 1.55 ppm (d, J = 7.0 Hz, 3H). 
13
C NMR (CDCl3, 100 MHz): δ = 137.7, 
135.3, 135.0, 128.7, 128.6, 128.6, 127.1, 126.3, 125.0, 122.3, 121.8, 120.4, 112.7, 34.2, 20.9 
ppm. HRMS calcd. for C18H15NBr
+
: 324.039610, found 324.039349. IR ῦ = 421, 488, 583, 
696, 749, 795, 865, 996, 1045, 1096, 1260, 1373, 1458, 1493, 1599, 1721, 2927, 2962, 3025, 
3421 cm
– 1
.  
 
Compound 120 
 
1–Methyl–2–phenylindole (45.6 mg, 0.220 mmol) and diene (26.0 mg, 0.200 mmol) were 
added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and 
KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 70 °C for 
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18 h. The resulting oil was purified by column chromatography (SiO2, Hexane:EtOAc = 20:1) 
to afford the desired compound 120 as a colorless oil (39.1 mg, 57% yield).
 1
H NMR (CDCl3, 
400 MHz): δ = 7.76 (dm, J = 8.0 Hz, 1H), 7.53 – 7.45 (m, 3H), 7.44 – 7.40 (m, 2H), 7.37 (dm, 
J = 8.0 Hz, 1H), 7.34 – 7.30 (m, 2H), 7.28 (m, 3H), 7.17 (tm, J = 7.1 Hz, 1H), 7.11 (tm, J = 
7.4 Hz, 1H), 6.62 (dd, J = 15.9 Hz, J = 5.8 Hz, 1H), 6.39 (dd, J = 15.9 Hz, J = 1.5 Hz, 1H), 
3.80 (m, 1H),  3.58 (s, 3H), 1.56 ppm (d, J = 7.2 Hz, 3H). 
13
C NMR (CDCl3, 100 MHz): δ = 
138.1, 137.5, 135.7, 132.3, 131.0, 128.6, 128.5, 128.4, 128.3, 128.0, 126.9, 126.4, 126.2, 
121.6, 120.7, 119.2, 116.3, 116.2, 109.6, 34.4, 30.9, 21.1 ppm. HRMS calcd. for C25H23NNa
+
: 
360.172400, found 360.172268. IR ῦ = 435, 486, 520, 592, 582, 601, 722, 735, 805, 921, 964, 
1017, 1098, 1135, 1157, 1247, 1264, 1335, 1362, 1397, 1429, 1466, 1492, 1600, 2926, 2963, 
3025 cm
– 1
.
 
Compound 121 
 
5–Methylindol (28.9 mg, 0.220 mmol) and phenyl 1,3–butadiene (26.0 mg, 0.200 mmol) were 
added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and 
KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 70 °C for 
18 h. The resulting oil was purified by column chromatography (SiO2, Hexane:EtOAc = 100:1 
to 20:1) to afford the desired compound 121 as a light yellow oil (41.2 mg, 76% yield).
 1
H 
NMR (CDCl3, 400 MHz): δ = 7.86 (br, 1H), 7.45 (m, 1H), 7.38 – 7.35 (m, 2H), 7.30 – 7.25 
(m, 3H), 7.19 (tm, J = 8.4 Hz, 1H), 7.2 (dd, J = 8.3 Hz, J = 1.2 Hz, 1H), 7.00 (d, J = 2.3 Hz, 
1H), 6.49 – 6.43 (m, 2H), 3.95 – 3.88 (m, 1H), 2.44 (s, 3H), 1.56 ppm (d, J = 7.0 Hz, 3H). 13C 
NMR (CDCl3, 100 MHz): δ = 138.0, 135.7, 135.0, 128.6, 128.2, 127.1, 127.0, 126.3, 126.9, 
123.7, 120.7, 120.1, 119.3, 110.9, 34.3, 21.7, 20.9 ppm. HRMS calcd. for C19H19NNa
+
: 
284.141150, found 284.140968. IR ῦ = 423, 460, 493, 589, 696, 748, 793, 698, 920, 996, 
1012, 1029, 1073, 1096, 1182, 1224, 1320, 1369, 1419, 1448, 1493, 1580, 1598, 2867, 2925, 
2962, 3023, 3414 cm
– 1
. 
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Compound 122 
 
1–Methylindol (28.8 mg, 0.220 mmol) and phenyl 1,3–butadiene (26.0 mg, 0.200 mmol) were 
added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and 
KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 70 °C for 
18 h. The resulting oil was purified by column chromatography (SiO2, Hexane:EtOAc = 20:1) 
to afford the desired compound 122 as colorless oil (32.1 mg, 63% yield).
 1
H NMR (CDCl3, 
400 MHz): δ = 7.67 (dm, J = 7.9 Hz, 1H), 7.38 – 7.25 (m, 2H), 7.31 – 7.27 (m, 2H), 7.24 – 
7.21 (m, 1H), 7.21 – 7.16 (m, 1H), 7.01 – 7.06 (m, 1H), 6.88 (s, 1H), 6.54 – 6.43 (m, 2H), 
3.93 (p, J = 6.8 Hz, 1H), 3.76 (s, 3H), 1.56 ppm (d, J = 7.0 Hz, 3H).
 13
C NMR (CDCl3, 100 
MHz): δ = 137.9, 137.4, 135.7, 128.6, 128.1, 127.3, 127.0, 126.3, 125.4, 121.7, 119.8, 119.0, 
118.8, 109.3, 34.3, 32.8, 21.0 ppm. HRMS calcd. for C19H19NNa
+
: 284.141100, found 
284.140968. IR ῦ = 424, 497, 581, 698, 746, 968, 992, 1093, 1242, 1373, 1470, 1493, 1528, 
1613, 1712, 1778, 2930, 2961, 3026, 3055 cm
– 1
.
 
Compound 123 
 
5–Fluoroindole (29.7 mg, 0.220 mmol) and phenyl 1,3–butadiene (26.0 mg, 0.200 mmol) 
were added to a solution of 122b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) 
and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 70 °C 
for 18 h. The resulting oil was purified by column chromatography (SiO2, Hexane:EtOAc = 
100:1 to 20:1) to afford the desired compound 123 as light yellow oil (34.4 mg, 65% yield).
 
1
H NMR (CDCl3, 400 MHz): δ = 8.00 (br, 1H), 7.36 – 7.33 (m, 2H), 7.28 – 7.25 (m, 2H), 
7.18 – 7.17 (m, 1H), 7.14 – 7.11 (m, 1H), 7.09 – 7.05 (m, 1H), 6.96 – 6.95 (m, 1H), 6.76 – 71 
(m, 1H), 6.54 – 6.42 (m, 2H), 4.08 (p, J = 6.8 Hz, 1H), 1.53 ppm (d, J = 6.9 Hz, 3H). 13C 
NMR (CDCl3, 100 MHz): δ = 152.3 (d, J = 247.0 Hz), 139.4 (d, J = 11.9), 138.1, 135.6 (d, J 
= 0.8), 128.6, 128.4 (d, J = 7.6), 128.2 (d, J = 1.0), 127.0, 126.3, 125.8 (d, J = 35.1), 122.7 (d, 
J = 8.0), 120.5 (d, J = 1.3), 120.3 (d, J = 3.9 Hz), 115.7 (d, J = 20.2), 115.7 (d, J = 20.2), 
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107.3 (d, J = 3.6), 104.9 (d, J = 20.2), 34.8 (d, J = 1.4), 21.5  ppm (d, J = 1.9). 
19
F NMR 
(CDCl3, 282 MHz): δ = – 120.8 ppm. HRMS calcd. for C18H15NF
+
: 264.119600, found 
264.119402. IR ῦ = 483, 649, 696, 732, 780, 908, 996, 1035, 1224, 1348, 1446, 1494, 1578, 
1628, 1628, 1694, 2962, 3025, 3416 cm
– 1
.
 
Compound 124 
 
1,3–Dimethoxybenzene (30.4 mg, 0.220 mmol) and phenyl 1,3–butadiene (26.0 mg, 0.200 
mmol) were added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 
mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture was stirred at 
70 °C for 18 h. The resulting oil was purified by column chromatography (SiO2, 
Hexane:EtOAc = 20:1) to afford the desired compound 124 as colorless oil (33.6 mg, 63% 
yield).
 1
H NMR (CDCl3, 400 MHz): δ = 7.37 – 7.34 (m, 2H), 7.30 – 7.27 (m, 2H), 7.20 – 7.15 
(m, 1H), 7.10 (d, J = 8.2 Hz, 1H), 6.47 – 6.40 (m, 4H), 4.00 – 3.97 (m, 1H), 3.83 (s, 3H), 3.80 
(s, 3H), 1.39 ppm (d, J = 7.0 Hz, 3H).
 13
C NMR (CDCl3, 100 MHz): δ = 159.3, 157.9, 138.1, 
135.4, 128.6, 128.1, 128.0, 126.9, 126.7, 126.2, 104.3, 98.9, 55.6, 55.5, 34.8, 20.3 ppm. 
HRMS calcd. for C18H21O2
+
: 269.153580, found 269.135605. IR ῦ = 495, 634, 692, 737, 798, 
909, 966, 1034, 1117, 1156, 1179, 1206, 1259, 1290, 1417, 1453, 1503, 1586, 1610, 2835, 
2928, 2959, 3024 cm
– 1
. 
Compound 125 
 
1–Methyl–2–phenylindole (45.6 mg, 0.220 mmol) and 1–phenyl–1,3–pentadiene (E/Z = 1:1, 
26.0 mg, 0.200 mmol)
[165]
 were added to a solution of 92b (9.6 mg, 0.010 mmol), 
[RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the 
reaction mixture was stirred at 70 °C for 18 h. The resulting oil was purified by column 
chromatography (SiO2, Hexane:EtOAc = 100:1 to 20:1) to afford the desired compound 125 
as colorless yellow oil (23.1 mg, 33% yield). 
1
H NMR (CDCl3, 400 MHz): δ = 7.72 (d, J = 
8.0 Hz, 1H), 7.49 – 7.38 (m, 3H), 7.38 – 7.30 (m, 3H), 7.28 – 7.25 (m, 2H), 7.24 – 7.19 (m, 
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3H), 7.15 – 7.04 (m, 2H), 6.58 (dd, J = 15.8, J = 7.0 Hz, 1H), 6.30 (d, J = 15.8 Hz, 1H), 3.52 
(s, 3H), 3.43 (q, J = 8.1, 7.6 Hz, 1H), 1.92 (qt, J = 13.7, J = 7.1 Hz, 2H), 0.75 ppm (t, J = 7.4 
Hz, 3H). 
13
C NMR (CDCl3, 100 MHz): δ = 138.45, 138.12, 134.56, 132.45, 131.11, 128.75, 
128.49, 128.43, 128.27, 126.84, 126.37, 126.22, 121.54, 120.68, 119.07, 114.70, 109.59, 
42.66, 30.92, 28.17, 12.83. HRMS calcd. for C26H25NNa
+
: 374.187880, found 374.187918. IR 
ῦ = 701, 741, 808, 908, 964, 1019, 1072, 1134, 1157, 1246, 1334, 1365, 1397, 1429, 1446, 
1467, 1601, 2869, 2928, 2959, 3025, 3056 cm
– 1
. 
Compound 126 
 
1,3–Dimethoxybenzene (30.4 mg, 0.220 mmol) and 1–phenyl–1,3–pentadiene (E/Z = 1:1, 
28.8 mg, 0.200 mmol)
[165]
 were added to a solution of 92b (9.6 mg, 0.010 mmol), 
[RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the 
reaction mixture was stirred at 70 °C for 18 h. The resulting oil was purified by column 
chromatography (SiO2, Hexane:EtOAc = 20:1) to afford the desired compound 126 as 
colorless oil (24.3 mg, 43% yield).
 1
H NMR (CDCl3, 400 MHz): δ = 7.28 – 7.25 (m, 2H), 7.21 
– 7.17 (m, 2H), 7.11 – 7.07 (m, 1H), 7.03 – 7.01 (m, 1H),  6.41 – 6.38 (m, 2H), 6.29 – 6.28 (m, 
2H), 3.74 (s, 3H), 3.73 (s, 3H), 3.63 (p, J = 6.4 Hz, 1H), 1.70 (m, 2H), 0.82 ppm (t, J = 7.4, 
3H). 
13
C NMR (CDCl3, 100 MHz): δ = 159.1, 158.2, 138.1, 134.3, 129.1, 128.5, 128.3, 126.9, 
126.2, 125.5, 104.3, 98.8, 55.6, 55.5, 43.0, 28.1, 12.4 ppm. HRMS calcd. for C19H23O2
+
: 
283.169380, found 283.169255. IR ῦ = 634, 694, 747, 797, 834, 936, 966, 1037, 1133, 1157, 
1179, 1207, 1259, 1289, 1438, 1463, 1504, 1586, 1610, 2834, 2871, 2931, 2959, 2998, 3024 
cm
– 1
.
 
Compound 127 
 
Indole (25.8 mg, 0.220 mmol) and 1–(p–methoxyphenyl)–1,3–butadiene (E/Z = 2.1:1, 32.0 
mg, 0.200 mmol)
[165]
 were added to a solution of 92b (9.6 mg, 0.010 mmol), [RhCl(CO)2]2 
(1.9 mg, 0.005 mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), and the reaction mixture 
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was stirred at 70 °C for 18 h. The resulting oil was purified by column chromatography (SiO2, 
Hexane:EtOAc = 20:1) to afford the desired compound 127 as colorless yellow oil (19.4 mg, 
35% yield). 
1
H NMR (CD2Cl2, 400 MHz): δ = 8.10 (s, 1H), 7.66 (dd, J = 7.9, 1.0 Hz, 1H), 
7.37 (dt, J = 8.2, 1.0 Hz, 1H), 7.32 – 7.27 (m, 2H), 7.16 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.10 – 
7.04 (m, 2H), 6.85 – 6.79 (m, 2H), 6.51 – 6.41 (m, 1H), 6.32 (dd, J = 15.8, 7.0 Hz, 1H), 3.91 
(tt, J = 7.1, 1.1 Hz, 1H), 3.78 (s, 3H), 1.55 ppm (d, J = 7.0 Hz, 3H). 
13
C NMR (CD2Cl2, 100 
MHz): δ = 159.17, 136.98, 133.75, 130.89, 129.60, 127.77, 127.49, 122.19, 120.84, 120.82, 
119.83, 119.43, 114.19, 111.47, 55.59, 34.67, 20.98 ppm. HRMS calcd. for C19H19NONa
+
: 
300.135910, found 300.135883, IR ῦ = 424, 488, 743, 815, 850, 967, 1010, 1032, 1096, 1175, 
1246, 1298, 1337, 1418, 1456, 4510, 1606, 2838, 2930, 2960, 3415 cm
– 1
.
 
Compound 128 
 
1,3–Dimethoxybenzene (30.4 mg, 0.220 mmol) and 1–(p–trifluoromethylphenyl)–1,3–
butadiene (E/Z = 1.8:1, 39.6 mg, 0.200 mmol)
[166]
  were added to a solution of 92b (9.6 mg, 
0.010 mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 
ml), and the reaction mixture was stirred at 70 °C for 18 h. The resulting oil was purified by 
column chromatography (SiO2, Hexane:EtOAc = 100:1 to 20:1) to afford the desired 
compound 128 as a colorless yellow oil (14.1 mg, 21% yield). 
1
H NMR (CDCl3, 400 MHz): δ 
= 7.52 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.1 Hz, 2H), 7.13 – 7.04 (m, 1H), 6.56 – 6.44 (m, 3H), 
6.44 – 6.35 (m, 1H), 4.01 (p, J = 6.3 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 1.40 ppm (d, J = 7.0 
Hz, 3H). 
13
C NMR (CDCl3, 100 MHz): δ = 159.44, 157.85, 141.62 (d, JC–F = 1.5 Hz), 138.28, 
128.73 (q, JC–F = 32.4 Hz), 127.93, 126.86, 126.32, 126.02, 125.81, 125.50 (q, JC– F = 3.8 Hz), 
104.33, 98.90, 55.60, 55.51, 34.98, 20.03 ppm. 
19
F NMR (CDCl3, 376 MHz): δ = – 62.35 ppm. 
HRMS calcd. for C19H19O2F3Na
+
: 359.122850, found 359.122934. IR ῦ = 502, 596, 636, 798, 
820, 864, 969, 1015, 1036, 1066, 1106, 1116, 1157, 1207, 1322, 1415, 1464, 1504, 1586, 
1612, 2837, 2935, 2962 cm
– 1
.
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Compound 129 
 
1,3–Dimethoxybenzene (E/Z = 1:1, 30.4 mg, 0.220 mmol) and 4–(1E or Z)–1,3–butadien–1–
yl–methyl ester[165] (37.6 mg, 0.200 mmol) were added to a solution of 92b (9.6 mg, 0.010 
mmol), [RhCl(CO)2]2 (1.9 mg, 0.005 mmol) and KB(Ar
F
)4 (14.3 mg, 0.020) in DCE (1 ml), 
and the reaction mixture was stirred at 70 °C for 18 h. The resulting oil was purified by 
column chromatography (SiO2, Hexane:EtOAc = 100:1 to 20:1) to afford the desired 
compound 129 as a colorless yellow oil (15.0 mg, 23% yield). 
1
H NMR (CD2Cl2, 400 MHz): 
δ = 7.89 – 7.79 (m, 2H), 7.37 – 7.29 (m, 2H), 7.00 (dt, J = 8.0, 0.6 Hz, 1H), 6.47 (dd, J = 16.0, 
6.4 Hz, 1H), 6.41 – 6.29 (m, 3H), 3.95 – 3.86 (m, 1H), 3.78 (s, 3H), 3.74 (s, 3H), 3.69 (s, 3H), 
1.30 ppm (d, J = 7.1 Hz, 3H). 
13
C NMR (CD2Cl2, 100 MHz): δ = 167.10, 159.74, 158.13, 
142.91, 138.69, 130.07, 128.77, 128.09, 127.39, 126.25, 126.14, 104.59, 98.89, 55.81, 55.66, 
52.23, 35.37, 20.04 ppm. HRMS calcd. for C20H22O4Na
+
: 349.141170, found 349.141029. IR 
ῦ = 699, 768, 833, 871, 936, 970, 1016, 1157, 1178, 1207, 1276, 1414, 1435, 1455, 1504, 
1586, 1607, 1644, 1717, 2836, 2954, 2996 cm
– 1
. 
 
Compound 133a 
 
To a solution of carbene 137 (1 g, 2.260 mmol) in THF (10 ml), Ph2PCl (0.418 ml, 2.26 
mmol) was added and the resulting mixture stirred at r.t. overnight. The initial pale yellow 
solution changed to a bright yellow suspension. Then the solution was filtered off and the 
remaining yellow solid washed with Et2O and dried in vacuo. The yellow solid thus obtained 
was dissolved in CH3CN, NaSbF6 (1.020 g, 3.95 mmol) was added to that solution and the 
resulting suspension stirred overnight at r.t. Removal of the solvents and the extraction with 
CH2Cl2 afforded the desired product 138a as a yellow solid, which can be further purified by 
recrystallization from CH2Cl2/Et2O (1.03 g, 66%). 
1
H NMR (400 MHz, CD2Cl2): δ = 7.59 – 
7.51 (m, 3H) , 7.50 – 7.44 (m, 4H), 7.43 – 7.31 (m, 6H), 2.54 – 2.43 (m, 4H), 1.59 (s, 6H), 
1.41 (s, 6H), 1.31 (d, J = 6.5 Hz, 6H), 0.90 ppm (d, J = 6.5 Hz, 6H). 
13
C NMR (100 MHz, 
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CD2Cl2): δ = 215.3 (d, J = 58.5 Hz), 144.7 (d, J = 2.4 Hz), 136.2 (d, J = 23.5 Hz), 132.4, 
132.8 (d, J = 4.9 Hz), 132.5 (d, J = 0.94 Hz), 130.4 (d, J = 9.4 Hz), 128.8 (d, J = 6.6 Hz), 
127.2, 83.1 (d, J = 3.4 Hz), 56.5 (d, J = 4.6 Hz), 52.7, 30.2, 29.6 (d, J = 2.2 Hz), 29.1 (d, J = 
1.1 Hz), 26.1, 24.7 ppm
 
(d, J = 5.9 Hz).
 31
P NMR (162 MHz, CD2Cl2): δ = 0.0 ppm. 
19
F NMR 
(CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 
Hz). HRMS calcd. for C32H41NP
+
: 470.296970, found: 470.297113. IR ῦ = 427, 481, 499, 
569, 651, 696, 752, 807, 931, 999, 1052, 1090, 1130, 1197, 1338, 1377, 1391, 1437, 1469, 
1520, 1586, 2944, 2977 cm
– 1
. 
 
Compound 138b 
 
To a solution of carbene 137 (1 g, 2.26 mmol) in THF (10 ml), Cy2PCl (0.5 ml, 2.26 mmol) 
was added and the resulting mixture stirred at r.t. overnight. The pale yellow solution changed 
to a bright yellow suspension. Then the solution was filtered off and the remaining yellow 
solid washed with diethyl ether and dried in vacuo. The yellow solid was dissolved in 
CH3CN, NaSbF6 (1.27 g, 4.92 mmol) was added to the solution and the resulting suspension 
stirred overnight at r.t. Removal of the solvents and extraction with CH2Cl2 afforded the 
desired product 138b as a yellow solid, which was purifiedyf by recrystallization from 
CH2Cl2/Et2O (1.06 g, 65%). 
1
H NMR (500 MHz, CD2Cl2) δ = 7.60 (t, J = 7.8 Hz, 1H), 7.41 
(d, J = 7.8 Hz, 2H), 2.53 (hept, J = 6.5 Hz, 2H), 2.40 (s, 2H), 2.25 – 2.15 (m, 2H), 1.89 – 1.81 
(m, 8H), 1.80 (s, 6H), 1.76 – 1.69 (m, 2H), 1.56 – 1.47 (m, 5H), 1.46 (s, 6H), 1.37 (d, J = 6.5 
Hz, 6H), 1.29 (d, J = 6.6 Hz, 6H), 1.28 – 1.21 ppm (m, 5H). 13C NMR (126 MHz, CD2Cl2) δ 
= 214.5 (d, J = 70.7 Hz), 144.9 (d, J = 2.7 Hz),  132.1, 131.7 (d, J = 2.5 Hz), 126.5, 83.1 (d, J 
= 2.7 Hz), 57.5 (d, J = 4.0 Hz), 52.1, 35.8 (d, J = 19.0 Hz), 32.9 (d, J = 13.1 Hz), 29.7, 29.5 
(d, J = 2.9 Hz), 27.7 (d, J = 11.5 Hz), 26.7 (d, J = 3.6 Hz), 25.9, 24.7 ppm. 
31
P NMR (122 
MHz, CDCl3) δ = 21.6 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–
Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for C32H53NP
+
: 482.391013, 
found: 482.391350. IR ῦ = 420, 463, 567, 606, 654, 774, 808, 849, 996, 1051, 1130, 1201, 
1337, 1389, 1459, 1518, 2866, 2935, 2971 cm
– 1
. 
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Compound 138c 
 
To a solution of carbene 137 (0.500 g, 1.132 mmol) in THF (5 ml), [(p-CF3)Ph]2PCl (403.9 
mg, 1.132 mmol) was added and the resulting mixture stirred at r.t. overnight. The initial pale 
yellow solution changed to a bright yellow suspension. Then the solvent was removed in 
vacuo and the remaining yellow solid washed with pentane and dried in vacuo. The solid thus 
obtained was dissolved in CH2Cl2 (20 ml) and NaSbF6 (732.6 g, 2.831 mmol) was added to a 
yellow suspension and stirred overnight at r.t. After that the solvent was filtered and the 
remaining solid was extracted with CH2Cl2. Evaporation of the organic solvents in vacuo 
afforded a yellow solid, which was purified by recrystallization from CH2Cl2/Et2O to afford 
the desired product 138c (610.0 mg, 64%). 
1
H NMR (CD2Cl2, 300 MHz, 298 K): δ = 7.82 – 
7.72 (m, 4H), 7.65 – 7.48 (m, 5H), 7.36 (d, J = 7.8 Hz, 2H), 2.53 (s, 2H), 2.48 (p, J = 6.5 Hz, 
2H), 1.63 (s, 6H), 1.46 (d, J = 0.7 Hz, 6H), 1.34 (d, J = 6.5 Hz, 6H), 0.92 ppm (d, J = 6.6 Hz, 
6H). 
13
C NMR (CD2Cl2, 100 MHz, 298 K): δ = 213.03 (d, JC–P = 57.2 Hz), 144.69 (d, JC–P = 
2.3 Hz), 136.63 (d, J = 23.8 Hz), 134.40 (q, JC–F = 33.4 Hz), 133.36 – 132.58 (m), 132.52 –
132.11 (m), 128.48 – 126.53 (m), 123.69 (d, JC–F = 272.9 Hz), 84.34 (d, JC–P = 3.2 Hz), 56.79 
(d, JC–P = 4.7 Hz), 52.56, 30.22, 29.69 (d, JC–P  = 1.9 Hz), 29.21, 25.97, 24.86 ppm (d, JC–P = 
5.7 Hz). 
31
P NMR (CD2Cl2, 121 MHz, 298K): δ = – 4.29 ppm. 
19
F NMR (CD2Cl2, 282 MHz, 
298K): δ = – 63.81 ppm. HRMS calcd. for C34H39NF6P
+
 606.272470, found: 606.271884. IR 
ῦ = 413, 514, 602, 654, 695, 711, 807, 836, 954, 1014, 1059, 1110, 1127, 1170, 1262, 1320, 
1396, 1461, 1607, 2966 cm
– 1
. 
 
Compound 139a 
 
(Me2S)AuCl (42.0 mg, 0.140 mmol) was added to a solution of compound 138a (100.2 mg, 
0.140 mmol) in CH2Cl2 (2 ml) and the resulting suspension stirred for 1 hour at r.t. After 
evaporation of the solvent, the resulting solid was dissolved in CH3CN and filtered. Removal 
of the solvent in vacuo afforded the desired product 139a as a yellow solid, which could be 
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further purified by recrystallization from CH2Cl2/Et2O (95.8 mg, 72%). 
1
H NMR (300 MHz, 
CD3CN): δ = 7.81 – 7.64 (m, 11H) , 7.52 (d, J = 7.8 Hz, 2H), 1.66 (s, 6H), 2.64 – 2.49 (m, 
4H), 1.35 (d, J = 6.6 Hz, 12H), 1.19 ppm (d, J = 6.6 Hz, 6H). 
13
C NMR (126 MHz, CD3CN): 
δ = 202.3(d, J = 12.8 Hz), 145.4, 135.8 (d, J = 15.2 Hz), 135.4 (d, J = 2.8 Hz), 133.7, 131.4 
(d, J = 12.7 Hz), 128.6, 124.4 (d, J = 60.0 Hz), 90.3 (d, J = 1.9 Hz), 59.5 (d, J = 2.2 Hz), 50.5 
(d, J = 2.2 Hz), 30.4 (d, J = 7.4 Hz), 29.8, 27.4, 25.0 ppm.
 31
P NMR (122 MHz, CD2Cl2): δ = 
29.5 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, 
octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for C32H41AuClNP
+
: 702.232519, found: 
702.232490. IR ῦ = 426, 452, 504, 537, 562, 609, 648, 657, 692, 744, 800, 999, 1052, 1091, 
1191, 1342, 1378, 1392, 1438, 1464, 1481, 1538, 1588, 2962 cm
– 1
. 
 
Compound 139b 
 
(Me2S)AuCl (42.0 mg, 0.140 mmol) was added to a solution of compound 138b (101.1 mg, 
0.140 mmol) in CH2Cl2 (2 ml) and the resulting suspension stirred for 1 hour at r.t. After 
evaporation of the solvent, the resulting solid dissolved in CH3CN and filtered. Removal of 
the solvents afforeded the desired solid 139b dried in vacuo to yield the new gold complex 
(90.0 mg, 90%). 
1
H NMR (300 MHz, CD3CN) δ = 7.63 (t, J = 7.8 Hz, 1H), 7.41 (d, J = 7.9 
Hz, 2H), 2.74 – 2.58 (m, 2H), 2.34 (hept, J = 6.6 Hz, 2H), 2.43 (s, 2H), 2.22 – 2.09 (m, 2H), 
1.82 (m, , 3H), 1.78 (s, 6H), 1.72 – 1.47 (m, 9H), 1.43 (d, J = 6.6 Hz, 6H), 1.41 – 1.38 (m, 
6H), 1.35 (d, J = 12.0 Hz, 3H), 1.28 (d, J = 6.3 Hz, 6H), 1.26 – 1.16 ppm (m, 3H). 13C NMR 
(150 MHz, CD3CN) δ = 204.7 (d, J = 3.4 Hz), 145.3, 27.0 (d, J = 14.1 Hz), 133.5, 128.2, 90.2, 
58.9 (d, J = 1.6 Hz), 50.9 (d, J = 2.3 Hz), 38.7 (d, J = 23.9 Hz), 34.9 (d, J = 3.4 Hz), 32.7 (d, J 
= 2.2 Hz), 30.2 (d, J = 16.3 Hz), 29.0 (d, J = 17.3 Hz), 27.4 (d, J = 15.3 Hz), 25.9 (d, J = 2.1 
Hz), 25.0 ppm.
 31
P NMR (121 MHz, CD3CN) δ = 54.97 ppm. 
19
F NMR (CD3CN, 282 MHz): 
δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for 
C32H53AuClNP
+
: 714.326419, found: 714.326670. IR ῦ = 431, 472, 527, 561, 605, 654, 771, 
799, 814, 851, 885, 919, 999, 1053, 1128, 1187, 1264, 1341, 1378, 1452, 1520, 2858, 2932 
cm
– 1
. 
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Compound 139c 
 
(Me2S)AuCl (17.5 mg, 0.059 mmol) was added to a solution of compound 138c (50.0 mg, 
0.059 mmol) in CH2Cl2 (1 ml) and the resulting suspension stirred for 1 hour at r.t. After 
evaporation of the solvent, the resulting solid was recrystallized from CH2Cl2/Et2O to afford 
the desired compound 139c as a yellow solid (45.6 mg, 70%). 
1
H NMR (CD2Cl2, 300 MHz, 
298 K): δ = 7.99 (m, 4H), 7.94 – 7.75 (m, 5H), 7.50 (d, J = 7.9 Hz, 2H), 2.72 (s, 2H), 2.53 (p, 
J = 6.6 Hz, 2H), 1.75 (s, 6H), 1.44 (s, 6H), 1.40 (d, J = 6.4 Hz, 6H), 1.22 ppm (d, J = 6.6 Hz, 
6H). 
13
C NMR (CD2Cl2, 100 MHz, 298 K): δ = 200.1 (d, JC–P = 14.3 Hz), 144.8, 136.78 (qd, 
JC–F = 33.8, JC–P = 2.9 Hz), 135.9 (d, JC–P = 15.9 Hz), 134.0, 132.5 (d, JC–P = 6.6 Hz), 128.5, 
128.1 (dq, JC–F = 13.0, JC–P = 3.6 Hz), 127.4 (d, JC–P = 1.7 Hz), 123.4 (q, JC–F = 273.3 Hz), 
90.6 (d, JC–P  = 1.8 Hz), 59.4 (d, JC–P = 2.1 Hz), 50.5 (d, JC–P = 2.2 Hz), 30.7, 30.4, 30.1, 27.5, 
25.3 ppm. 
31
P NMR (CD2Cl2, 121 MHz, 298K): δ = 27.40 ppm. 
19
F NMR (CD2Cl2, 282 MHz, 
298K): δ = – 64.02 ppm. HRMS calcd. for C32H53AuClNP
+
: 838.207200,  found: 838.207290. 
IR ῦ = 421, 437, 517, 539, 563, 605, 652, 710, 771, 802, 833, 954, 1011, 1062, 1117, 1138, 
1318, 1337, 1399, 1464, 2308, 2854, 2925, 2962, 3104 cm
– 1
. 
 
Compound 140a 
 
Potassium graphite (74.6 mg, 0.552 mmol) was added to a solution of 138a (390.0 mg, 0.552 
mmol) in THF (2 ml) at – 78 oC and the resulting suspension stirred for 5 min. Then the 
reaction was allowed to warm up to r.t and further stirred for 1 h. The solvent was removed in 
vacuo and the resulting solid extracted with pentane to afford, after the evaporation of 
pentane, the desired product 140a as a black solid (81%, 212.0 mg). Crystals suitable for X– 
ray analysis were obtained from a saturated solution of 140a in pentane at – 20 oC. Elemental 
analysis calcd. for C32H41NP
·
: C: 81.66%, H: 8.78%, N: 2.98%, found: C: 81.75%, H: 8.84%, 
N: 2.97%. UV– visible absorption bands found at 213 and 265 nm (in CH2Cl2). HRMS calcd. 
for C32H41NP
+
: 470.296830, found: 470.297113. 
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Compound 140b 
 
Potassium graphite (21.5 mg, 0.159 mmol) was added to a solution of 138b (114.0 mg, 0.159 
mmol) in THF (2 ml) at – 78 oC and the resulting suspension stirred for 5 min. Then the 
reaction was allowed to warm up to r.t and further stirred for 1 h. The solvent was removed in 
vacuo and the resulting solid extracted with pentane to afford, after the evaporation of the 
solvent, the desired product 140b as a orange solid (70%, 54.0 mg). UV–visible absorption 
bands found at 285 and 321 nm (in CH2Cl2). HRMS calcd. for C32H53NP
+
: 482.391500, 
found: 482.391013. 
 
Compound 140c 
 
Potassium graphite (18.8 mg, 0.126 mmol) was added to a solution of 138c (106.0 mg, 0.126 
mmol) in THF (2 ml) at – 78 oC and the resulting suspension stirred for 5 min. Then the 
reaction was allowed to warm up to r.t and further stirred for 1 h. The solvent was removed in 
vacuo and the resulting solid extracted with pentane to afford, after the evaporation of 
pentane, the desired product 140c as a black solid (60%, 46.0 mg). Crystals suitable for X–ray 
analysis were obtained from a saturated solution of 140c in pentane at – 20 oC. UV–visible 
absorption bands found at 250 and 276 nm (in CH2Cl2). HRMS calcd. for C34H39NPF
+
: 
606.272470, found: 606.271884. 
 
Compound 141 
 
(Me2S)AuCl (12.5 mg, 0.043 mmol) was added to a solution of 140a (20.0 mg, 0.043 mmol) 
in THF (1 ml) at – 78 oC and the resulting solution stirred for 5 min. Then, the reaction was 
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warmed up to r.t and further stirred for 1 h. Removal of the solvents in vacuo afforded a red 
solid, which was washed with pentane to afforded the desired product 141 as red solid (87%, 
24.0 mg). Red crystals suitable for X–ray analysis were obtained from CH2Cl2/pentane at r.t. 
Elemental analysis calcd. for C32H41NPAuCl: C: 54.67%, H: 5.88%, N: 1.99%, found: C: 
51.99%, H: 6.09%, N: 2.02%. UV– visible absorption bands found at 234 and 246 nm (in 
CH2Cl2). HRMS calcd. for C32H41NPAuCl
+
: 702.233360, found: 702.232519. 
 
Compound 142 
 
(THT)Au(C6F5) (19.2 mg, 0.043 mmol) was added to 140a (20.0 mg, 0.043 mmol) in THF (1 
ml) at – 78 oC and  and the resulting mixture was stirred for 5 min. Then the reaction was 
warmed up to r.t and further stirred for 1 h. Removal of the solvents in vacuo and afforded a 
red solid, which was washed with pentane to afford the desired product 142 as yellow solid 
(76%, 27.0 mg). Red crystals suitable for X– ray analysis were obtained from a solution of 
142 in benzene/pentane at r.t. UV– visible absorption bands found at 234 and 246 nm (in 
CH2Cl2). HRMS calcd. for C38H41NPAuF5
+
: 834.256130, found: 834.255683. 
 
Compound 143 
 
(Me2S)AuCl (12.2 mg, 0.041 mmol) was added to 140b (20.0 mg, 0.041 mmol) in THF (1 ml) 
at – 78 oC and the mixture stirred for 5 min. Then the reaction was warmed up to r.t and 
further stirred for 1 h. Removal of the solvents in vacuo afforded a solid, which was washed 
with pentane to afford the desired product 143 as a red solid (88%, 26.0 mg). Red crystals 
suitable for X– ray analysis were obtained from a solution of 143 in benzene/pentane at 4 oC. 
Elemental analysis calcd. for C32H41NPAuCl
·
: C: 57.54%, H: 7.50%, N: 1.77%, found: C: 
54.49%, H: 7.21%, N: 1.69%. UV– visible absorption bands found at 229 and 276 nm (in 
CH2Cl2). HRMS calcd. for C32H41AuClNP
+
: 702.232514, found: 702.232490. 
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Compound 146 
 
m–CPBA (63.5 mg, 0.283 mmol) was added to a solution of phosphine 138a (200.0 mg, 
0.283 mmol) in CH2Cl2 (2 ml), and the resulting mixture stirred for 1 h. Partly removal of the 
solvent to approximately 2 ml and addition of Et2O (10 ml) resulted in precipitation of the 
desired product, which was further washed with Et2O to afford clean 146 as a white solid 
(97%, 200.0 mg). 
1
H NMR (CD3CN, 300 MHz): δ = 7.91 – 7.63 (m, 10H), 7.53 (dd, J = 8.5, 
7.0 Hz, 1H), 7.44 – 7.35 (m, 2H), 2.67 (p, J = 6.5 Hz, 2H), 2.56 (s, 2H), 1.53 (s, 6H), 1.38 (d, 
J = 6.4 Hz, 6H), 1.27 (s, 6H), 1.00 ppm (d, J = 6.6 Hz, 6H), 
13
C NMR (CD3CN, 100 MHz): δ 
= 202.6 (d, J = 43.3 Hz), 143.5, 134.5 (d, J = 3.0 Hz), 132.9 (d, J = 11.2 Hz), 130.7, 130.5, 
129.2 (d, J = 13.3 Hz), 128.2 (d, J = 110.1 Hz), 125.2, 87.7 (d, J = 5.2 Hz), 54.2 (d, J = 8.4 
Hz), 48.8 (d, J = 3.8 Hz), 29.3, 28.4, 27.9, 25.5, 22.9 ppm. 
31
P NMR (CD3CN, 121 MHz) δ = 
24.50 ppm. 
19
F NMR (CD3CN, 282 MHz): δ = – 122.4 ppm (sextet, JF–Sb(I=5/2) = 1945 Hz, 
octet, JF–Sb(I=7/2) = 1071 Hz). HRMS calcd. for C32H41ONP
+
: 486.292280, found: 486.292028. 
IR ῦ = 447, 472, 502, 536, 655, 697, 732, 754, 799, 807, 1098, 1114, 1219, 1378, 1438, 1471, 
2979 cm
– 1
. 
 
Compound 147 
 
Potassium graphite (10.3 mg, 0.069 mmol) was added to 146 (50.0 mg, 0.069 mmol) in THF 
(2 ml) at – 78 oC and the resulting suspension stirred for 5 min. Then, the reaction was 
warmed up to r.t and further stirred for 1 h. Removal of the solvents in vacuo, followed by 
extraction with pentane afforded the desired product 147 as a black solid (84%, 28.3 mg). 
Crystals suitable for X–ray analysis were obtained from a solution of 147 in pentane at – 20 
o
C. Elemental analysis calcd. for C32H41NOP: C: 78.98%, H: 8.48%, N: 2.88%, found: C: 
77.34%, H: 8.86%, N: 2.68%. UV– visible absorption bands found at 228 and 270 nm (in 
CH2Cl2). HRMS calcd. for C32H41NOP
+
: 486.292230, found: 486.292028. 
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6 Appendix 
6.1  NMR Spectra of Representative Compounds 
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1
H NMR (CD3CN, 300 MHz) (Compound 62) 
 
 
13
C NMR (CD3CN, 75 MHz) (Compound 62) 
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31
P NMR (CD3CN, 162 MHz) (Compound 62) 
 
 
11
B NMR (CD3CN, 128 MHz) (Compound 62) 
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19
F NMR (CD3CN, 282 MHz) (Compound 62) 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 63) 
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13
C NMR (CD3CN, 101 MHz) (Compound 63) 
 
 
31
P NMR (CD3CN, 162 MHz) (Compound 63) 
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11
B NMR (CD3CN, 128 MHz) (Compound 63) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 63) 
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1
H NMR (CD3CN, 400 MHz) (Compound 64) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 64) 
 
  
  147 
 
31
P NMR (CD3CN, 162 MHz) (Compound 64)
 
 
 
11
B NMR (CD3CN, 128 MHz) (Compound 64) 
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19
F NMR (CD3CN, 282 MHz) (Compound 64)
 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 67) 
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13
C NMR (CD3CN, 100 MHz) (Compound 67)
 
 
 
31
P NMR (CD3CN, 162 MHz) (Compound 67) 
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19
F NMR (CD3CN, 282 MHz) (Compound 67) 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 68) 
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13
C NMR (CD3CN, 100 MHz) (Compound 68)
 
 
  
31
P NMR (CD3CN, 162 MHz) (Compound 68) 
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19
F NMR (CD3CN, 282 MHz) (Compound 68)
 
 
 
1
H NMR (CD3CN, 300 MHz) (Compound 69) 
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13
C NMR (CD3CN, 75 MHz) (Compound 69)
 
 
 
31
P NMR (CD3CN, 121 MHz) (Compound 69) 
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11
F NMR (CD3CN, 282 MHz) (Compound 69)
 
 
 
1
H NMR (CD3CN, 300 MHz) (Compound 73) 
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13
C NMR (CD3CN, 100 MHz) (Compound 73)
 
 
 
31
P NMR (CD3CN, 162 MHz) (Compound 73) 
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19
F NMR (CD3CN, 282 MHz) (Compound 73)
 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 76) 
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13
C NMR (CD3CN, 100 MHz) (Compound 76)
 
 
 
31
P NMR (CD3CN, 162 MHz) (Compound 76) 
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11
B NMR (CD3CN, 128 MHz) (Compound 76) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 76) 
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1
H NMR (CD3CN, 300 MHz) (Compound 79) 
 
 
13
C NMR (CD3CN, 75 MHz) (Compound 79) 
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31
P NMR (CD3CN, 121 MHz) (Compound 79) 
 
 
11
B NMR (CD3CN, 96 MHz) (Compound 79) 
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11
F NMR (CD3CN, 282 MHz) (Compound 79) 
 
 
1
H NMR (CD3CN, 300 MHz) (Compound 82) 
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13
C NMR (CD3CN, 100 MHz) (Compound 82)
 
 
 
31
P NMR (CD3CN, 121 MHz) (Compound 82) 
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19
F NMR (CD3CN, 282 MHz) (Compound 82)
 
 
 
1
H NMR (CD2Cl2, 500 MHz) (Compound 91) 
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13
C NMR (CD3CN, 125 MHz) (Compound 91) 
 
 
31
P NMR (CD3CN, 121 MHz) (Compound 91)
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11
B NMR (CD3CN, 96 MHz) (Compound 91)
 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 92a) 
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13
C NMR (CD3CN, 100 MHz) (Compound 92a) 
 
 
31
P NMR (CDCl3, 121 MHz) (Compound 92a) 
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11
B NMR (CD3CN, 96 MHz) (Compound 92a)
 
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 92a)
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1
H NMR (CD3CN, 400 MHz) (Compound 92b) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 92b)
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31
P NMR (CD3CN, 121 MHz) (Compound 92b)
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 92b) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 92c) 
 
 
13
C NMR (CD2Cl2, 125 Mz) (Compound 92c)
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31
P NMR (CD2Cl2, 162 MHz) (Compound 92c) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 92c) 
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11
B NMR (CD2Cl2, 96 MHz) (Compound 92c) 
 
 
 
1
H NMR (CDCl3, 400 MHz) (Compound 99)
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13
C NMR (CDCl3, 100 MHz) (Compound 99)
 
 
 
31
P NMR (CDCl3, 121 MHz) (Compound 99)
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1
H NMR (CDCl3, 400 MHz) (Compound 100)
 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 100)
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31
P NMR (CDCl3, 121 MHz) (Compound 100)
 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 101a)
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13
C NMR (CD3CN, 100 MHz) (Compound 101a)
 
 
 
31
P NMR (CD3CN, 121 MHz) (Compound 101a)
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11
B NMR (CD3CN, 96 MHz) (Compound 101a)
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 101a)
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1
H NMR (CD3CN, 400 MHz) (Compound 101b) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 101b)
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31
P NMR (CD3CN, 121 MHz) (Compound 101b)
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 101b)
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1
H NMR (CD3CN, 400 MHz) (Compound 102) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 102) 
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31
P NMR (CD3CN, 121 MHz) (Compound 102)
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 102)
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1
H NMR (CD3CN, 400 MHz) (Compound 103)
 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 103) 
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31
P NMR (CD3CN, 121 MHz) (Compound 103) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 103)
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1
H NMR (CD3CN, 400 MHz) (Compound 104) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 104) 
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31
P NMR (CD3CN, 121 MHz) (Compound 104)
 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 104) 
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1
H NMR (C6D6, 400 MHz) (Compound 105)
 
 
 
13
C NMR (C6D6, 100 MHz) (Compound 105) 
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31
P NMR (C6D6, 121 MHz) (Compound 105) 
 
 
19
F NMR (C6D6, 282 MHz) (Compound 105)
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1
H NMR (C6D6, 300 MHz) (Compound 106) 
 
 
13
C NMR (C6D6, 100 Mz) (Compound 106) 
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31
P NMR (C6D6, 121 MHz) (Compound 106) 
 
 
1
H NMR (CD3CN, 400 MHz) (Compound 107a) 
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13
C NMR (CD3CN, 125 Mz) (Compound 107a)
 
 
 
31
P NMR (CD3CN, 162 MHz) (Compound 107a) 
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19
F NMR (CD3CN, 282 MHz) (Compound 107a)
 
 
 
1
H NMR (CD2Cl2, 400 MHz) (Compound 107b) 
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13
C NMR (CD2Cl2, 100 Mz) (Compound 107b)
 
 
 
31
P NMR (CD2Cl2, 162 MHz) (Compound 107b) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 107c)
 
 
 
13
C NMR (CD2Cl2, 100 Mz) (Compound 107c) 
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31
P NMR (CD2Cl2, 162 MHz) (Compound 107c)
 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 107c)
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13
H NMR (CD3CN, 400 MHz) (Compound 108)
 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 108) 
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31
P NMR (CD3CN, 121 MHz) (Compound 108) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 108)
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1
H NMR (CD3CN, 400 MHz) (Compound 109a) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 109a)
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31
P NMR (CD3CN, 121 MHz) (Compound 109a) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 109a)
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1
H NMR (CD3CN, 400 MHz) (Compound 109b) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 109b) 
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31
P NMR (CD3CN, 121 MHz) (Compound 109b) 
 
 
19
F NMR (CD3CN, 376 MHz) (Compound 109b) 
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1
H NMR (CD3CN, 400 MHz) (Compound 109e) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 109e) 
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31
P NMR (CD3CN, 121 MHz) (Compound 109e) 
 
 
19
F NMR (CD3CN, 376 MHz) (Compound 109e) 
 
  
  203 
 
1
H NMR (CD3CN, 400 MHz) (Compound 109f) 
 
 
13
C NMR (CD3CN, 150 MHz) (Compound 109f)
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31
P NMR (CD3CN, 121 MHz) (Compound 109f) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 109f)
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1
H NMR (CD3CN, 400 MHz) (Compound 110) 
 
 
13
C NMR (CD3CN, 150 MHz) (Compound 110)
 
 
  
  206 
 
31
P NMR (CD3CN, 121 MHz) (Compound 110) 
 
 
11
B NMR (CD3CN, 96 MHz) (Compound 110) 
 
  
  207 
 
19
F NMR (CD3CN, 282 MHz) (Compound 110)
 
 
 
 
1
H NMR (CD2Cl2, 600 MHz): (Compound 112b) 
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13
C NMR (CD2Cl2, 150 MHz) (Compound 112b) 
 
 
31
P NMR (CD2Cl2, 121 MHz) (Compound 112b) 
 
  
  209 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 112b) 
 
 
1
H NMR (CD2Cl2, 400 MHz) (Compound 112c)
 
 
  
  210 
 
13
C NMR (CD2Cl2, 100 MHz) (Compound 112c) 
 
 
31
P NMR (CD2Cl2, 121 MHz) (Compound 112c) 
 
 
  
  211 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 112c)
 
 
 
1
H NMR (CD2Cl2, 400 MHz) 
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13
C NMR (CD2Cl2, 100 MHz)
 
 
 
31
P NMR (CD2Cl2, 121 MHz) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 112d)
 
 
 
13
C NMR (CD2Cl2, 100 MHz) (Compound 112d) 
 
 
  
  214 
 
31
P NMR (CD2Cl2, 121 MHz) (Compound 112d)
 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 112d) 
 
  
  215 
 
1
H NMR (CD2Cl2, 500 MHz) (Compound 112e) 
 
 
13
C NMR (CD2Cl2, 125 Mz) (Compound 112e) 
 
  
  216 
 
31
P NMR (CD2Cl2, 162 MHz) (Compound 112e) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 112e) 
 
  
  217 
 
1
H NMR (CD2Cl2, 300 MHz) (Compound 112f) 
 
 
13
C NMR (CD2Cl2, 125 Mz) (Compound 112f) 
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31
P NMR (CD2Cl2, 162 MHz) (Compound 112f) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 112f) 
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1
H NMR (CD3CN, 400 MHz) (Compound 112g) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 112g)
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31
P NMR (CD3CN, 121 MHz) (Compound 112g) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 112g) 
 
  
  221 
 
11
B NMR (CD3CN, 96 MHz) (Compound 112g) 
 
 
1
H NMR (CD3COCD3, 400 MHz) (Compound 112h)
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13
C NMR (CD3COCD3, 100 MHz) (Compound 112h)
 
 
 
31
P NMR (CD3COCD3, 121 MHz) (Compound 112h)
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11
B NMR (CD3COCD3, 96 MHz) (Compound 112h)
 
 
 
19
F NMR (CD3COCD3, 282 MHz) (Compound 112h) 
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1
H NMR (CD3CN, 600 MHz) (Compound 113)
 
 
 
13
C NMR (CD3CN, 125 Mz) (Compound 113) 
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31
P NMR (CD3CN, 162 MHz) (Compound 113) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 113) 
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1
H NMR (CD2Cl2, 600 MHz) (Compound 114) 
 
 
13
C NMR (CD2Cl2, 125 Mz) (Compound 114) 
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31
P NMR (CD2Cl2, 162 MHz) (Compound 114) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 114) 
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1
H NMR (CDCl3, 400 MHz) (Compound 118) 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 118) 
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1
H NMR (CDCl3, 400 MHz) (Compound 119)
 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 119) 
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1
H NMR (CDCl3, 400 MHz) (Compound 120)
 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 120) 
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1
H NMR (CDCl3, 400 MHz) (Compound 121) 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 121) 
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1
H NMR (CDCl3, 400 MHz) (Compound 122) 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 122) 
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1
H NMR (CDCl3, 400 MHz) (Compound 123) 
 
 
13
C NMR (CDCl3, 100 MHz) (Compound 123) 
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19
F NMR (CDCl3, 282 MHz) (Compound 123) 
 
 
1
H NMR (CDCl3, 400 MHz) (Compound 124) 
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13
C NMR (CDCl3, 100 MHz) (Compound 124) 
 
 
1
H NMR (CDCl3, 400 MHz) (Compound 125) 
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13
C NMR (CDCl3, 100 MHz) (Compound 125) 
 
 
1
H NMR (CDCl3, 400 MHz) (Compound 126) 
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13
C NMR (CDCl3, 100 MHz) (Compound 126) 
 
 
1
H NMR (CD2Cl2, 400 MHz) (Compound 127) 
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13
C NMR (CD2Cl2, 100 MHz) (Compound 127) 
 
 
1
H NMR (CDCl3, 400 MHz) (Compound 128)
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13
C NMR (CDCl3, 100 MHz) (Compound 128) 
 
 
19
F NMR (CDCl3, 376 MHz) (Compound 128) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 129) 
 
 
13
C NMR (CD2Cl2, 100 MHz) (Compound 129) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 138a) 
 
 
13
C NMR (CD2Cl2, 100 MHz) (Compound 138a) 
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31
P NMR (CD2Cl2, 162 MHz) (Compound 138a) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 138a) 
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1
H NMR (CD2Cl2, 400 MHz) (Compound 138b) 
 
 
13
C NMR (CD2Cl2, 125 MHz) (Compound 138b) 
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31
P NMR (CD2Cl2, 162 MHz) (Compound 138b) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 138b) 
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1
H NMR (CD2Cl2, 300 MHz) (Compound 138c) 
 
 
13
C NMR (CD2Cl2, 100 MHz) (Compound 138c) 
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31
P NMR (CD2Cl2, 121 MHz) (Compound 138c) 
 
 
19
F NMR (CD2Cl2, 282 MHz) (Compound 138c) 
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1
H NMR (CD3CN, 300 MHz) (Compound 139a) 
 
 
13
C NMR (CD3CN, 125 MHz) (Compound 139a) 
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P NMR (CD3CN, 121 MHz, 298K) (Compound 139a) 
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F NMR (CD3CN, 282 MHz) (Compound 139a) 
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1
H NMR (CD3CN, 300 MHz) (Compound 139b) 
 
 
13
C NMR (CD3CN, 125 MHz) (Compound 139b) 
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P NMR (CD3CN, 121 MHz) (Compound 139b) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 139b) 
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1
H NMR (CH2Cl2, 300 MHz) (Compound 139c) 
 
 
13
C NMR (CH2Cl2, 100 MHz) (Compound 139c) 
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P NMR (CH2Cl2, 121 MHz) (Compound 139c) 
 
 
19
F NMR (CH2Cl2, 282 MHz) (Compound 139c) 
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1
H NMR (CD3CN, 300 MHz) (Compound 146) 
 
 
13
C NMR (CD3CN, 100 MHz) (Compound 146) 
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P NMR (CD3CN, 161 MHz) (Compound 146) 
 
 
19
F NMR (CD3CN, 282 MHz) (Compound 146) 
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6.2 X-ray Strutures 
6.2.1 Crystal Data and Structure Refinement of Compound 63 
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Empirical formula  C13 H13 B F3 N4 O3 P S 
 Color  colourless 
 Formula weight  404.11 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  ORTHORHOMBIC 
 Space group  Pna21, (no. 33)  
 Unit cell dimensions a = 20.258(2) Å α= 90°. 
 
b = 10.0335(10) Å β= 90°. 
 
c = 8.2844(8) Å γ = 90°. 
Volume 1683.9(3) Å3 
 Z 4 
 Density (calculated) 1.594 mg · m-3 
 Absorption coefficient 0.341 mm-1 
 F(000) 824 e 
 Crystal size 0.48 x 0.07 x 0.05 mm3 
 θ range for data collection θ 2.01 to 28.39°. 
 Index ranges -27 ≤ h ≤ 27, -13≤ k ≤ 13, -11 ≤ l ≤ 11 
 Reflections collected 39971 
 Independent reflections 4204 [Rint = 0.0253] 
 Reflections with I>2s(I) 4118 
 Completeness to θ = 27.50° 100.00% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.98 and 0.91 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 4204 / 1 / 243 
 Goodness-of-fit on F2 1.063 
 Final R indices [I>2s(I)] R1 = 0.0222 wR2 = 0.0599 
R indices (all data) R1 = 0.0229 wR2 = 0.0604 
Absolute structure parameter -0.03(5) 
 Largest diff. peak and hole 0.3 and -0.2 e·Å-3 
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6.2.2 Crystal Data and Structure Refinement of Compound 65 
O3
F1
F3
C14
C11
C10
S1
O1
C12
O2
F2
C9
O5
C1
F6
C13
C8
C2
N1
F4
C3
C15
N2
S2
N4
O6
C4
C7
P1
N3
F5
O4C6
C5
 
Empirical formula  C15 H13 F6 N4 O6 P S2 
 Color  colourless 
 Formula weight  554.38 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  P¯1, (no. 2)  
 Unit cell dimensions a = 9.1777(11) Å α= 102.624(3)°. 
 
b = 9.9125(12) Å β= 98.632(3)°. 
 
c = 13.419(2) Å γ = 112.612(2)°. 
Volume 1061.9(3) Å3 
 Z 2 
 Density (calculated) 1.734 mg · m-3 
 Absorption coefficient 0.421 mm-1 
 F(000) 560 e 
 Crystal size 0.11 x 0.07 x 0.03 mm3 
 θ range for data collection 2.34 to 31.16°. 
 Index ranges -13 ≤ h ≤ 13, -14 ≤ k ≤ 14, -19 ≤ l ≤ 19 
 Reflections collected 31528 
 Independent reflections 6834 [Rint = 0.0306] 
 Reflections with I>2s(I) 5721 
 Completeness to θ = 31.16° 99.50% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.99and 0.95 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 6834 / 0 / 307 
 Goodness-of-fit on F2 1.035 
 Final R indices [I>2s(I)] R1 = 0.0385 wR2 = 0.0975 
R indices (all data) R1 = 0.0491 wR2 = 0.1039 
Largest diff. peak and hole 1.2 and -0.6 e · Å-3 
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6.2.3 Crystal Data and Structure Refinement of Compound 67 
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Empirical formula  C13 H18 F6 N5 O6 P S2 
 Color  colourless 
 Formula weight  549.41 g·mol
-1
  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/n, (no. 14)  
 Unit cell dimensions a = 12.814(3) Å    α= 90° 
 
b = 12.704(3) Å        β= 113.697(4)° 
 
c = 14.321(3) Å         γ = 90° 
Volume 2134.8(9) Å
3
 
 Z 4 
 Density (calculated) 1.709 mg·m
-3
 
 Absorption coefficient 0.419 mm-1 
 F(000) 1120 e 
 Crystal size 0.31 x 0.27 x 0.20 mm
3
 
 θ range for data collection 1.80 to 31.38°. 
 Index ranges -18 ≤ h ≤ 18, -18 ≤ k ≤ 18, -20 ≤ l ≤ 20 
 
Reflections collected 58788 
 
Independent reflections 6998 [Rint = 0.0543] 
 Reflections with I>2s(I) 5519 
 Completeness to θ = 31.38° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.92807 and 0.86261 
 Refinement method Full-matrix least-squares on F
2
 
 
Data / restraints / parameters 6998 / 0 / 300 
 Goodness-of-fit on F
2
 1.075 
 Final R indices [I>2s(I)] R1 = 0.0342                    wR2 = 0.0847 
R indices (all data) R1 = 0.0524                    wR2 = 0.09 
Largest diff. peak and hole 0.733 and -0.555 e·Å
-3
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6.2.4 Crystal Data and Structure Refinement of Compound 76 
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Empirical formula  C18 H23.50 B F6 N6.50 O6 P S2 
 Color  colourless 
 Formula weight  646.83 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/n, (no. 14)  
 Unit cell dimensions a = 12.9893(16) Å α= 90°. 
 
b = 10.6028(13) Å β= 94.762(2)°. 
 
c = 21.575(3) Å γ = 90°. 
Volume 2961.1(6) Å3 
 Z 4 
 Density (calculated) 1.451 mg · m-3 
 Absorption coefficient 0.315 mm-1 
 F(000) 1324 e 
 Crystal size 0.33 x 0.26 x 0.16 mm3 
 θ range for data collection 1.89 to 36.32°. 
 Index ranges -21 ≤ h ≤ 21, -17 ≤ k ≤ 17, -35 ≤ l ≤ 35 
 Reflections collected 111154 
 Independent reflections 14234 [Rint = 0.0235] 
 Reflections with I>2s(I) 12489 
 Completeness to θ = 27.50° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.95 and 0.78 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14234 / 0 / 390 
 Goodness-of-fit on F2 1.081 
 Final R indices [I>2s(I)] R1 = 0.0511 wR2 = 0.1672 
R indices (all data) R1 = 0.0573 wR2 = 0.1752 
Largest diff. peak and hole 2.0 and -0.6 e · Å-3 
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6.2.5 Crystal Data and Structure Refinement of Compound 79 
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Empirical formula  C16 H15 B F6 N9 O6 P S2 
 Color  colourless 
 Formula weight  649.27 g · mol-1  
 Temperature  100 K 
 Wavelength  1.54178 Å 
 Crystal system  TRICLINIC 
 Space group  P¯1, (no. 2)  
 Unit cell dimensions a = 11.615(15) Å α = 115.626(15)°. 
 
b = 11.639(9) Å β = 102.37(2)°. 
 
c = 11.913(9) Å γ = 105.87(2)°. 
Volume 1290(2) Å3 
 Z 2 
 Density (calculated) 1.672 mg · m-3 
 Absorption coefficient 3.361 mm-1 
 F(000) 656 e 
 Crystal size 0.58 x 0.34 x 0.12 mm3 
 θ range for data collection 4.28 to 63.68°. 
 Index ranges -13 ≤ h ≤ 13, -13 ≤ k ≤ 13, -13 ≤ l ≤ 13 
 Reflections collected 34084 
 Independent reflections 4161 [Rint = 0.0469] 
 Reflections with I>2s(I) 4028 
 Completeness to θ = 63.68° 97.70% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.68 and 0.17 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 4161 / 0 / 371 
 Goodness-of-fit on F2 1.054 
 Final R indices [I>2s(I)] R1 = 0.0357 wR2 = 0.0916 
R indices (all data) R1 = 0.0366 wR2 = 0.0922 
Largest diff. peak and hole 0.484 and -0.433 e · Å-3 
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6.2.6 Crystal Data and Structure Refinement of Compound 91 
 
Empirical formula  C50 H74 B2 Cl4 F8 N4 P2 
 Color  yellow 
 Formula weight  1109.05 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/n, (no. 14)  
 Unit cell dimensions a = 15.178(3) Å α = 90°. 
 
b = 10.0356(17) Å β = 97.184(3)°. 
 
c = 36.990(6) Å γ = 90°. 
Volume 5590.0(16) Å3 
 Z 4 
 Density (calculated) 1.318 mg · m-3 
 Absorption coefficient 0.334 mm-1 
 F(000) 2329 e 
 Crystal size 0.17 x 0.16 x 0.07 mm3 
 θ range for data collection 1.110 to 27.498°. 
 Index ranges -19 ≤ h ≤19, -13 ≤ k ≤ 13, -48 ≤ l ≤ 48 
 Reflections collected 127328 
 Independent reflections 12834 [Rint = 0.0371] 
 Reflections with I>2σ(I) 11133 
 Completeness to θ = 25.242° 100.00% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.99 and 0.96 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 12834 / 10 / 653 
 Goodness-of-fit on F2 1.033 
 Final R indices [I>2 σ (I)] R1 = 0.0744 wR2 = 0.1719 
R indices (all data) R1 = 0.0843 wR2 = 0.1801 
Largest diff. peak and hole 2.0 and -2.9 e · Å-3 
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6.2.7 Crystal Data and Structure Refinement of Compound 92b 
 
 
Empirical formula  C28 H34 F12 N4 P2 Sb2 · 0.25 CH2 Cl2 
 Color  colorless 
 Formula weight  981.26 g · mol-1  
 Temperature  150 K 
 Wavelength  1.54178 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/c, (no. 14)  
 Unit cell dimensions a = 15.3374(6) Å α = 90°. 
 
b = 37.0863(14) Å β = 104.8921(17)°. 
 
c = 13.4231(5) Å γ = 90°. 
Volume 7378.7(5) Å3 
 Z 8 
 Density (calculated) 1.767 mg · m-3 
 Absorption coefficient 13.564 mm-1 
 F(000) 3844 e 
 Crystal size 0.20 x 0.11 x 0.03 mm3 
 θ range for data collection 2.383 to 65.082°. 
 Index ranges -18 ≤ h ≤ 17, -43 ≤ k ≤ 43, -15 ≤ l ≤ 15 
 Reflections collected 172322 
 Independent reflections 12440 [Rint = 0.0844] 
 Reflections with I>2σ(I) 10497 
 Completeness to θ = 67.679° 93.10% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.68 and 0.08 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 12440 / 0 / 895 
 Goodness-of-fit on F2 1.028 
 Final R indices [I>2σ(I)] R1 = 0.0724 wR2 = 0.1879 
R indices (all data) R1 = 0.0840 wR2 = 0.1972 
Extinction coefficient 0.00034(3) 
 Largest diff. peak and hole 1.8 and -1.6 e ·Å-3 
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6.2.8 Crystal Data and Structure Refinement of Compound 101a 
 
Empirical formula  C37 H44 B2 Cl2 F8 N4 P2 
 Color  yellow 
 Formula weight  851.22 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/c, (no. 14)  
 Unit cell dimensions a = 19.5245(8) Å α = 90°. 
 
b = 12.1720(11) Å β = 102.298(4)°. 
 
c = 17.6079(10) Å γ = 90°. 
Volume 4088.5(5) Å3 
 Z 4 
 Density (calculated) 1.383 mg · m-3 
 Absorption coefficient 0.306 mm-1 
 F(000) 1760 e 
 Crystal size 0.18 x 0.18 x 0.17 mm3 
 θ range for data collection 2.713 to 33.139°. 
 Index ranges -30 ≤ h ≤ 30, -18 ≤ k ≤ 18, -27 ≤ l ≤ 27 
 Reflections collected 123046 
 Independent reflections 15544 [Rint = 0.0289] 
 Reflections with I>2σ(I) 13476 
 Completeness to θ = 25.242° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.75 and 0.68 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 15544 / 0 / 502 
 Goodness-of-fit on F2 1.052 
 Final R indices [I>2 σ (I)] R1 = 0.0342 wR2 = 0.0892 
R indices (all data) R1 = 0.0420 wR2 = 0.0949 
Largest diff. peak and hole 0.6 and -0.5 e · Å-3 
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6.2.9 Crystal Data and Structure Refinement of Compound 103 
 
Empirical formula  C28 H45 F12 N4 P Sb2 
 Color  colourless 
 Formula weight  940.15 g·mol-1  
 Temperature  100 K 
 Wavelength  1.54178 Å 
 Crystal system  TRICLINIC 
 Space group  p -1, (no. 2)  
 Unit cell dimensions a = 10.2341(2) Å α = 82.3872(10)°. 
 
b = 11.9121(3) Å β = 82.2212(9)°. 
 
c = 14.5106(3) Å γ = 87.2389(10)°. 
Volume 1736.43(7) Å3 
 Z 2 
 Density (calculated) 1.798 mg·m-3 
 Absorption coefficient 13.602 mm-1 
 F(000) 932 e 
 Crystal size 0.26 x 0.12 x 0.04 mm3 
 θ range for data collection 3.099 to 67.509°. 
 Index ranges -12 ≤ h ≤ 12, -14 ≤ k ≤ 14, -16 ≤ l ≤ 17 
 Reflections collected 41228 
 Independent reflections 6054 [Rint = 0.0676] 
 Reflections with I>2σ(I) 5404 
 Completeness to θ = 67.679° 96.30% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.60027 and 0.11584 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 6054 / 0 / 424 
 Goodness-of-fit on F2 1.021 
 Final R indices [I>2σ(I)] R1 = 0.0320 wR2 = 0.0778 
R indices (all data) R1 = 0.0380 wR2 = 0.0815 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.661 and -1.106 e·Å-3 
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6.2.10 Crystal Data and Structure Refinement of Compound 107a 
 
Empirical formula  C33 H35.50 F12 Mo N4.50 O4 P2 Sb2 
 Color  yellow 
 Formula weight  1188.54 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  P¯1, (no. 2)  
 Unit cell dimensions a = 10.5620(5) Å α = 99.497(8)°. 
 
b = 14.8442(13) Å β = 92.181(6)°. 
 
c = 14.9641(14) Å γ = 92.074(6)°. 
Volume 2310.2(3) Å3 
 Z 2 
 Density (calculated) 1.709 mg · m-3 
 Absorption coefficient 1.584 mm-1 
 F(000) 1158 e 
 Crystal size 0.15 x 0.08 x 0.03 mm3 
 θ range for data collection 2.633 to 32.031°. 
 Index ranges 15 ≤ h ≤ -15, 21 ≤ k ≤ -22, 22 ≤ l ≤ 0 
 Reflections collected 53813 
 Independent reflections 15951 [Rint = 0.0520] 
 Reflections with I>2σ(I) 14303 
 Completeness to θ = 25.242° 99.20% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.75 and 0.44 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 15951 / 0 / 544 
 Goodness-of-fit on F2 1.042 
 Final R indices [I>2 σ(I)] R1 = 0.0631 wR2 = 0.1740 
R indices (all data) R1 = 0.0683 wR2 = 0.1784 
Largest diff. peak and hole 7.060 and -3.420 e · Å-3 
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6.2.11 Crystal Data and Structure Refinement of Compound 108 
 
Empirical formula  C28 H34 F12 N4 P2 S Sb2 
 Color  colorless 
 Formula weight  992.09 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  C2/c, (no. 15)  
 Unit cell dimensions a = 39.801(4) Å α = 90°. 
 
b = 12.189(5) Å β = 112.724(12)°. 
 
c = 17.500(6) Å γ = 90°. 
Volume 7831(4) Å3 
 Z 8 
 Density (calculated) 1.683 mg · m-3 
 Absorption coefficient 1.597 mm-1 
 F(000) 3888 e 
 Crystal size 0.10 x 0.04 x 0.04 mm3 
 θ range for data collection 2.640 to 33.168°. 
 Index ranges -61 ≤ h ≤ 61, -18 ≤ k ≤ 18, -25 ≤ l ≤ 26 
 Reflections collected 77801 
 Independent reflections 14892 [Rint = 0.0550] 
 Reflections with I>2σ(I) 11755 
 Completeness to θ = 25.242° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.95 and 0.86 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14892 / 0 / 446 
 Goodness-of-fit on F2 1.056 
 Final R indices [I>2σ(I)] R1 = 0.0365 wR2 = 0.0829 
R indices (all data) R1 = 0.0530 wR2 = 0.0888 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.7 and -1.3 e · Å-3 
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6.2.12 Crystal Data and Structure Refinement of Compound 109a 
 
Empirical formula  C29 H36 Cl2 F12 I2 N4 P2 Pt Sb2 
 Color  yellow 
 Formula weight  1493.85 g·mol-1  
 Temperature  293(2) K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/c, (no. 14)  
 Unit cell dimensions a = 17.976(6) Å α = 90°. 
 
b = 14.1503(12) Å β = 100.40(3)°. 
 
c = 17.202(5) Å γ = 90°. 
Volume 4303.5(19) Å3 
 Z 4 
 Density (calculated) 2.306 mg·m-3 
 Absorption coefficient 6.202 mm-1 
 F(000) 2784 e 
 Crystal size 0.16 x 0.10 x 0.01 mm3 
 θ range for data collection 2.717 to 33.132°. 
 Index ranges -27 ≤ h ≤ 27, -21≤ k ≤ 21, -26 ≤ l ≤ 26 
 Reflections collected 135279 
 Independent reflections 16334 [Rint = 0.0675] 
 Reflections with I>2 σ (I) 14409 
 Completeness to θ = 26.000° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.94105 and 0.50116 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 16334 / 0 / 491 
 Goodness-of-fit on F2 1.051 
 Final R indices [I>2 σ (I)] R1 = 0.0342 wR2 = 0.0832 
R indices (all data) R1 = 0.0420 wR2 = 0.0883 
Extinction coefficient n/a 
 Largest diff. peak and hole 3.007 and -3.217 e·Å-3 
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6.2.13 Crystal Data and Structure Refinement of Compound 109c 
 
 
Empirical formula  C62 H80 Cl14 F24 N8 P4 Rh2 Sb4 
 Color  orange 
 Formula weight  2706.38 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/n, (no. 14)  
 Unit cell dimensions a = 13.2883(12) Å α = 90°. 
 
b = 13.0485(16) Å β = 92.308(7)°. 
 
c = 26.3951(12) Å γ = 90°. 
Volume 4573.0(7) Å3 
 Z 2 
 Density (calculated) 1.965 mg · m-3 
 Absorption coefficient 2.088 mm-1 
 F(000) 2632 e 
 Crystal size 0.10 x 0.07 x 0.04 mm3 
 θ range for data collection 2.727 to 27.500°. 
 Index ranges -17 ≤ h ≤ 17, -16 ≤ k ≤ 16, -34 ≤ l ≤ 34 
 Reflections collected 87023 
 Independent reflections 10476 [Rint = 0.0536] 
 Reflections with I>2σ(I) 9134 
 Completeness to θ = 25.242° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.94 and 0.83 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 10476 / 0 / 530 
 Goodness-of-fit on F2 1.054 
 Final R indices [I>2 σ (I)] R1 = 0.0593 wR2 = 0.1638 
R indices (all data) R1 = 0.0672 wR2 = 0.1762 
Largest diff. peak and hole 3.6 and -1.8 e · Å-3 
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6.2.14 Crystal Data and Structure Refinement of Compound 109d 
 
Empirical formula  C32 H34 Cl D6 F12 N6 P2 Rh Sb2 
 Color  orange 
 Formula weight  1186.53 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/c, (no. 14)  
 Unit cell dimensions a = 17.492(2) Å α = 90°. 
 
b = 15.774(2) Å β = 111.088(2)°. 
 
c = 17.985(2) Å γ = 90°. 
Volume 4629.8(11) Å3 
 Z 4 
 Density (calculated) 1.702 mg · m-3 
 Absorption coefficient 1.716 mm-1 
 F(000) 2304 e 
 Crystal size 0.1 x 0.1 x 0.1 mm3 
 θ range for data collection 2.296 to 31.082°. 
 Index ranges -25 ≤ h ≤ 25, -22 ≤ k ≤ 22, -26 ≤ l ≤ 26 
 Reflections collected 129694 
 Independent reflections 14793 [Rint = 0.0730] 
 Reflections with I>2 σ (I) 11201 
 Completeness to θ = 25.242° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.89 and 0.83 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14793 / 0 / 511 
 Goodness-of-fit on F2 1.059 
 Final R indices [I>2 σ (I)] R1 = 0.0511 wR2 = 0.1030 
R indices (all data) R1 = 0.0748 wR2 = 0.1098 
Largest diff. peak and hole 3.4 and -2.0 e · Å-3 
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6.2.15 Crystal Data and Structure Refinement of Compound 109f 
 
Empirical formula  C28 H34 Au Cl F12 N4 P2 Sb2 
 Color  colorless 
 Formula weight  1192.45 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  C 2/c, (no. 15)  
 Unit cell dimensions a = 36.725(5) Å α = 90°. 
 
b = 12.1334(15) Å β = 108.584(2)°. 
 
c = 17.956(2) Å γ = 90°. 
Volume 7584.1(16) Å3 
 Z 8 
 Density (calculated) 2.089 mg·m-3 
 Absorption coefficient 5.514 mm-1 
 F(000) 4528 e 
 Crystal size 0.06 x 0.05 x 0.03 mm3 
 θ range for data collection 2.393 to 31.060°. 
 Index ranges -53 ≤ h ≤ 53, -17 ≤ k ≤ 17, -25 ≤ l ≤ 26 
 Reflections collected 110234 
 Independent reflections 12111 [Rint = 0.0641] 
 Reflections with I>2σ(I) 10022 
 Completeness to θ = 25.242° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.83 and 0.65 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 12111 / 0 / 455 
 Goodness-of-fit on F2 1.021 
 Final R indices [I>2σ(I)] R1 = 0.0253 wR2 = 0.0464 
R indices (all data) R1 = 0.0387 wR2 = 0.0501 
Largest diff. peak and hole 2.3 and -1.4 e·Å-3 
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6.2.16 Crystal Data and Structure Refinement of Compound 110 
 
Empirical formula  C38 H45 B2 Cl F8 N5 P2 Rh 
 Color  yellow 
 Formula weight  945.71 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/n, (no. 14)  
 Unit cell dimensions a = 17.7583(18) Å α = 90°. 
 
b = 12.1947(12) Å β = 91.115(2)°. 
 
c = 18.3067(18) Å γ = 90°. 
Volume 3963.7(7) Å3 
 Z 4 
 Density (calculated) 1.585 mg · m-3 
 Absorption coefficient 0.654 mm-1 
 F(000) 1928 e 
 Crystal size 0.34 x 0.10 x 0.03 mm3 
 θ range for data collection 1.582 to 26.818°. 
 Index ranges -22 ≤ h ≤ 22, -15 ≤ k ≤ 15, -23 ≤ l ≤ 23 
 Reflections collected 76406 
 Independent reflections 8461 [Rint = 0.0750] 
 Reflections with I>2σ(I) 6803 
 Completeness to θ = 25.242° 100.00% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.99 and 0.87 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 8461 / 0 / 521 
 Goodness-of-fit on F2 1.138 
 Final R indices [I>2 σ (I)] R1 = 0.0332 wR2 = 0.0890 
R indices (all data) R1 = 0.0517 wR2 = 0.1114 
Largest diff. peak and hole 0.8 and -0.9 e · Å-3 
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6.2.17 Crystal Data and Structure Refinement of Compound 112b 
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Empirical formula  C42 H24 F10 P2 Pd 
 Color  colourless 
 Formula weight  886.95 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  monoclinic 
 Space group  P 21/n, (no. 14)  
 Unit cell dimensions a = 15.061(3) Å α = 90°. 
 
b = 14.768(3) Å β = 102.298(4)°. 
 
c = 16.339(4) Å γ = 90°. 
Volume 3550.9(13) Å3 
 Z 4 
 Density (calculated) 1.659 mg·m-3 
 Absorption coefficient 0.698 mm-1 
 F(000) 1768 e 
 Crystal size 0.07 x 0.06 x 0.04 mm3 
 θ range for data collection 3.039 to 33.647°. 
 Index ranges -23 ≤ h ≤ 23, -22 ≤ k ≤ 22, -25 ≤ l ≤ 25 
 Reflections collected 117912 
 Independent reflections 14026 [Rint = 0.0724] 
 Reflections with I>2σ(I) 11056 
 Completeness to θ = 25.242° 99.80% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.97433 and 0.95301 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14026 / 0 / 496 
 Goodness-of-fit on F2 1.02 
 Final R indices [I>2 σ (I)] R1 = 0.0303 wR2 = 0.0651 
R indices (all data) R1 = 0.0483 wR2 = 0.0706 
Extinction coefficient 0 
 Largest diff. peak and hole 0.839 and -0.716 e·Å-3 
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6.2.18 Crystal Data and Structure Refinement of Compound 112f 
 
Empirical formula  C38 H24 F10 N P Pd 
 Color  yellow 
 Formula weight  821.95 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/c, (no. 14)  
 Unit cell dimensions a = 11.0106(11) Å α = 90°. 
 
b = 14.0190(14) Å β = 96.5422(19)°. 
 
c = 21.167(2) Å γ = 90°. 
Volume 3246.0(6) Å3 
 Z 4 
 Density (calculated) 1.682 mg·m-3 
 Absorption coefficient 0.709 mm-1 
 F(000) 1640 e 
 Crystal size 0.22 x 0.21 x 0.19 mm3 
 θ range for data collection 2.421 to 37.341°. 
 Index ranges -18 ≤ h ≤ 18, -23 ≤ k ≤ 23, -35 ≤ l ≤ 35 
 Reflections collected 127102 
 Independent reflections 16348 [Rint = 0.0252] 
 Reflections with I>2σ(I) 14984 
 Completeness to θ = 25.242° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.90265 and 0.82904 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 16348 / 0 / 462 
 Goodness-of-fit on F2 1.058 
 Final R indices [I>2σ(I)] R1 = 0.0214 wR2 = 0.0575 
R indices (all data) R1 = 0.0250 wR2 = 0.0596 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.687 and -0.528 e·Å-3 
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6.2.19 Crystal Data and Structure Refinement of Compound 112g 
 
Empirical formula  C46 H43 B2 F18 N7 P2 Pd 
 Color  colourless 
 Formula weight  1225.83 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/c, (no. 14)  
 Unit cell dimensions a = 18.3894(13) Å α = 90°. 
 
b = 14.7845(14) Å β = 114.994(4)°. 
 
c = 20.6566(7) Å γ = 90°. 
Volume 5090.2(7) Å3 
 Z 4 
 Density (calculated) 1.600 mg·m-3 
 Absorption coefficient 0.535 mm-1 
 F(000) 2464 e 
 Crystal size 0.15 x 0.09 x 0.04 mm3 
 θ range for data collection 2.609 to 35.008°. 
 Index ranges -29 ≤ h ≤ 29, -23 ≤ k ≤ 23, -32 ≤ l ≤ 33 
 Reflections collected 124759 
 Independent reflections 22373 [Rint = 0.0428] 
 Reflections with I>2σ(I) 18998 
 Completeness to θ = 25.242° 99.80% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.98046 and 0.93073 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 22373 / 0 / 692 
 Goodness-of-fit on F2 1.048 
 Final R indices [I>2σ(I)] R1 = 0.0361 wR2 = 0.0924 
R indices (all data) R1 = 0.0465 wR2 = 0.0988 
Extinction coefficient 0 
 Largest diff. peak and hole 2.507 and -1.787 e·Å-3 
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6.2.20 Crystal Data and Structure Refinement of Compound 112h 
 
Empirical formula  C54 H54 B2 F18 N4 O2 P2 Pd 
 Color  yellow 
 Formula weight  1322.97 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  p -1, (no. 2)  
 Unit cell dimensions a = 12.5325(6) Å α = 93.239(6)°. 
 
b = 13.8883(13) Å β = 103.518(7)°. 
 
c = 18.2445(18) Å γ = 115.502(6)°. 
Volume 2741.7(4) Å3 
 Z 2 
 Density (calculated) 1.603 mg·m-3 
 Absorption coefficient 0.505 mm-1 
 F(000) 1340 e 
 Crystal size 0.14 x 0.14 x 0.09 mm3 
 θ range for data collection 2.607 to 35.056°. 
 Index ranges -20 ≤ h ≤ 20, -22 ≤ k ≤ 22, -29 ≤ l ≤ 29 
 Reflections collected 78461 
 Independent reflections 24146 [Rint = 0.0279] 
 Reflections with I>2σ(I) 21322 
 Completeness to θ = 25.242° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.96402 and 0.92959 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 24146 / 0 / 767 
 Goodness-of-fit on F2 1.047 
 Final R indices [I>2σ(I)] R1 = 0.0352 wR2 = 0.0900 
R indices (all data) R1 = 0.0425 wR2 = 0.0946 
Extinction coefficient 0 
 Largest diff. peak and hole 1.251 and -1.121 e·Å-3 
  
  
C18
C17
C54
C19
C3
C4
C52
C53
C16
O1
C31
C2
C20
F10
O2
F9
C15
C5
C50
C13
C29
N2 F5
C49
C51
C1
C48
C47
F4
C6
C22
C28
C27
C42
P1
F16A
F15C
C41
C23
P2 C43
Pd1
C46
F8
F16B
F15B
N1
C21
C35
C7
C37
F16C
C12
F15A
C14
B2
F17
C40
C8
C24
C44 C45
F3
N4 C32
C38
C26
C30
C11
C39
F18C
C25
F18A
F18B
C9
F6 F7
F1
C10
N3C33
F2
C36
C34
F11
F12
B1
F13
F14
  275 
 
6.2.21 Crystal Data and Structure Refinement of Compound 113 
 
Empirical formula  C30 H37 F12 N5 P2 Pd Sb2 
 Color  yellow 
 Formula weight  1107.48 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  P¯1, (no. 2)  
 Unit cell dimensions a = 10.3416(10) Å α = 77.0009(18)°. 
 
b = 13.4178(13) Å β = 79.6302(17)°. 
 
c = 15.5829(15) Å γ = 80.8707(17)°. 
Volume 2056.7(3) Å3 
 Z 2 
 Density (calculated) 1.788 mg · m-3 
 Absorption coefficient 1.897 mm-1 
 F(000) 1076 e 
 Crystal size 0.19 x 0.05 x 0.04 mm3 
 q range for data collection 1.570 to 31.543°. 
 Index ranges -15 ≤ h ≤ 15, -19 ≤ k ≤ 19, -22 ≤ l ≤ 22 
 Reflections collected 61748 
 Independent reflections 13489 [Rint = 0.0329] 
 Reflections with I>2σ(I) 11188 
 Completeness to q = 25.242° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.93 and 0.78 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 13489 / 0 / 470 
 Goodness-of-fit on F2 1.079 
 Final R indices [I>2σ(I)] R1 = 0.0359 wR2 = 0.0837 
R indices (all data) R1 = 0.0457 wR2 = 0.0873 
Largest diff. peak and hole 4.0 and -3.1 e · Å-3 
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6.2.22 Crystal Data and Structure Refinement of Compound 114 
 
Empirical formula  C37 H43 F12 N5 Ni P2 Sb2 
 Color  yellow 
 Formula weight  1149.91 g·mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/n,  (no. 14)  
 Unit cell dimensions a = 11.903(2) Å α = 90°. 
 
b = 12.036(2) Å β = 97.511(13)°. 
 
c = 33.183(4) Å γ = 90°. 
Volume 4713.2(14) Å3 
 Z 4 
 Density (calculated) 1.621 mg·m-3 
 Absorption coefficient 1.680 mm-1 
 F(000) 2272 e 
 Crystal size 0.26 x 0.22 x 0.08 mm3 
 θ range for data collection 2.696 to 33.092°. 
 Index ranges -18 ≤ h ≤ 18, -18 ≤ k ≤ 18, -50 ≤ l ≤ 50 
 Reflections collected 64200 
 Independent reflections 16882 [Rint = 0.0373] 
 Reflections with I>2σ(I) 14536 
 Completeness to θ = 25.242° 97.50% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.87772 and 0.69551 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 16882 / 0 / 538 
 Goodness-of-fit on F2 1.123 
 Final R indices [I>2σ(I)] R1 = 0.0338 wR2 = 0.0963 
R indices (all data) R1 = 0.0427 wR2 = 0.1028 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.846 and -2.010 e·Å-3 
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6.2.23 Crystal Data and Structure Refinement of Compound 138a 
 
Empirical formula  C32.50 H41.50 Cl F6 N P Sb 
 Color  yellow 
 Formula weight  748.33 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P2/c, (no. 13)  
 Unit cell dimensions a = 21.327(4) Å α = 90°. 
 
b = 10.399(2) Å β = 111.57(3)°. 
 
c = 15.717(3) Å γ = 90°. 
Volume 3241.6(12) Å3 
 Z 4 
 Density (calculated) 1.533 mg · m-3 
 Absorption coefficient 1.041 mm-1 
 F(000) 1522 e 
 Crystal size 0.16 x 0.08 x 0.05 mm3 
 θ range for data collection 2.809 to 33.316°. 
 Index ranges -32 ≤ h ≤ 24, -16 ≤ k ≤16, -22 ≤ l ≤24 
 Reflections collected 31424 
 Independent reflections 10918 [Rint = 0.0322] 
 Reflections with I>2σ(I) 8637 
 Completeness to θ = 25.242° 91.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.96 and 0.88 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 10918 / 0 / 389 
 Goodness-of-fit on F2 1.032 
 Final R indices [I>2σ(I)] R1 = 0.0468 wR2 = 0.1206 
R indices (all data) R1 = 0.0641 wR2 = 0.1315 
Largest diff. peak and hole 1.5 and -2.0 e · Å-3 
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6.2.24 Crystal Data and Structure Refinement of Compound 138b 
 
Empirical formula  C32 H53 F6 N P Sb 
 Color  yellow 
 Formula weight  718.47 g · mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  P21/c, (no. 14)  
 Unit cell dimensions a = 16.9548(10) Å α = 90°. 
 
b = 12.0609(8) Å β = 122.735(4)°. 
 
c = 19.0889(13) Å γ = 90°. 
Volume 3283.5(4) Å3 
 Z 4 
 Density (calculated) 1.453 mg · m-3 
 Absorption coefficient 0.945 mm-1 
 F(000) 1488 e 
 Crystal size 0.14 x 0.08 x 0.07 mm3 
 θ range for data collection 2.722 to 33.180°. 
 Index ranges -25 ≤ h ≤ 26, -18 ≤ k ≤ 18, -29 ≤ l ≤ 27 
 Reflections collected 64557 
 Independent reflections 12528 [Rint = 0.0314] 
 Reflections with I>2σ(I) 10720 
 Completeness to θ = 25.242° 99.70% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.95 and 0.88 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 12528 / 0 / 378 
 Goodness-of-fit on F2 1.054 
 Final R indices [I>2σ(I)] R1 = 0.0256 wR2 = 0.0606 
R indices (all data) R1 = 0.0346 wR2 = 0.0655 
Largest diff. peak and hole 0.728 and -1.593 e · Å-3 
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6.2.25 Crystal Data and Structure Refinement of Compound 138c 
 
Empirical formula  C34 H39 F12 N P Sb 
 Color  yellow 
 Formula weight  842.38 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21, (no. 4)  
 Unit cell dimensions a = 10.6294(9) Å α = 90°. 
 
b = 17.9592(17) Å β = 101.285(5)°. 
 
c = 18.9360(18) Å γ = 90°. 
Volume 3544.9(6) Å3 
 Z 4 
 Density (calculated) 1.578 mg·m-3 
 Absorption coefficient 0.912 mm-1 
 F(000) 1696 e 
 Crystal size 0.30 x 0.13 x 0.12 mm3 
 θ range for data collection 3.576 to 38.006°. 
 Index ranges -18 ≤ h ≤ 18, -31≤ k ≤ 31, -32 ≤ l ≤ 32 
 Reflections collected 259850 
 Independent reflections 38502 [Rint = 0.0336] 
 Reflections with I>2σ(I) 36933 
 Completeness to θ = 25.242° 99.20% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.90987 and 0.78315 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 38502 / 1 / 895 
 Goodness-of-fit on F2 1.044 
 Final R indices [I>2σI)] R1 = 0.0272 wR2 = 0.0705 
R indices (all data) R1 = 0.0295 wR2 = 0.0725 
Absolute structure parameter -0.0103(16) 
 Extinction coefficient n/a 
 Largest diff. peak and hole 1.400 and -1.179 e·Å-3 
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6.2.26 Crystal Data and Structure Refinement of Compound 139a 
 
Empirical formula  C32 H41 Au Cl F6 N P Sb 
 Color  yellow 
 Formula weight  938.79  g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  ORTHORHOMBIC 
 Space group  Pbc21,  (no. 29)  
 Unit cell dimensions a = 15.9504(19) Å α = 90°. 
 
b = 13.9759(16) Å β = 90°. 
 
c = 14.6811(17) Å γ = 90°. 
Volume 3272.7(7) Å3 
 Z 4 
 Density (calculated) 1.905 mg · m-3 
 Absorption coefficient 5.491 mm-1 
 F(000) 1824 e 
 Crystal size 0.28 x 0.21 x 0.18 mm3 
 θ range for data collection 2.915 to 31.355°. 
 Index ranges -23 ≤ h ≤ 22, -20 ≤ k ≤ 20, -21 ≤ l ≤ 21 
 Reflections collected 87398 
 Independent reflections 10246 [Rint = 0.0235] 
 Reflections with I>2σ(I) 9981 
 Completeness to θ = 25.242° 99.70% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.50 and 0.23 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 10246 / 1 / 396 
 Goodness-of-fit on F2 1.038 
 Final R indices [I>2σ(I)] R1 = 0.0130 wR2 = 0.0366 
R indices (all data) R1 = 0.0136 wR2 = 0.0368 
Absolute structure parameter 0.0213(14) 
 Largest diff. peak and hole 1.4 and -0.6 e · Å-3 
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6.2.27 Crystal Data and Structure Refinement of Compound 139b 
 
Empirical formula  C32 H53 Au Cl F6 N P Sb 
 Color  colourless 
 Formula weight  950.89  g·mol-1  
 Temperature  200 K 
 Wavelength  1.54178 Å 
 Crystal system  ORTHORHOMBIC 
 Space group  p b c a,  (no. 61)  
 Unit cell dimensions a = 12.2072(4) Å α = 90°. 
 
b = 16.6468(6) Å β = 90°. 
 
c = 34.4701(12) Å γ = 90°. 
Volume 7004.7(4) Å3 
 Z 8 
 Density (calculated) 1.803 mg·m-3 
 Absorption coefficient 15.486 mm-1 
 F(000) 3744 e 
 Crystal size 0.33 x 0.13 x 0.09 mm3 
 θ range for data collection 2.564 to 67.932°. 
 Index ranges -14 ≤ h ≤ 14, -19 ≤ k ≤ 19, -41 ≤ l ≤ 41 
 Reflections collected 158214 
 Independent reflections 6320 [Rint = 0.0545] 
 Reflections with I>2σ(I) 5711 
 Completeness to θ = 67.679° 99.70% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.34226 and 0.06402 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 6320 / 0 / 396 
 Goodness-of-fit on F2 1.077 
 Final R indices [I>2σ(I)] R1 = 0.0313 wR2 = 0.0750 
R indices (all data) R1 = 0.0354 wR2 = 0.0775 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.482 and -1.356 e·Å-3 
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6.2.28 Crystal Data and Structure Refinement of Compound 139c 
 
Empirical formula  C34 H39 Au Cl F12 N P Sb 
 Color  yellow 
 Formula weight  1074.80 g · mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  P¯1,  (no. 2)  
 Unit cell dimensions a = 10.5114(12) Å α = 85.859(6)°. 
 
b = 11.3443(3) Å β = 73.535(10)°. 
 
c = 18.509(3) Å γ = 65.998(4)°. 
Volume 1931.2(4) Å3 
 Z 2 
 Density (calculated) 1.848 mg · m-3 
 Absorption coefficient 4.687 mm-1 
 F(000) 1040 e 
 Crystal size 0.06 x 0.03 x 0.02 mm3 
 θ range for data collection 3.448 to 33.142°. 
 Index ranges -16 ≤ h ≤ 16, -17≤ k ≤ 17, -26 ≤ l ≤ 28 
 Reflections collected 38171 
 Independent reflections 14633 [Rint = 0.0818] 
 Reflections with I>2σ(I) 12487 
 Completeness to θ = 25.242° 99.80% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.92 and 0.77 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14633 / 0 / 465 
 Goodness-of-fit on F2 1.04 
 Final R indices [I>2σ(I)] R1 = 0.0567 wR2 = 0.1447 
R indices (all data) R1 = 0.0668 wR2 = 0.1543 
Largest diff. peak and hole 3.3 and -6.1 e · Å-3 
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6.2.29 Crystal Data and Structure Refinement of Compound 140a 
 
Empirical formula  C32 H41 N P 
 Color  colourless 
 Formula weight  470.63 g·mol-1  
 Temperature  80(2) K 
 Wavelength  0.56305 Å 
 Crystal system  monoclinic 
 Space group  P 21/c, (no. 14)  
 Unit cell dimensions a = 17.015(3) Å α = 90°. 
 
b = 10.280(2) Å β = 101.80(3)°. 
 
c = 31.520(6) Å γ = 90°. 
Volume 5397(2) Å3 
 Z 8 
 Density (calculated) 1.158 mg·m-3 
 Absorption coefficient 0.072 mm-1 
 F(000) 2040 e 
 Crystal size 0.035 x 0.059 x 0.076 mm3 
 θ range for data collection 0.969 to 22.047°. 
 Index ranges -22 ≤ h ≤ 22, -13 ≤ k ≤ 13, -42 ≤ l ≤ 42 
 Reflections collected 175228 
 Independent reflections 13398 [Rint = 0.0811] 
 Reflections with I>2σ(I) 11256 
 Completeness to θ = 19.745° 100.00% 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 13398 / 0 / 613 
 Goodness-of-fit on F2 1.036 
 Final R indices [I>2σI)] R1 = 0.0443 wR2 = 0.1140 
R indices (all data) R1 = 0.0545 wR2 = 0.1210 
Extinction coefficient 0 
 Largest diff. peak and hole 0.404 and -0.556 e·Å-3 
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6.2.30 Crystal Data and Structure Refinement of Compound 140c 
 
Empirical formula  C34 H39 F6 N P 
 Color  brown_black 
 Formula weight  606.63 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  c 2/c,  (no. 15)  
 Unit cell dimensions a = 61.265(8) Å α = 90°. 
 
b = 16.892(2) Å β = 104.35°. 
 
c = 15.1854(19) Å γ = 90°. 
Volume 15225(3) Å3 
 Z 16 
 Density (calculated) 1.059 mg·m-3 
 Absorption coefficient 0.121 mm-1 
 F(000) 5104 e 
 Crystal size 0.30 x 0.15 x 0.08 mm3 
 θ range for data collection 1.253 to 31.018°. 
 Index ranges -88 ≤ h ≤ 88, -24 ≤ k ≤ 24, -21 ≤ l ≤ 21 
 Reflections collected 174699 
 Independent reflections 21294 [Rint = 0.1008] 
 Reflections with I>2σ(I) 12135 
 Completeness to θ = 25.242° 79.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.99085 and 0.97202 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 21294 / 0 / 764 
 Goodness-of-fit on F2 0.996 
 Final R indices [I>2σ(I)] R1 = 0.0749 wR2 = 0.2094 
R indices (all data) R1 = 0.1260 wR2 = 0.2387 
Extinction coefficient n/a 
 Largest diff. peak and hole 1.023 and -0.719 e·Å-3 
 Remarks SQUEEZE was used !! 
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6.2.31 Crystal Data and Structure Refinement of Compound 141 
 
Empirical formula  C32 H41 Au Cl N P 
 Color  red 
 Formula weight  703.04 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  Triclinic 
 Space group  p 1, (no. 1)  
 Unit cell dimensions a = 9.5266(4) Å α = 96.442(4)°. 
 
b = 10.7603(6) Å β = 93.835(5)°. 
 
c = 15.1726(8) Å γ = 107.932(4)°. 
Volume 1461.94(13) Å3 
 Z 2 
 Density (calculated) 1.597 mg·m-3 
 Absorption coefficient 5.199 mm-1 
 F(000) 702 e 
 Crystal size 0.09 x 0.06 x 0.06 mm3 
 θ range for data collection 3.146 to 33.135°. 
 Index ranges -14 ≤ h ≤ 14, -16 ≤ k ≤16, -23 ≤ l ≤ 23 
 Reflections collected 41586 
 Independent reflections 11061 [Rint = 0.0416] 
 Reflections with I>2σ(I) 10796 
 Completeness to θ = 25.242° 98.30% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.77363 and 0.65074 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 11061 / 0 / 333 
 Goodness-of-fit on F2 1.031 
 Final R indices [I>2σ(I)] R1 = 0.0186 wR2 = 0.0490 
R indices (all data) R1 = 0.0192 wR2 = 0.0495 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.906 and -2.467 e·Å-3 
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6.2.32 Crystal Data and Structure Refinement of Compound 142 
 
Empirical formula  C38 H41 Au F5 N P  
 Color  red brown 
 Formula weight  834.65  g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/c,  (no. 14)  
 Unit cell dimensions a = 10.195(3) Å α = 90°. 
 
b = 17.089(5) Å β = 92.858(5)°. 
 
c = 19.065(5) Å γ = 90°. 
Volume 3317.5(15) Å3 
 Z 4 
 Density (calculated) 1.671 mg·m-3 
 Absorption coefficient 4.540 mm-1 
 F(000) 1660 e 
 Crystal size 0.21 x 0.06 x 0.04 mm3 
 θ range for data collection 1.601 to 34.434°. 
 Index ranges -16 ≤ h ≤ 16, -27 ≤ k ≤ 27, -30 ≤ l ≤ 30 
 Reflections collected 234997 
 Independent reflections 13970 [Rint = 0.0478] 
 Reflections with I>2σ(I) 12179 
 Completeness to θ = 25.242° 99.90% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.82889 and 0.52465 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 13970 / 0 / 423 
 Goodness-of-fit on F2 1.042 
 Final R indices [I>2σ(I)] R1 = 0.0169 wR2 = 0.0355 
R indices (all data) R1 = 0.0242 wR2 = 0.0377 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.709 and -0.504 e·Å-3 
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C29
C18
C19
C30
C4
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C28
C7
C14
C13
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C10
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F4
C15
C16
C38
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C21
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C24
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6.2.33 Crystal Data and Structure Refinement of Compound 143 
 
Empirical formula  C35 H56 Au Cl N P 
 Color  yellow 
 Formula weight  754.19 g·mol-1  
 Temperature  100.15 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/n, (no. 14)  
 Unit cell dimensions a = 15.848(2) Å α = 90°. 
 
b = 11.1500(4) Å β = 104.562(9)°. 
 
c = 19.4741(18) Å γ = 90°. 
Volume 3330.6(6) Å3 
 Z 4 
 Density (calculated) 1.504 mg·m-3 
 Absorption coefficient 4.569 mm-1 
 F(000) 1536 e 
 Crystal size 0.12 x 0.08 x 0.07 mm3 
 θ range for data collection 3.722 to 37.981°. 
 Index ranges -27 ≤ h ≤ 27, -19 ≤ k ≤ 19, -33 ≤ l ≤ 33 
 Reflections collected 138753 
 Independent reflections 18058 [Rint = 0.0335] 
 Reflections with I>2σ(I) 16658 
 Completeness to θ = 25.242° 99.40% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.7475 and 0.6354 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 18058 / 0 / 360 
 Goodness-of-fit on F2 1.055 
 Final R indices [I>2σ(I)] R1 = 0.0175 wR2 = 0.0411 
R indices (all data) R1 = 0.0209 wR2 = 0.0428 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.704 and -2.347 e·Å-3 
 
Cl1
C31
C30
C32
C19
C12
C13
Au1
C29
C27
C11
C20
C14
C18
C28
C26
P1
C10
C9
C16
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6.2.34 Crystal Data and Structure Refinement of Compound 144 
 
Empirical formula  C32 H41 Br3 N P 
 Color  yellow 
 Formula weight  710.36 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  ORTHORHOMBIC 
 Space group  p 21 21 21, (no. 19)  
 Unit cell dimensions a = 10.2579(8) Å α = 90°. 
 
b = 12.5039(12) Å β = 90°. 
 
c = 23.888(2) Å γ = 90°. 
Volume 3063.9(5) Å3 
 Z 4 
 Density (calculated) 1.540 mg·m-3 
 Absorption coefficient 4.024 mm-1 
 F(000) 1440 e 
 Crystal size 0.20 x 0.13 x 0.10 mm3 
 θ range for data collection 3.411 to 36.060°. 
 Index ranges -16 ≤ h ≤ 16, -20 ≤ k ≤ 20, -39 ≤ l ≤ 39 
 Reflections collected 147315 
 Independent reflections 14503 [Rint = 0.0247] 
 Reflections with I>2σ(I) 13716 
 Completeness to θ = 25.242° 98.50% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.85103 and 0.69602 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 14503 / 0 / 343 
 Goodness-of-fit on F2 1.105 
 Final R indices [I>2σ(I)] R1 = 0.0332 wR2 = 0.0979 
R indices (all data) R1 = 0.0372 wR2 = 0.1025 
Absolute structure parameter 0.028(6) 
 Extinction coefficient n/a 
 Largest diff. peak and hole 1.307 and -2.311 e·Å-3 
 
Br3
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Br1
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C24
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C16
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6.2.35 Crystal Data and Structure Refinement of Compound 145 
 
Empirical formula  C52.50 H73 Cl5 Co N2 P 
 Color  green 
 Formula weight  999.27 g · mol-1  
 Temperature  1070 K 
 Wavelength  0.71073 Å 
 Crystal system  Triclinic 
 Space group  P¯1, (no. 2)  
 Unit cell dimensions a = 9.6217(17) Å α = 88.834(8)°. 
 
b = 16.010(2) Å β = 74.718(13)°. 
 
c = 17.5101(8) Å γ = 87.487(11)°. 
Volume 2599.3(6) Å3 
 Z 2 
 Density (calculated) 1.277 mg · m-3 
 Absorption coefficient 0.654 mm-1 
 F(000) 1058 e 
 Crystal size 0.17 x 0.16 x 0.04 mm3 
 θ range for data collection 2.600 to 34.985°. 
 Index ranges -15 ≤ h ≤ 15, -25 ≤ k ≤ 25, -28 ≤ l ≤ 27 
 Reflections collected 78065 
 Independent reflections 22645 [Rint = 0.0467] 
 Reflections with I>2σ(I) 19493 
 Completeness to θ = 27.500° 99.60% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.97108 and 0.88551 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 22645 / 0 / 584 
 Goodness-of-fit on F2 1.108 
 Final R indices [I>2σ(I)] R1 = 0.0407 wR2 = 0.1157 
R indices (all data) R1 = 0.0499 wR2 = 0.1278 
Largest diff. peak and hole 0.7 and -1.3 e · Å-3 
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6.2.36 Crystal Data and Structure Refinement of Compound 146 
 
Empirical formula  C32 H41 F6 N O P Sb 
 Color  light_yellow 
 Formula weight  722.38  g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  MONOCLINIC 
 Space group  p 21/n,  (no. 14)  
 Unit cell dimensions a = 10.1990(7) Å a= 90°. 
 
b = 29.947(2) Å b= 106.681(7)°. 
 
c = 10.7797(12) Å g = 90°. 
Volume 3153.8(5) Å3 
 Z 4 
 Density (calculated) 1.521 mg·m-3 
 Absorption coefficient 0.987 mm-1 
 F(000) 1472 e 
 Crystal size 0.12 x 0.09 x 0.03 mm3 
 θ range for data collection 3.428 to 33.166°. 
 Index ranges -15 ≤ h ≤ 15, -46 ≤ k ≤ 46, -16 ≤ l ≤16 
 Reflections collected 96734 
 Independent reflections 12014 [Rint = 0.0512] 
 Reflections with I>2σ(I) 9562 
 Completeness to θ = 25.242° 99.70% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.97109 and 0.89230 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 12014 / 0 / 423 
 Goodness-of-fit on F2 1.066 
 Final R indices [I>2σ(I)] R1 = 0.0336 wR2 = 0.0745 
R indices (all data) R1 = 0.0515 wR2 = 0.0836 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.852 and -1.303 e·Å-3 
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6.2.37 Crystal Data and Structure Refinement of Compound 147 
 
Empirical formula  C32 H41 N O P 
 Color  orange 
 Formula weight  486.63 g·mol-1  
 Temperature  100 K 
 Wavelength  0.71073 Å 
 Crystal system  TRICLINIC 
 Space group  p -1,  (no. 2)  
 Unit cell dimensions a = 10.4546(15) Å α = 74.418(3)°. 
 
b = 10.6918(15) Å β = 81.735(3)°. 
 
c = 14.304(2) Å γ = 62.736(2)°. 
Volume 1368.6(3) Å3 
 Z 2 
 Density (calculated) 1.181 mg·m-3 
 Absorption coefficient 0.125 mm-1 
 F(000) 526 e 
 Crystal size 0.14 x 0.1 x 0.06 mm3 
 θ range for data collection 2.353 to 37.160°. 
 Index ranges -17 ≤ h ≤ 17, -17≤ k ≤ 17, -24 ≤ l ≤ 23 
 Reflections collected 54925 
 Independent reflections 13485 [Rint = 0.0333] 
 Reflections with I>2σ(I) 10776 
 Completeness to θ = 25.242° 99.80% 
 Absorption correction Gaussian 
 Max. and min. transmission 0.99258 and 0.97918 
 Refinement method Full-matrix least-squares on F2 
 Data / restraints / parameters 13485 / 0 / 324 
 Goodness-of-fit on F2 1.031 
 Final R indices [I>2σ(I)] R1 = 0.0378 wR2 = 0.1000 
R indices (all data) R1 = 0.0526 wR2 = 0.1090 
Extinction coefficient n/a 
 Largest diff. peak and hole 0.596 and -0.364 e·Å-3 
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Summary 
1) Bis- and Trispyrazoylborate/methane-Stabilized P(III)-Centered Cations 
Making use of an –onium substituent transfer strategy, we have been able to isolate and 
structurally characterize several P-centered polycations stabilized by bis- and tris-
(pyrazoyl)borate or methane ligands. In all of these compounds, the phosphorus center adopts 
a pyramidal environment, which is indicative of the presence of a lone pair mainly located on 
this atom. However, the high positive charge at phosphorus lowers the energy of this orbital to 
a level that makes it unavailable for donation. The same positive charge also stabilizes quite 
efficiently the σ*(P-N) orbitals, thus conferring Lewis acid character to the phosphorus atom. 
This Lewis acidity is evident from the short contacts observed between the triflate anions and 
the phosphorus centers. 
 
2) Dicationic Chelating Phosphines: Synthesis, Structure and Reactivity  
We outlined the preparation of new bidentate dicationic phosphines and their coordination 
chemistry towards different metals. Moreover, we showcased for the first time the utility of 
cationic ligands to promote difficult reductive elimination processes under mild condition, 
such as the formation of polyfluorinated biaryls from Pd(II) centers. Finally, the unique 
properties of these ligands in catalysis has been proven in the hydorarylation of phenyl diene 
with indoles and electron rich arenes. 
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3) Isolation and Coordination Chemistry of CAACs Substituted α-Radical Phosphines  
We have successfully isolated and characterized a series of CAAC (Cyclic 
(Alkyl)(Amino)Carbene) derived cationic phophines. Their cyclovoltammetry showed a 
quasi-reversible redox potential, which indicated that stable radicals were formed after one 
electron reduction. As a result, a series of α-radical phosphines have been synthesized and 
fully characterized. More intriguingly, these radical phosphines could coordinate to Au(I) and 
form a range of stable gold complexes that are unprecedented. In addition, we were also able 
to synthesize the radical phosphorus oxide. All of the synthesized radicals have been 
characterized by EPR and most have been crystallized. These novel compounds could be 
named as α-radical phosphine ligands, which might be useful in catalysis. 
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Zusammenfassung 
1) Bi- und Tri-Pyrazolyl(borat/methan) stabilisierte P(III)-zentrierte Kationen 
Durch eine Onium-Substituenten-Transfer-Strategie ist es uns gelungen, mehrere Phosphor-
zentrierte Polykationen, die durch Bi- und Tri-Pyrazolyl(borat/methan)-Liganden stabilisiert 
sind, zu isolieren und strukturell zu charakterisieren. Bei all diesen Verbindungen befindet 
sich das  Phosphor-Zentrum in einer trigonal-pyramidalen Umgebung, was auf ein 
hauptsächlich am Phosphor lokalisiertes, freies Elektronenpaar hinweist. Die hohe positive 
Ladung am Phosphor senkt die Energie dieses Orbitals so weit ab, dass es als Donor nicht 
mehr zur Verfügung steht. Des Weiteren stabilisiert diese positive Ladung das σ*(P-N)-
Orbital und sorgt so für einen Lewis-aciden Charakter am Phosphor-Atom. Die Lewis-
Acidität spiegelt sich in der geringen Bindungslänge zwischen dem Triflat-Anion und dem 
Phosphor-Zentrum wieder.  
 
2) Dikationische chelatisierende Phosphine: Synthese, Struktur und Reaktivität 
Im Rahmen dieser Arbeit haben wir die Darstellung und Koordinationschemie bidentater 
dikationischer Phosphine gegenüber verschiedenen Metallen beschrieben. Ebenso haben wir 
erstmalig die Anwendung kationischer Liganden auf schwierige reduktive Eliminierungen 
unter milden Bedingungen aufgezeigt, wie z.B. die Bildung polyfluorierter Biaryle von 
Pd(II)-Zentren. Darüber hinaus konnten die besonderen Eigenschaften dieser Liganden in 
Hydroarylierungen von Phenyl-Dienen mit Indolen und elektronenreichen Aromaten 
aufgezeigt werden. 
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3) Isolierung und Koordinationschemie von CAACs-substituierten α-radikalen 
Phosphinen 
Wir haben erfolgreich eine Reihe von „CAAC“ (Zyklische(Alkyl)(Amino)Carbene) 
abgeleiteten kationischen Phosphinen isoliert und charakterisiert. Durch Cyclovoltammetrie 
konnte ein quasi-reversibles Redoxpotential aufgezeigt werden, was ein Indiz für die Bildung 
stabiler Radikale durch Ein-Elektron-Reduktion ist. Wir haben eine Reihe α-radikaler 
Phosphine synthetisiert und diese voll charakterisiert. Diese Radikale wurden an Au(I) 
koordiniert und lieferten eine Reihe stabiler Gold-Komplexe, welche bis dato unbekannt 
waren. Wir konnten ferner ein Phosphoroxid-Radikal darstellen.  Die Radikale wurden durch 
EPR-Spektroskopie charakterisiert und die meisten wurden darüber hinaus durch 
Kristallstrukturanalysen bestätigt. Die neuen Verbindungen können als α-radikale Phosphin-
Liganden bezeichnet werden mit potentiellen Anwendungsmöglichkeiten in der Katalyse. 
 
